000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1642|3123|lyfalmen|V1070|1887|00|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1642||1642|3123| 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|4,5000|Vistor hf|Janssen-Cilag AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|44231|57392|lyfsjukr|||00|2|0|24,0000|Icepharma hf|Roche|Epóetín||44231||44231|57392| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|66242|85016|lyfsjukr|||00|2|0|36,0000|Icepharma hf|Roche|Epóetín||66242||66242|85016| 000149|A02BC0102 |Losec|sh-tfl|10|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|3,5000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000153|A02BC0102 |Losec|sh-tfl|20|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|11174|16163|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||11174||11174|16163| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|33246|44003|lyfalmen|||00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||33246||33246|44003| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|43237|56542|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||43237||43237|56542| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|21752|29578|lyfalmen|V0813|29577|00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21752||21752|29578| 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|DKK|9065|13278|lyfalmen|||02|0|0|0,0000|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||9065||9065|13278| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|6371|9195|lyfsjukr|||00|1|0|0,0400|Vistor hf|Ferring|Atosíban||6371||6371|9195| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|8186|15891|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||8186||8186|15891| 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|17520|23870|lyfsjukr|||00|5|0|0,2300|Vistor hf|Ferring|Atosíban||17520||17520|23870| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|21802|29641|lyfalmen|||00|0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||21802||21802|29641| 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5791|8358|lyfsjukr|||00|3000|0|3,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5791||5791|8358| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|43248|56555|lyfalmen|||00|1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||43248||43248|56555| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5742|8732|lyfalmen|||00|6|0|6,0000|Icepharma hf|M.S.D.|Rizatriptan||5742||5742|8732| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||00|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3432|5572|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3432|5572| 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|30123|40083|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||30123||30123|40083| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2110|3764|lyfalmen|||06|5|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||2110||2110|3764| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5598|8535|lyfalmen|||23|2|0|2,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||5598||5598|8535| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4877|7549|lyfalmen|||00|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4877||4877|7549| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5781|8785|lyfalmen|||00|24|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5781||5781|8785| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|16114|22106|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Fitusambönd||16114||16114|22106| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4935|7628|lyfalmen|||00|30|0|60,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||||4935|7628| 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|USD|11899|16816|lyfsjukr|||00|1|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||11899||11899|16816| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4082|6461|lyfalmen|||23|2|0|1,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||4082||4082|6461| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|195510|247248|lyfsjukr|||00|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||195510||195510|247248| 000957|H01AC0101|Genotropin|sts|5|mg|1|hgl|1|pakki|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|31272|41129|lyfsjukr|||02|5|0|7,4963|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||31272||31272|41129| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|6811|9830|lyfsjukr|||02|0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||6811||6811|9830| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1848|3405|lyfalmen|||00|10|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||1848||1848|3405| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12751|18282|lyfalmen|||00|30|0|120,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||12751||12751|18282| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|24400|32901|lyfalmen|||00|100|0|400,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||24400||24400|32901| 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2696|4565|lyfalmen|V0091|3913|43|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2696||2696|4565| 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|0|0|SOP|0|0|0|100|XEU|12664|18172|lyfalmen|||00|98|0|98,0000|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||12664||12664|18172| 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|478289|602135|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||478289||478289|602135| 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|0|0|SOP|0|0|0|100|XEU|5015|7738|lyfalmen|||00|56|0|37,3330|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||5015||5015|7738| 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000|28.02.2010|R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|1216|lyfalmen|||00|28|0|9,3400|Actavis Group hf|Actavis hf|Simvastatín||248||248|1216| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|34977|45779|lyfsjukr|||02|2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||34977||34977|45779| 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000|28.02.2010|R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|868|2065|lyfalmen|||00|98|0|32,6667|Actavis Group hf|Actavis hf|Simvastatín||868||868|2065| 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2147|lyfalmen|||00|28|0|18,6667|Actavis Group hf|Actavis hf|Simvastatín||928||928|2147| 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4571|lyfalmen|||00|28|0|37,3400|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4571| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|7180|10699|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||7180||7180|10699| 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5233|8036|lyfalmen|||10|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||5233||5233|8036| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2085|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2085| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4237|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4237| 001574|C09AA0209|Enalapril Mylan|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2009||R|A||0|0|B|0|PCO|0|0|0|100|SEK|554|1635|lyfalmen|||00|50|1|12,5000|Distica|Distica - óskráð lyf|Enalapríl||554||554|1635| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|28847|38085|lyfsjukr|||00|4104|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||28847||28847|38085| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|14687|20711|lyfalmen|V0011|20710|00|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíð (sykurflétta)||14687||14687|20711| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|39095|50947|lyfsjukr|||00|6160|0|6,1600|Icepharma hf|Fresenius Kabi|Blöndur||39095||39095|50947| 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26529|35176|lyfsjukr|||00|5132|0|5,1300|Icepharma hf|Fresenius Kabi|Blöndur||26529||26529|35176| 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|7451|10754|lyfsjukr|||02|50|0|0,0000|Vistor hf|Octapharma AB|Albúmín||7451||7451|10754| 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|11898|16814|lyfsjukr|||02|100|0|0,0000|Vistor hf|Octapharma AB|Albúmín||11898||11898|16814| 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|2,1600|Vistor hf|Bayer A/S|Acetýlsalicýlsýra|||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1396|2015|lyfsjukr|||02|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1396||1396|2015| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4296|6754|lyfalmen|||06|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíð||4296||4296|6754| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1219|2545|lyfalmen|||00|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1219||1219|2545| 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|82276|105139|lyfsjukr|||00|60|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín, lamívúdín og abacavír||82276||82276|105139| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4103|lyfalmen|V0791|4103|00|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||2358||2358|4103| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18555|lyfalmen|V0795|18555|00|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||12969||12969|18555| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|5204|7996|lyfalmen|||00|45|0|45,0000|Icepharma hf|Bioglan AB|Capsaicin||5204||5204|7996| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|4691|7294|lyfalmen|V0793|7294|00|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||4691||4691|7294| 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9695|14140|lyfalmen|V0456|14014|43|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9695||9695|14140| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4400|6896|lyfalmen|V0084|6895|00|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4400||4400|6896| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11833|lyfalmen|V0794|11833|00|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||8009||8009|11833| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8600|12642|lyfalmen|||0|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8600||8600|12642| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1608|3077|lyfalmen|||00|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1608||1608|3077| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6020|9112|lyfalmen|V0085|8772|00|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6020||6020|9112| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5513|8419|lyfalmen|||00|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5513||5513|8419| 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23036|30793|lyfsjukr|||00|4800|0|4,8000|Icepharma hf|Fresenius Kabi|Blöndur||23036||23036|30793| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7359|10944|lyfalmen|||00|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7359||7359|10944| 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20603|27739|lyfsjukr|||00|3840|0|3,8400|Icepharma hf|Fresenius Kabi|Blöndur||20603||20603|27739| 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33714|44194|lyfsjukr|||00|5760|0|5,7600|Icepharma hf|Fresenius Kabi|Blöndur||33714||33714|44194| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15138|21277|lyfalmen|V0087|21276|00|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||15138||15138|21277| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9601|14011|lyfalmen|||00|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9601||9601|14011| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|3384|5506|lyfalmen|||02|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín aspart||3384||3384|5506| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21457|29208|lyfalmen|V0089|28781|00|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||21457||21457|29208| 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7667|11365|lyfalmen|V0092|11155|00|120|0|120,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||7667||7667|11365| 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4463|6982|lyfalmen|||00|60|0|60,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||4463||4463|6982| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|18526|25529|lyfalmen|||00|98|0|39,2000|Icepharma hf|M.S.D.|Montelúkast||18526||18526|25529| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|117606|149478|lyfsjukr|||00|1|0|2,0000|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||117606||117606|149478| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|59075|76022|lyfsjukr|||00|1|0|1,0000|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||59075||59075|76022| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|33863|44381|lyfsjukr|||00|1|0|0,5000|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||33863||33863|44381| 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3158|5197|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||3158|5197| 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3158|5197|lyfalmen|||00|84|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3158||3158|5197| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1679|3174|lyfalmen|V0984|3174|00|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||1679||1679|3174| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|213333|269615|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||213333||213333|269615| 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|3096|5401|vetorma|||0|10|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||||3096|5401| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1363|2742|lyfalmen|||07|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||1363||1363|2742| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|34603|45309|lyfsjukr|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||34603||34603|45309| 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|75625|97188|lyfalmen|||00|1|0|14,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||75625||75625|97188| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|15311|16435|lyfalmen|V2220|5241|00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||11373||11373|16435| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|11341|16391|lyfalmen|||00|100|0|12,5000|Vistor hf|U.C.B|Levetíracetam||11341||11341|16391| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|300020|378408|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||300020||300020|378408| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|19580|26852|lyfalmen|V1710|26851|00|100|0|25,0000|Vistor hf|U.C.B|Levetíracetam||19580||19580|26852| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|38045|50026|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Levetíracetam||38045||38045|50026| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|10164|14781|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||10164||10164|14781| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|15163|21309|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||15163||15163|21309| 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|20208|27244|lyfsjukr|||00|2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||20208||20208|27244| 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|30104|39663|lyfsjukr|||00|2|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||30104||30104|39663| 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|31351|41228|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||31351||31351|41228| 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1639|lyfalmen|||00|0|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||557||557|1639| 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|46348|60049|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||46348||46348|60049| 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|60722|78089|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||60722||60722|78089| 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|74890|95869|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||74890||74890|95869| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|237494|299937|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||237494||237494|299937| 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9319|13625|lyfalmen|||0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9319||9319|13625| 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|89939|114756|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||89939||89939|114756| 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|8516|12527|lyfalmen|||00|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8516||8516|12527| 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|118588|150710|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||118588||118588|150710| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|DKK|64456|83171|lyfalmen|||00|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||64456||64456|83171| 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|146327|185523|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||146327||146327|185523| 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|218748|276411|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||218748||218748|276411| 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|109423|139208|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||109423||109423|139208| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4477|7002|lyfalmen|||00|28|0|14,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||4477||4477|7002| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3848|6141|lyfalmen|||00|60|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Mísóprostól||3848||3848|6141| 003468|C09AA0208|Enalapril|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.08.2009|28.02.2010|R|A||0|0|B|0|PCO|0|0|0|100|SEK|1161|2465|lyfalmen|||00|100|1|25,0000|Distica|Distica - óskráð lyf|Enalapríl||||1161|2465| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|15027|21138|lyfalmen|||00|98|0|49,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||15027||15027|21138| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|6884|10294|lyfalmen|||00|28|0|28,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||6884||6884|10294| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|22066|29972|lyfalmen|||00|98|0|98,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||22066||22066|29972| 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|951|2178|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||951||951|2178| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1017|2268|lyfalmen|V0931|2268|00|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||1017||1017|2268| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|694|1827|lyfalmen|||67|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||694||694|1827| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|3016|5003|lyfalmen|V0933|5003|00|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||3016||3016|5003| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|102442|130447|lyfsjukr|||00|60|0|7,5000|Vistor hf|Abbott Laboratories A/S|Lopinavír||102442||102442|130447| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2319|4050|lyfalmen|V0608|2282|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2319||2319|4050| 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|36127|47222|lyfsjukr|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||36127||36127|47222| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8629|12681|lyfalmen|||00|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8629||8629|12681| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|100|0|2,0000|Vistor hf|Janssen-Cilag AB|Lóperamíð|||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|0|0|GSK|0|0|0|100|GBP|4256|6699|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4256||4256|6699| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|646|1761|lyfalmen|||00|7|0|3,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||646||646|1761| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1155|2457|lyfalmen|||10|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1155||1155|2457| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|6743|10101|lyfalmen|||00|14|0|7,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||6743||6743|10101| 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|6210|9372|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6210||6210|9372| 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|8644|12702|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8644||8644|12702| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|817|1995|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||817||817|1995| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|6462|9717|lyfalmen|||00|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||6462||6462|9717| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|24256|32324|lyfsjukr|||00|1|0|0,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||24256||24256|32324| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1806|3348|lyfalmen|V1901|3345|00|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1806||1806|3348| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8650|12710|lyfalmen|||0|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8650||8650|12710| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|5050|7785|lyfalmen|||00|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||5050||5050|7785| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4979|9733|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||4979||4979|9733| 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3540|5720|lyfalmen|||00|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3540||3540|5720| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|743|1894|lyfalmen|||00|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||743||743|1894| 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3476|5632|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3476||3476|5632| 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4722|7337|lyfalmen|||00|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4722||4722|7337| 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKA|0|0|0|100|DKK|35809|46823|lyfsjukr|||00|21|0|0,0000|Icepharma hf|Merck KgaA|Tegafur||35809||35809|46823| 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6669|10000|lyfalmen|||00|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6669||6669|10000| 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8876|13019|lyfalmen|||00|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8876||8876|13019| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2057|3691|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2057||2057|3691| 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKA|0|0|0|100|DKK|59681|76782|lyfsjukr|||00|35|0|0,0000|Icepharma hf|Merck KgaA|Tegafur||59681||59681|76782| 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKA|0|0|0|100|DKK|71618|91763|lyfsjukr|||00|42|0|0,0000|Icepharma hf|Merck KgaA|Tegafur||71618||71618|91763| 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKA|0|0|0|100|DKK|47746|61804|lyfsjukr|||00|28|0|0,0000|Icepharma hf|Merck KgaA|Tegafur||47746||47746|61804| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4879|7551|lyfalmen|||00|90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríð||4879||4879|7551| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4374|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4374|31.03.2010 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EMA|0|0|0|100|SEK|44340|57529|lyfsjukr|||00|1|0|4,0000|Icepharma hf|E. Merck AB|Sómatrópín||44340||44340|57529| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|2095|3743|lyfalmen|||20|25|0|25,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||2095||2095|3743| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2666|4524|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2666||2666|4524| 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5192|7980|lyfalmen|||51|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5192||5192|7980| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|3389|lyfalmen|V0927|3389|00|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1836||1836|3389| 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5188|7974|lyfalmen|V0929|7974|00|56|0|112,0000|Actavis Group hf|Actavis hf|Cítalópram||5188||5188|7974| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|8557|lyfalmen|V0930|8557|00|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||5614||5614|8557| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1939|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|1939|31.03.2010 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4575|lyfalmen|V0922|4575|00|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4575| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|926|2144|lyfalmen|V0923|2144|00|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||926||926|2144| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1731| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|46594|60358|lyfsjukr|||00|5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||46594||46594|60358| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3309|lyfalmen|V0925|3309|00|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3309| 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|179382|227007|lyfsjukr|||00|19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||179382||179382|227007| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EMA|0|0|0|100|SEK|221701|280117|lyfsjukr|||00|5|0|20,0000|Icepharma hf|E. Merck AB|Sómatrópín||221701||221701|280117| 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|11395|16465|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11395||11395|16465| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9597|7929|lyfalmen|V0714|7584|0|100|0|16,6667|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5155||5155|7929| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12572|10524|lyfalmen|V0715|10458|10|100|0|22,2222|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||7052||7052|10524| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|708|1846|lyfalmen|||41|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||708||708|1846| 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|75112|96148|lyfsjukr|||00|2|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||75112||75112|96148| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5905|8522|lyfsjukr|||00|1|0|1,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||5905||5905|8522| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|419|1450|lyfalmen|||41|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||419||419|1450| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|715|1855|lyfalmen|||41|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||715||715|1855| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1353|2728|lyfalmen|||41|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1353||1353|2728| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1795|3333|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1795||1795|3333| 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2524|4330|lyfalmen|||00|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2524|4330| 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|9555|7530|lyfalmen|V0437|5363|00|90|0|90,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4863||4863|7530| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1909|lyfalmen|||10|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||754||754|1909| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1921|lyfalmen|||10|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||763||763|1921| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2349|lyfalmen|||10|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1076||1076|2349| 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|27957|37365|lyfalmen|||00|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27957||27957|37365| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|50639|65831|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||50639||50639|65831| 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3340|5446|lyfalmen|||00|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3340||3340|5446| 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Napp|Joð/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1227|2556|lyfalmen|||00|2|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1227||1227|2556| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|69823|89907|lyfalmen|||00|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||69823||69823|89907| 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|45638|59555|lyfalmen|||00|2|0|0,0000|Icepharma hf|PhotoCure ASA|Metýlamínólevúlínat||45638||45638|59555| 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1620|3093|lyfalmen|||24|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1620||1620|3093| 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|32209|19578|lyfalmen|||00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13784||13784|19578| 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|5778|8781|lyfalmen|||00|4|0|28,0000|Icepharma hf|M.S.D.|Alendrónsýra||5778||5778|8781| 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|40964|53689|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||40964||40964|53689| 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1226|2554|lyfalmen|V2200|2522|23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1226||1226|2554| 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|14337|6634|lyfalmen|V0718|6054|00|12|0|84,0000|Icepharma hf|M.S.D.|Alendrónsýra||4208||4208|6634| 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6822|10209|lyfalmen|||00|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||6822||6822|10209| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|7189|10711|lyfalmen|||0|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||||7189|10711| 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4318|6784|lyfalmen|||00|0|0|0,0000|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4318||4318|6784| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1741|3259|lyfalmen|||00|30|0|5,6300|Icepharma hf|Servier|Glíklazíð||1741||1741|3259| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|3035|4552|lyfalmen|||00|60|0|11,2500|Icepharma hf|Servier|Glíklazíð||2686||2686|4552| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|8059|11902|lyfalmen|||00|180|0|33,7500|Icepharma hf|Servier|Glíklazíð||8059||8059|11902| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4429|6936|lyfalmen|||00|90|0|16,8800|Icepharma hf|Servier|Glíklazíð||4429||4429|6936| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6704|10048|lyfalmen|||00|180|0|90,0000|Icepharma hf|Servier|Estradíól||6704||6704|10048| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|1948|3542|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1948||1948|3542| 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEU|0|0|0|100|SEK|5290|7635|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Serono Europe Ltd|Cetrorelix||5290||5290|7635| 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|80788|103271|lyfsjukr|||00|15|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||80788||80788|103271| 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEU|0|0|0|100|SEK|41473|53931|lyfsjukr|||00|7|0|0,0000|Icepharma hf|Serono Europe Ltd|Cetrorelix||41473||41473|53931| 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEU|0|0|0|100|SEK|41473|53931|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Serono Europe Ltd|Cetrorelix||41473||41473|53931| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7243|10785|lyfalmen|V0940|9556|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7243||7243|10785| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|3434|5575|lyfalmen|V0939|4660|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3434||3434|5575| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|18006|31411|vetorma|||16|5|0|0,0000|Vistor hf|Merial (MSD)|||18006||18006|31411| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6996|10447|lyfalmen|||00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6996||6996|10447| 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|90073|114924|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||90073||90073|114924| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|11517|16632|lyfalmen|V0938|14425|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11517||11517|16632| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|5516|8423|lyfalmen|V0941|7624|00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5516||5516|8423| 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3425|5562|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||3425||3425|5562| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3251|5324|lyfalmen|||59|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3251||3251|5324| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|962|2193|lyfalmen|||00|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||962||962|2193| 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|11207|16208|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||11207||11207|16208| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|17831|24657|lyfalmen|V0942|24657|00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||17831||17831|24657| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4010|6363|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4010||4010|6363| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7046|10516|lyfalmen|V0943|8960|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7046||7046|10516| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|10291|13431|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||9177||9177|13431| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|13806|19606|lyfalmen|||00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13806||13806|19606| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|5113|7872|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||5113||5113|7872| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|13987|18944|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||13279||13279|18944| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|92842|118399|lyfsjukr|||00|2|0|0,7500|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||92842||92842|118399| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6301|9497|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||6301||6301|9497| 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|134812|171072|lyfsjukr|||00|1|0|1,4000|Icepharma hf|M.S.D.|Caspofungin||134812||134812|171072| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|6112|9238|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||6112||6112|9238| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|165716|209856|lyfsjukr|||00|3|0|1,5000|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||165716||165716|209856| 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|86698|110688|lyfsjukr|||00|1|0|1,0000|Icepharma hf|M.S.D.|Caspofungin||86698||86698|110688| 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1434|2839|lyfalmen|||00|4|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||1434||1434|2839| 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10101|14695|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10101||10101|14695| 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BAV|0|0|0|100|SEK|44261|57430|lyfsjukr|||00|1200|0|4,8000|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||44261||44261|57430| 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BAV|0|0|0|100|SEK|76099|97387|lyfsjukr|||00|2400|0|9,6000|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||76099||76099|97387| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|A||0|0|0|0|REP|0|0|1|100|SEK|2846|4770|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2846||2846|4770| 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2855|4783|lyfalmen|||43|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2855||2855|4783| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9608|18621|vetalmen|||00|50|0|0,0000|Vistor hf|Boehringer Ingelheim|||9608||9608|18621| 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7953|11757|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7953||7953|11757| 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|13484|19202|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13484||13484|19202| 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|38200|50220|lyfalmen|||02|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||38200||38200|50220| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|1,6700|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0,0000|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|16924|23519|lyfalmen|||10|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||16924||16924|23519| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|15927|22267|lyfalmen|||00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan||15927||15927|22267| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4524|7066|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4524||4524|7066| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|828|2010|lyfalmen|||00|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||828||828|2010| 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|30573|40648|lyfalmen|V1200|40648|00|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||30573||30573|40648| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|26375|50817|vetalmen|||27|20|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||26375||26375|50817| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14391|20340|lyfalmen|V2208|20340|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14391||14391|20340| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2159|3831|lyfalmen|||00|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2159||2159|3831| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6778|10149|lyfalmen|||00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6778||6778|10149| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21566|29344|lyfalmen|V0341|29344|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21566||21566|29344| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|6985|10432|lyfalmen|||00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||6985||6985|10432| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8998|13186|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8998||8998|13186| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|27819|37192|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||27819||27819|37192| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|179450|227092|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||179450||179450|227092| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|316992|399707|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||316992||316992|399707| 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2298|4021|lyfalmen|||10|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2298||2298|4021| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|3168|5211|lyfalmen|||00|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3168||3168|5211| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|162864|206277|lyfsjukr|||00|1|0|20,0000|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||162864||162864|206277| 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|250649|316447|lyfsjukr|||00|1|0|40,0000|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||250649||250649|316447| 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|217914|275365|lyfsjukr|||00|1|0|30,0000|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||217914||217914|275365| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|142194|180336|lyfsjukr|||00|3000|0|5,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||142194||142194|180336| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|344822|434634|lyfsjukr|||00|30|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||344822||344822|434634| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3520|5692|lyfalmen|V0988|5691|06|2|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tímólól í blöndum||3520||3520|5692| 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|8533|12315|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Clintec parenteral SA|||8533||8533|12315| 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|131458|166862|lyfsjukr|||00|100|0|0,0000|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||131458||131458|166862| 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|26536|35185|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Sevóflúran||26536||26536|35185| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|0|DKK|||vetorma|||16|7|0|0,0000|Vistor hf|Bayer Animal Health GmbH||||||3742| 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6807|10189|lyfalmen|||00|30|0|10,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||6807||6807|10189| 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|5403|8268|lyfalmen|||00|60|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5403||5403|8268| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3611|5817|lyfalmen|V2215|5817|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3611||3611|5817| 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|5403|8268|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5403||5403|8268| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|9916|14311|lyfsjukr|||00|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||9916||9916|14311| 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|23414|31664|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||23414||23414|31664| 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|10530|15282|lyfalmen|||00|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||10530||10530|15282| 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11490|16595|lyfalmen|V2216|16595|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||11490||11490|16595| 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2757|3979|lyfsjukr|||02|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2757||2757|3979| 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2751|4640|lyfalmen|V2211|4640|00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2751||2751|4640| 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7827|11584|lyfalmen|||00|30|0|21,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||7827||7827|11584| 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|23725|32054|lyfalmen|||00|100|0|70,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||23725||23725|32054| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3241|lyfalmen|V1075|3241|00|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3241| 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4361|6843|lyfalmen|||00|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||4361||4361|6843| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0,0000|Icepharma hf|Baxter|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 007920|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2430|4201|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|||2430||2430|4201| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1372|2754|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Ólópatadín||1372||1372|2754| 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|173481|219601|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjað)||173481||173481|219601| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|24230|32291|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|Nituroxíð||24230||24230|32291| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1874|lyfalmen|||00|30|1|10,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1874| 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|43712|56741|lyfsjukr|||00|1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjað)||43712||43712|56741| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|608|1709|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||608||608|1709| 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3861|6159|lyfalmen|||00|1|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3861||3861|6159| 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29037|38324|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||29037||29037|38324| 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|36298|47436|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||36298||36298|47436| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5989|9070|lyfalmen|||00|6|0|3,0000|Icepharma hf|M.S.D.|Rizatriptan||5989||5989|9070| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|100790|128374|lyfsjukr|||00|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||100790||100790|128374| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|202629|256182|lyfsjukr|||00|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||202629||202629|256182| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|146938|186290|lyfsjukr|||00|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||146938||146938|186290| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|167384|211949|lyfsjukr|||00|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||167384||167384|211949| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|252491|318759|lyfsjukr|||00|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||252491||252491|318759| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2213|3905|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||2213||2213|3905| 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|291|1275|lyfalmen|||20|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||291||291|1275| 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|38240|49874|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||38240||38240|49874| 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29859|39356|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||29859||29859|39356| 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|477|1530|lyfalmen|||33|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||477||477|1530| 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|37420|48845|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||37420||37420|48845| 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8479|12476|lyfalmen|V2212|12476|00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8479||8479|12476| 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1281|2630|lyfalmen|V0733|2630|00|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||1281||1281|2630| 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2955|4920|lyfalmen|V2213|4920|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2955||2955|4920| 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1258|2598|lyfalmen|||33|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1258||1258|2598| 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9403|13740|lyfalmen|V2214|13740|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9403||9403|13740| 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4013|6367|lyfalmen|V0734|6367|00|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||4013||4013|6367| 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|6159|9302|lyfalmen|V0736|9302|00|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||6159||6159|9302| 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|9325|13633|lyfalmen|V0738|13633|00|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||9325||9325|13633| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|225314|284652|lyfsjukr|||02|2|0|0,0000|Vistor hf|Genzyme BV|Thýrótrópín||225314||225314|284652| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|XEU|824|2004|lyfalmen|V0431|2004|00|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||824||824|2004| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|XEU|716|1857|lyfalmen|V0430|1857|00|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||716||716|1857| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5290|9228|vetorma|||00|1000|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||5290||5290|9228| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|11879|22982|vetalmen|||00|50|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||11879||11879|22982| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|||lyfalmen|||00|100|0|100,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3149|5185|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3149||3149|5185| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|143220|181624|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||143220||143220|181624| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|141246|179146|lyfsjukr|||00|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||141246||141246|179146| 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2710|4727|vetorma|||00|500|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||2710||2710|4727| 008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3354|5465|lyfalmen|||00|15|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3354||3354|5465| 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3611|5817|lyfalmen|V2222|5817|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3611||3611|5817| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2493|4288|lyfalmen|||20|60|0|60,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2493||2493|4288| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6584|9884|lyfalmen|V1350|9882|00|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6584|9884| 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|DKK|1236|2393|lyfalmen|||02|5|1|13,3333|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||1108||1108|2393| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12970|18556|lyfalmen|V1351|18555|00|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12970|18556| 009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5658|8617|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5658||5658|8617| 009079|D11AH0201|Elidel|krem|1|%|100|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|17563|24321|lyfalmen|||00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||17563||17563|24321| 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|8006|11829|lyfalmen|||03|5|0|5,0000|Vistor hf|Pfizer Limited|Parekoxíb||8006||8006|11829| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|15197|21351|lyfalmen|||03|10|0|10,0000|Vistor hf|Pfizer Limited|Parekoxíb||15197||15197|21351| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|66406|85222|lyfsjukr|||00|30|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||66406||66406|85222| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||1784| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6045|9147|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||6045||6045|9147| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1484|2907|lyfalmen|||23|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1484||1484|2907| 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1595|3059|lyfalmen|||23|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1595||1595|3059| 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1879|3448|lyfalmen|||23|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1879||1879|3448| 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2162|3835|lyfalmen|||23|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||2162||2162|3835| 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981|28.02.2010|L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||04|10|0|1,6667|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8181|11807|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||8181||8181|11807| 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8181|11807|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||8181||8181|11807| 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8181|11807|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||8181||8181|11807| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|257910|325560|lyfsjukr|||00|30|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||257910||257910|325560| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6200|9359|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||6200||6200|9359| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|76624|98046|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||76624||76624|98046| 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11488|16592|lyfalmen|V2223|16592|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||11488||11488|16592| 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|45019|58381|lyfsjukr|||00|1|0|20,0000|Icepharma hf|Roche|Epóetín||45019||45019|58381| 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|916|2130|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||916||916|2130| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7162|10675|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||7162||7162|10675| 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7030|10494|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|||7030||7030|10494| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8200|12094|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|||8200||8200|12094| 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|598|1695|lyfalmen|||00|6|0|3,0000|Vistor hf|N.V. Organon|Mirtazapín||598||598|1695| 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7586|11255|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|||7586||7586|11255| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8362|12316|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|||8362||8362|12316| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6433|9677|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||6433||6433|9677| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2540|4352|lyfalmen|V1151|2527|00|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2540||2540|4352| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|4507|7043|lyfalmen|V1152|4500|00|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4507||4507|7043| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|9626|14045|lyfalmen|||00|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||9626||9626|14045| 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|185487|234669|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||185487||185487|234669| 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|5416|8286|lyfalmen|||00|1|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||5416||5416|8286| 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1312|2672|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||1312||1312|2672| 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|55647|72116|lyfalmen|||00|10|0|10,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||55647||55647|72116| 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|33390|44184|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||33390||33390|44184| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|264496|333825|lyfsjukr|||00|60|0|30,0000|Icepharma hf|Roche Registration Limited|Valgancíklóvír||264496||264496|333825| 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|457202|575671|lyfsjukr|||00|30|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||457202||457202|575671| 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|176697|223637|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||176697||176697|223637| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|7900|11402|lyfsjukr|||00|1|0|0,0000|Icepharma hf|M.S.D.|Ertapenem||7900||7900|11402| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|13990|19837|lyfalmen|V1153|7226|00|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||13990||13990|19837| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|19726|27035|lyfalmen|||00|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||19726||19726|27035| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|25277|34002|lyfalmen|||00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||25277||25277|34002| 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|4233|6668|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||4233||4233|6668| 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|9737|14197|lyfalmen|||51|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||9737||9737|14197| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|13675|19441|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||13675||13675|19441| 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|80694|155117|vetalmen|||00|1000|0|0,0000|Icepharma hf|Pfizer A/S (Í)|||80694||80694|155117| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|7575|11239|lyfalmen|||00|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7575||7575|11239| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|14583|20184|lyfsjukr|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||14583||14583|20184| 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9107|13144|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Amínósýrur||9107||9107|13144| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1294|2647|lyfalmen|||00|5|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||1294||1294|2647| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|5813|8829|lyfalmen|||00|4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|||5813||5813|8829| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7726|11151|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Kolvetni||7726||7726|11151| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|14168|19663|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Kolvetni||14168||14168|19663| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5392|7782|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||5392||5392|7782| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3090|4460|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||3090||3090|4460| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8811|12930|lyfalmen|||00|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8811||8811|12930| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|14168|19663|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||14168||14168|19663| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7777|11224|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Elektrólýtar||7777||7777|11224| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5184|7482|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||5184||5184|7482| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|15074|8713|lyfalmen|||00|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|||5728||5728|8713| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2878|4154|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2878||2878|4154| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|DKK|455746|573844|lyfsjukr|||00|56|0|14,0000|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||455746||455746|573844| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|DKK|426678|537363|lyfsjukr|||00|56|0|28,0000|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||426678||426678|537363| 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|683313|859440|lyfsjukr|||00|30|0|45,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||683313||683313|859440| 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|909417|1143201|lyfsjukr|||00|30|0|60,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||909417||909417|1143201| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2724|lyfalmen|||10|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||1350||1350|2724| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4936|7629|lyfalmen|V2171|7218|10|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||4936||4936|7629| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3182|4323|lyfalmen|V2170|4323|10|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4323| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|68976|88447|lyfsjukr|||03|10|0|0,0000|Icepharma hf|Baxter Medical AB|Bleómýcín||68976||68976|88447| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|3234|4667|lyfsjukr|||03|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3234||3234|4667| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|3237|5305|lyfalmen|||00|28|0|14,0000|Icepharma hf|Wyeth AB|Lansóprazól||3237||3237|5305| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|22073|29981|lyfalmen|||00|28|0|18,6700|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22073||22073|29981| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|21816|29658|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21816||21816|29658| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|50|0|16,6667|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|37583|49446|lyfalmen|V1702|49444|00|56|0|37,3300|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37583||37583|49446| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|37327|49124|lyfalmen|V1703|49124|00|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37327||37327|49124| 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|20717|28279|lyfalmen|||00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníð||20717||20717|28279| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|4920|7608|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Etoríkoxíb||4920||4920|7608| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5112|7870|lyfalmen|||00|28|0|42,0000|Icepharma hf|M.S.D.|Etoríkoxíb||5112||5112|7870| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|22181|30116|lyfalmen|V2172|27552|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||22181||22181|30116| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|XEU|1305|2662|lyfalmen|||00|7|0|14,0000|Icepharma hf|M.S.D.|Etoríkoxíb||1305||1305|2662| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|992|2234|lyfalmen|V0195|2234|00|28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||992||992|2234| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|13435|19140|lyfalmen|||02|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||13435||13435|19140| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1427|2829|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1427||1427|2829| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|3872|lyfalmen|V0197|3872|00|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||2189||2189|3872| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9293|13590|lyfalmen|||00|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9293||9293|13590| 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7682|11386|lyfalmen|||00|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7682||7682|11386| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|9025|13025|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Baxter Medical AB|Mannitól||9025||9025|13025| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2638|3807|lyfsjukr|||00|50|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||2638||2638|3807| 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002|28.02.2010|R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6688|10026|lyfalmen|||00|28|0|56,0000|Icepharma hf|M.S.D.|Etoríkoxíb||6688||6688|10026| 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|10036|14606|lyfalmen|||00|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||10036||10036|14606| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1705|3392|vetalmen|||00|25|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||1705||1705|3392| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|5275|7613|lyfsjukr|||00|20|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||5275||5275|7613| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1588|3050|lyfalmen|||00|64|0|28,8000|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1588||1588|3050| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|109019|138701|lyfsjukr|||00|168|0|33,6000|Icepharma hf|Roche Registration Limited|Ribavirin||109019||109019|138701| 011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|11257|16276|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||11257||11257|16276| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1773|3303|lyfalmen|V0935|3303|00|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||1773||1773|3303| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5098|7851|lyfalmen|V0937|7851|00|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||5098||5098|7851| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4742|6844|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4742||4742|6844| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4307|6216|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4307||4307|6216| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8732|12822|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8732|12822| 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4882|7556|lyfalmen|||00|28|0|37,3400|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||4882||4882|7556| 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|16804|23368|lyfalmen|||00|98|0|130,6667|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||16804||16804|23368| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|46778|60589|lyfsjukr|||00|30|0|30,0000|Icepharma hf|M.S.D.|Efavirenz||46778||46778|60589| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11615|16766|lyfalmen|||00|90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||11615||11615|16766| 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1500|2929|lyfalmen|||00|20|0|35,7143|Vistor hf|Meda AB|Azelastínum||1500||1500|2929| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6561|9852|lyfalmen|||00|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6561||6561|9852| 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5986|10442|vetorma|||00|20|0|0,0000|Icepharma hf|Icepharma hf|||5986||5986|10442| 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|969|2203|lyfalmen|||00|30|0|15,0000|Vistor hf|Aventis Pharma |Glímepíríð||969||969|2203| 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|11894|17148|lyfalmen|||00|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||11894||11894|17148| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|28132|49075|vetorma|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||28132||28132|49075| 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|DKK|488795|615320|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Díbótermín alfa||488795||488795|615320| 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1859|lyfalmen|||08|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1859| 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4761|7390|lyfalmen|||00|9|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4761||4761|7390| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|7362|10948|lyfalmen|||00|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||7362||7362|10948| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6743|10101|lyfalmen|||00|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6743||6743|10101| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7394|14370|vetalmen|||00|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7394||7394|14370| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|10181|14804|lyfalmen|||00|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||10181||10181|14804| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1917|3813|vetalmen|||00|20|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||1917||1917|3813| 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|1236|2568|lyfalmen|||00|14|0|7,0000|Icepharma hf|Wyeth AB|Lansóprazól||1236||1236|2568| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|24230|32291|lyfsjukr|||00|2|0|0,0000|Ísaga ehf|AGA AB|Nituroxíð||24230||24230|32291| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|10546|15118|lyfsjukr|||17|2|0|0,0000|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||10546||10546|15118| 013259|B02BD0901|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|32312|42434|lyfsjukr|||00|250|0|0,8300|Icepharma hf|Wyeth Europe|Storkuþáttur IX||32312||32312|42434| 013270|B02BD0901|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|64628|82991|lyfsjukr|||00|500|0|1,4300|Icepharma hf|Wyeth Europe|Storkuþáttur IX||64628||64628|82991| 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|A||0|0|E|0|ANO|0|0|0|100|XEU|3682|5335|lyfalmen|V2120|5335|00|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||3259||3259|5335| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4856|9497|vetalmen|||00|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||4856||4856|9497| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|11672|22585|vetalmen|||00|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||11672||11672|22585| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1224|2435|vetalmen|||00|20|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||1224||1224|2435| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|216345|273395|lyfsjukr|||00|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||216345||216345|273395| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|A||0|1|0|1|AZD|0|0|0|100|SEK|479201|603280|lyfsjukr|||00|30|0||Vistor hf|AstraZeneca A/S DK|||479201||479201|603280| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|36057|47134|lyfsjukr|||00|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||36057||36057|47134| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|144229|182890|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||144229||144229|182890| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|70237|90030|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||70237||70237|90030| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|5914|8967|lyfalmen|||00|28|0||Icepharma hf|M.S.D.|Ezetimíb||5914||5914|8967| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|20536|28052|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb||20536||20536|28052| 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|185375|234528|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||185375||185375|234528| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1332|2699|lyfalmen|||00|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||||1332|2699| 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0,0000|Actavis Group hf|Actavis Group hf|Blöndur|||||1408| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2559|4378|lyfalmen|||00|5|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||||2559|4378| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1494|2921|lyfalmen|||00|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1494||1494|2921| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|406|1433|lyfalmen|||00|30|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||406||406|1433| 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|46424|60145|lyfsjukr|||00|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|||46424||46424|60145| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|5133|7899|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5133||5133|7899| 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|15507|21740|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||15507||15507|21740| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|1055|2320|lyfalmen|||00|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||1055|2320| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2539|lyfalmen|V0465|2539|00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2539| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7602|11276|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||7602||7602|11276| 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5905|8955|lyfalmen|||51|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||5905||5905|8955| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2893|4835|lyfalmen|||51|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2893||2893|4835| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5067|7809|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||5067||5067|7809| 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|226815|286535|lyfsjukr|||00|60|0|0,0000|Vistor hf|Novartis Europharm Ltd|Imatiníb||226815||226815|286535| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|394301|496730|lyfsjukr|||00|30|0|0,0000|Vistor hf|Novartis Europharm Ltd|Imatiníb||394301||394301|496730| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2868|4801|lyfalmen|||71|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2868||2868|4801| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|17244|23524|lyfsjukr|||00|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||17244||17244|23524| 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|25642|34460|lyfalmen|||00|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||25642||25642|34460| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|62514|80734|lyfalmen|||AC|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||62514||62514|80734| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|39292|51194|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||39292||39292|51194| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|0|0|AZD|0|0|0|100|SEK|27878|37266|lyfalmen|||00|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||27878|37266| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1522|2959|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1522||1522|2959| 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24204|32259|lyfsjukr|||00|3940|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||24204||24204|32259| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||29|4|0|0,0000|Vistor hf|Janssen-Cilag AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26588|35250|lyfsjukr|||00|3944|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||26588||26588|35250| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34672|45396|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||34672||34672|45396| 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24204|32259|lyfsjukr|||00|3940|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||24204||24204|32259| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|flaska||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|4043|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Metrónídazól||||2314|4043| 014435|QM01AE03  |Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2504|4981|vetalmen|||00|45|0|0,0000|Dýraheilsa ehf|Vetcare Ltd.|||||2504|4981| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|18313|25262|lyfalmen|||23|1|0|1825,0000|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||18313||18313|25262| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|90452|115400|lyfsjukr|||0|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|||||90452|115400| 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|6224|12124|vetalmen|||16|24|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6224||6224|12124| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|309316|390074|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíð||309316||309316|390074| 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2636|4483|lyfalmen|||10|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2636||2636|4483| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|1359|2736|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||||1359|2736| 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5140|7909|lyfalmen|V2217|7909|00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5140||5140|7909| 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|16141|22536|lyfalmen|V2218|22536|00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||16141||16141|22536| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|74088|94863|lyfsjukr|||00|2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||74088||74088|94863| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|115924|147367|lyfsjukr|||00|2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||115924||115924|147367| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|A||0|0|E|0|MYL|0|0|0|100|SEK|874|2073|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||||874|2073| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|21108|28770|lyfalmen|||00|60|0|10,0000|Icepharma hf|Novartis Healthcare A/S|Everolímus||21108||21108|28770| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|63695|82216|lyfalmen|||00|60|0|30,0000|Icepharma hf|Novartis Healthcare A/S|Everolímus||63695||63695|82216| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|42398|55489|lyfalmen|||00|60|0|20,0000|Icepharma hf|Novartis Healthcare A/S|Everolímus||42398||42398|55489| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|764|1922|lyfalmen|||00|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||764||764|1922| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7561|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||4886||4886|7561| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|9405|13743|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||9405||9405|13743| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|1920|3504|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1920||1920|3504| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4653|lyfalmen|||00|100|1|33,3333|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4653| 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1192|2508|lyfalmen|||23|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1192||1192|2508| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3500|lyfalmen|V0832|3500|00|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3500| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4623|lyfalmen|V0831|4623|00|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4623| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|11580|16718|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||11580||11580|16718| 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|377977|476244|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||377977||377977|476244| 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|100464|127965|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||100464||100464|127965| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6703|10047|lyfalmen|||00|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6703||6703|10047| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14771|20817|lyfalmen|V1732|20815|00|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14771||14771|20817| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6703|10047|lyfalmen|||00|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6703||6703|10047| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15968|22319|lyfalmen|V1731|22318|00|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15968||15968|22319| 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|39847|52287|lyfalmen|||00|1000|0|1000,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||39847||39847|52287| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|87440|111620|lyfsjukr|||43|60|0|0,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||87440||87440|111620| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|87440|111620|lyfsjukr|||43|60|0|0,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||87440||87440|111620| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|81485|104146|lyfsjukr|||43|60|0|0,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||81485||81485|104146| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6703|10047|lyfalmen|||00|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6703||6703|10047| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14616|20622|lyfalmen|V1730|20621|00|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14616||14616|20622| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|87440|111620|lyfsjukr|||43|60|0|0,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||87440||87440|111620| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|24711|33291|lyfalmen|||00|120|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||24711||24711|33291| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|52805|68549|lyfalmen|||00|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||52805||52805|68549| 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1024|2278|lyfalmen|||06|15|0|0,0000|K.Pétursson hf|Alcon|Cýklópentólat||1024||1024|2278| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3485|6079|vetorma|||16|2|0|0,0000|Vistor hf|Bayer HealthCare AG|||3485||3485|6079| 015833|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009|28.02.2010|R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|4543|6557|lyfsjukr|||00|750|0|0,2500|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||4543|6557| 015844|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009|28.02.2010|R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|8691|12543|lyfsjukr|||00|1500|0|0,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||8691|12543| 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4898|8544|vetorma|||16|12|0|0,0000|Vistor hf|Bayer HealthCare AG|||4898||4898|8544| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3109|5423|vetorma|||16|1|0|0,0000|Vistor hf|Bayer HealthCare AG|||3109||3109|5423| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3899|6802|vetorma|||16|3|0|0,0000|Vistor hf|Bayer HealthCare AG|||3899||3899|6802| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4968|7673|lyfalmen|||10|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4968||4968|7673| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4368|7620|vetorma|||16|8|0|0,0000|Vistor hf|Bayer HealthCare AG|||4368||4368|7620| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2194|3879|lyfalmen|||0|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||||2194|3879| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2464|4248|lyfalmen|||00|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||2464||2464|4248| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1584|3044|lyfalmen|||02|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1584||1584|3044| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3485|6079|vetorma|||16|1|0|0,0000|Vistor hf|Bayer HealthCare AG|||3485||3485|6079| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|100|GBP|1523|2961|lyfalmen|||00|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1523||1523|2961| 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|16943|23543|lyfalmen|||00|90|0|180,0000|Icepharma hf|Servier|Perindópríl||16943||16943|23543| 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|5860|8893|lyfalmen|||00|6|0|6,0000|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||5860||5860|8893| 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|5699|8673|lyfalmen|||00|30|0|60,0000|Icepharma hf|Servier|Perindópríl||5699||5699|8673| 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|8296|12226|lyfalmen|||00|9|0|9,0000|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||8296||8296|12226| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14722|20755|lyfalmen|V2208|20755|00|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14722||14722|20755| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1177|2487|lyfalmen|||02|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1177||1177|2487| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|22044|29944|lyfalmen|V0341|29943|00|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22044||22044|29944| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1247|2583|lyfalmen|||02|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1247||1247|2583| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|3025|5015|lyfalmen|||00|3|0|3,0000|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||3025||3025|5015| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen|||||| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8201|12096|lyfalmen|||00|112|0|56,0000|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||8201||8201|12096| 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|8790|12902|lyfalmen|||00|28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||8790||8790|12902| 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4588|7153|lyfalmen|||00|112|0|56,0000|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||4588||4588|7153| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3595|5795|lyfalmen|||00|14|0|7,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3595||3595|5795| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7320|10891|lyfalmen|||00|56|0|14,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7320||7320|10891| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEU|0|0|0|100|SEK|5466|8354|lyfalmen|||00|0|0|1,0000|Icepharma hf|Serono Europe Ltd|Chóríógónadótrópín alfa||5466||5466|8354| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11100|16061|lyfalmen|||00|56|0|28,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11100||11100|16061| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2415|4181|lyfalmen|||00|14|0|3,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2415||2415|4181| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16126|22517|lyfalmen|V0103|22516|00|56|0|56,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16126||16126|22517| 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|12209|17601|lyfalmen|||10|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||12209||12209|17601| 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4951|7650|lyfalmen|||00|28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||4951||4951|7650| 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000|31.01.2010|R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|5363|7740|lyfsjukr|||00|25|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||5363||5363|7740| 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6422|9269|lyfsjukr|||00|10|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||6422||6422|9269| 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995|31.01.2010|R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|19718|26629|lyfsjukr|||00|20|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||19718||19718|26629| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|153774|194869|lyfsjukr|||00|70|0|7,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||153774||153774|194869| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|9327|13461|lyfsjukr|||00|10|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||9327||9327|13461| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2861|4791|lyfalmen|||00|56|0|4,6667|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2861||2861|4791| 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|8623|12445|lyfsjukr|||00|20|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||8623||8623|12445| 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|29234|38571|lyfsjukr|||00|25|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||29234||29234|38571| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004|31.01.2010|L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|245501|309986|lyfsjukr|||00|225|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||245501||245501|309986| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|86100|109938|lyfsjukr|||00|75|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||86100||86100|109938| 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|19239|26424|lyfalmen|V1701|26424|00|28|0|6,2000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19239||19239|26424| 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7636| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|37583|49446|lyfalmen|V0106|49444|00|56|0|12,4000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37583||37583|49446| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2266|lyfalmen|V0466|2266|00|12|0|12,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2266| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|262810|331709|lyfsjukr|||00|2|0|180,0000|Icepharma hf|Roche|Epóetín||262810||262810|331709| 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|229756|290226|lyfsjukr|||00|6|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||229756||229756|290226| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8577|12610|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8577||8577|12610| 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|76586|97998|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||76586||76586|97998| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3357|5469|lyfalmen|V0789|5469|10|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3357||3357|5469| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|6197|9354|lyfalmen|V0713|9354|10|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||6197||6197|9354| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|70579|90856|lyfalmen|||00|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||70579||70579|90856| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|104326|133208|lyfalmen|||00|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||104326||104326|133208| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|33950|44886|lyfalmen|||00|28|0|0,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||33950||33950|44886| 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|62441|80643|lyfalmen|||00|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||62441||62441|80643| 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|23884|32254|lyfalmen|||00|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||23884||23884|32254| 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|35823|47237|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||35823||35823|47237| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|2292|4013|lyfalmen|||00|14|0|14,0000|Icepharma hf|Wyeth AB|Lansóprazól||2292||2292|4013| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|A||0|0|0|0|WAB|0|0|0|100|DKK|3896|6207|lyfalmen|||00|56|0|28,0000|Icepharma hf|Wyeth AB|Lansóprazól||||3896|6207| 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|4448|6962|lyfalmen|||00|28|0|28,0000|Icepharma hf|Wyeth AB|Lansóprazól||4448||4448|6962| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|8661|12725|lyfalmen|||00|98|0|49,0000|Icepharma hf|Wyeth AB|Lansóprazól||8661||8661|12725| 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|6988|10436|lyfalmen|||00|56|0|56,0000|Icepharma hf|Wyeth AB|Lansóprazól||6988||6988|10436| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|44087|57212|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||44087||44087|57212| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|15288|21466|lyfalmen|||00|98|0|98,0000|Icepharma hf|Wyeth AB|Lansóprazól||15288||15288|21466| 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3790|6062|lyfalmen|||00|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3790||3790|6062| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|20619|39764|vetalmen|||16|60|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||20619||20619|39764| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35676|46656|lyfsjukr|||00|4824|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||35676||35676|46656| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1679|3174|lyfalmen|||03|3|0|21,4286|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Medroxýprógesterón||1679||1679|3174| 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1697|3199|lyfalmen|||10|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1697||1697|3199| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|316013|398479|lyfsjukr|||00|5|0|0,0000|Icepharma hf|SkyPharma PLC|Cýtarabín||316013||316013|398479| 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7607|11283|lyfalmen|||10|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7607||7607|11283| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|192176|243063|lyfsjukr|||00|1|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||192176||192176|243063| 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|49822|64409|lyfsjukr|||00|6|0|1,0000|Icepharma hf|Roche|||49822||49822|64409| 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36874|48159|lyfsjukr|||00|5712|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||36874||36874|48159| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1498|2926|lyfalmen|V0221|2926|00|100|0|33,3333|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1498||1498|2926| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|150097|190254|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||150097||150097|190254| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|55601|72058|lyfalmen|||00|28|0|28,0000|Icepharma hf|Roche|||55601||55601|72058| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|165958|210556|lyfalmen|||00|84|0|84,0000|Icepharma hf|Roche|||165958||165958|210556| 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|5992|9074|lyfalmen|||00|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5992||5992|9074| 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|12530|18004|lyfalmen|||00|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||12530||12530|18004| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2961|4928|lyfalmen|||00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2961||2961|4928| 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|12517|17591|lyfsjukr|||00|3|0|0,0000|Icepharma hf|M.S.D.|Aprepitant||12517||12517|17591| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1961|lyfalmen|||00|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||792||792|1961| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3404|5534|lyfalmen|||00|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3404||3404|5534| 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7941|11740|lyfalmen|||00|100|0|66,6667|Medico ehf|Solvay Duphar |Betahistín||7941||7941|11740| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2539|lyfalmen|V0465|2539|00|20|0|12,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2539| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7359|14303|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||7359||7359|14303| 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|41860|54813|lyfalmen|V1371|54812|00|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||41860||41860|54813| 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|13100|18720|lyfalmen|V1370|18717|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||13100||13100|18720| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12314|17733|lyfalmen|||00|30|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||12314||12314|17733| 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|46613|60778|lyfalmen|||00|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||46613||46613|60778| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10460|15186|lyfalmen|||00|30|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||10460||10460|15186| 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1373|2755|lyfalmen|||00|30|1|30,0000|Parlogis hf|Parlogis - óskráð lyf|Metrónídazól||1373||1373|2755| 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|7112|10606|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||7112||7112|10606| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2969|4939|lyfalmen|||00|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2969||2969|4939| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|4384|6874|lyfalmen|||00|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||4384||4384|6874| 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|72113|92384|lyfsjukr|||00|5|0|0,0000|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||72113||72113|92384| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|13730|19510|lyfalmen|||00|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||13730||13730|19510| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|9643|14068|lyfalmen|||00|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||9643||9643|14068| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3847|6140|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3847||3847|6140| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4202|6625|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||4202||4202|6625| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|11325|16369|lyfalmen|||00|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||11325||11325|16369| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2928|lyfalmen|||00|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1499||1499|2928| 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|19343|26158|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||19343||19343|26158| 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|95648|121921|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||95648||95648|121921| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3687|5921|lyfalmen|||00|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3687||3687|5921| 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|38961|50779|lyfsjukr|||00|17|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||38961||38961|50779| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|9076|13293|lyfalmen|||00|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||9076||9076|13293| 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|15028|20743|lyfsjukr|||03|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||15028||15028|20743| 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|1604|3071|lyfalmen|||00|14|0|7,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1604||1604|3071| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|22240|30190|lyfalmen|||00|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||22240||22240|30190| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3209|5267|lyfalmen|||00|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3209||3209|5267| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MKA|0|0|1|100|XEU|974|2210|lyfalmen|||00|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||974||974|2210| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|7161|10673|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||7161||7161|10673| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|18108|25005|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||18108||18108|25005| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|41055|53803|lyfalmen|||00|100|0|100,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||41055||41055|53803| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|160483|203289|lyfsjukr|||00|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||||160483|203289| 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3420|5556|lyfalmen|||00|30|0|60,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3420||3420|5556| 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|10581|15352|lyfalmen|||00|100|0|200,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||10581||10581|15352| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|60635|77979|lyfsjukr|||43|60|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fosamprenavír||60635||60635|77979| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|654|1772|lyfalmen|||00|100|0|50,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||654||654|1772| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1362|2709|vetalmen|||27|100|0|0,0000|Icepharma hf|Kela Laboratoria NV|||1362||1362|2709| 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|13096|18715|lyfalmen|V1052|15072|00|5|0|62,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||13096||13096|18715| 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16148|22545|lyfalmen|||00|56|0|37,3300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16148||16148|22545| 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16148|22545|lyfalmen|||00|56|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16148||16148|22545| 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15222|21383|lyfalmen|V1372|21383|00|56|0|18,6700|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15222||15222|21383| 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9419|13762|lyfalmen|V1051|11022|00|5|0|41,6667|Vistor hf|Janssen-Cilag AB|Fentanýl||9419||9419|13762| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|34412|45070|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||34412||34412|45070| 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|8074|11922|lyfalmen|||00|28|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||8074||8074|11922| 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|5096|7848|lyfalmen|V1050|6145|00|5|0|20,8333|Vistor hf|Janssen-Cilag AB|Fentanýl||5096||5096|7848| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|40972|53302|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||40972||40972|53302| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|41472|53930|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||41472||41472|53930| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|47507|61504|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||47507||47507|61504| 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|16138|22532|lyfalmen|V1053|17935|00|5|0|83,3333|Vistor hf|Janssen-Cilag AB|Fentanýl||16138||16138|22532| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16141|22536|lyfalmen|V2218|22536|00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||16141|22536| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5140|7909|lyfalmen|V2217|7909|00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||5140|7909| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|62511|80334|lyfsjukr|||00|1|0|0,0000|Gróco ehf|Nycomed Danmark A/S|||62511||62511|80334| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|814588|1024190|lyfsjukr|||00|10|0|0,0000|Gróco ehf|Nycomed Danmark A/S|Bívalirúdín||814588||814588|1024190| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|A||0|0|0|0|VET|0|0|0|100|DKK|23208|44735|vetalmen|||00|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||23208|44735| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7492|11126|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|||7492||7492|11126| 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|58319|75073|lyfsjukr|||AC|4|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||58319||58319|75073| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7492|11126|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|||7492||7492|11126| 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|18437|25418|lyfalmen|||00|140|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|||18437||18437|25418| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|657|1776|lyfalmen|||00|100|0|100,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||657||657|1776| 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005|31.01.2010|R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|4390|6883|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||4390||4390|6883| 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005|31.01.2010|R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|10968|15881|lyfalmen|||00|98|0|98,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||10968||10968|15881| 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005|31.01.2010|R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|6257|9437|lyfalmen|||00|28|0|56,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||6257||6257|9437| 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005|31.01.2010|R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|16824|23393|lyfalmen|||00|98|0|196,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||16824||16824|23393| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005|31.01.2010|R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|4390|6883|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||4390||4390|6883| 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005|31.01.2010|R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|15328|21516|lyfalmen|||00|98|0|98,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||15328||15328|21516| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6634|9575|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||6634||6634|9575| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005|31.01.2010|R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|6257|9437|lyfalmen|||00|28|0|56,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||6257||6257|9437| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005|31.01.2010|R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|17774|24585|lyfalmen|||00|98|0|196,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||17774||17774|24585| 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|687|1817|lyfalmen|||00|250|0|250,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||687||687|1817| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|32165|42250|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||32165||32165|42250| 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|217461|274796|lyfsjukr|||AC|16|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||217461||217461|274796| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1108|2393|lyfalmen|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1108||1108|2393| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|236541|298741|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||236541||236541|298741| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13328|19006|lyfalmen|||00|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13328||13328|19006| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13328|19006|lyfalmen|||00|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13328||13328|19006| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|61056|78904|lyfalmen|||00|1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||61056||61056|78904| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13328|19006|lyfalmen|||00|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13328||13328|19006| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13328|19006|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13328||13328|19006| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13328|19006|lyfalmen|||00|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13328||13328|19006| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|861879|1083541|lyfsjukr|||02|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||861879||861879|1083541| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|400|1424|lyfalmen|||00|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||400||400|1424| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|68710|88114|lyfsjukr|||00|30|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||68710||68710|88114| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1659|3147|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1659||1659|3147| 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||43|100|0|50,0000|Vistor hf|GlaxoSmithKline CH AB|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020180|C03CC0101|Edecrin|sts|50|mg|1|hgl|1|pakki||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|26861|35593|lyfsjukr|||00|50|1|1,0000|Parlogis hf|Parlogis - óskráð lyf|||26861||26861|35593| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4885|7560|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4885||4885|7560| 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|26790|35901|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||26790||26790|35901| 020268|N04BX0202|Comtess (Lyfjaver)|töflur|200|mg|100|stk|1|glas||N04BX02|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|12643|18146|lyfalmen|||00|100|0|20,0000|Lyfjaver ehf|Lyfjaver ehf|Entakapón||12643||12643|18146|28.02.2010 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2898|4842|lyfalmen|||04|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2898||2898|4842| 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|DKK|791|1959|lyfalmen|V0953|1624|00|7|0|2,6300|Icepharma hf|Wyeth AB|Venlafaxín||791||791|1959| 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|7459|11081|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||7459||7459|11081| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|58219|75344|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||58219||58219|75344| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4214|6642|lyfalmen|||00|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4214||4214|6642| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12184|17570|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12184||12184|17570| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|26994|36157|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||26994||26994|36157| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|795|1965|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||795||795|1965| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7588|11257|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||7588||7588|11257| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2318|4048|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2318||2318|4048| 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4469|6991|lyfalmen|V0709|5311|00|60|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||4469||4469|6991| 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|7357|10941|lyfalmen|V0710|8082|00|60|0|10,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||7357||7357|10941| 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|13289|18957|lyfalmen|V0711|13901|00|60|0|20,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||13289||13289|18957| 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A||0|0|B|0|DAC|0|1|0|100|DKK|3433|5527|lyfalmen|V0939|4660|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Escítalópram||3399||3399|5527| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|22261|30217|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||22261||22261|30217| 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki||G03CA03|01.04.2010||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|2085|3729|lyfalmen|V0418|3729|05|15|0|15,0000|D.A.C. ehf|D.A.C. ehf|Estradíól||||2085|3729| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2435|4248|vetorma|||16|8|0|0,0000|Vistor hf|Merial SAS|||2435||2435|4248| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|199391|252118|lyfsjukr|||00|200|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||199391||199391|252118| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2762|4580|lyfalmen|V0429|4580|00|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2707||2707|4580| 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6610|9919|lyfalmen|||63|28|0|28,0000|Icepharma hf|M.S.D.|Montelúkast||6610||6610|9919| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2549|4364|lyfalmen|||00|60|0|60,0000|Icepharma hf|Galderma Nordic AB|Adapalen||2549||2549|4364| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|827|1854|lyfalmen|||00|12|0|7,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1854| 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.04.2010||R|K||0|0|*|0|DAC|0|0|0|100|DKK|3519|5691|lyfalmen|V0988|5691|06|2|0|0,0000|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||||3519|5691| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2266|lyfalmen|V0466|2266|00|12|0|12,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1015||1015|2266| 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1478|lyfalmen|V0609|1465|00|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||439||439|1478| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1114|2401|lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Dexpantenól||1114||1114|2401| 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|3256|3464|lyfalmen|V0931|2268|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Sertralín||1891||1891|3464| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2501|lyfalmen|V0610|2501|00|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2501| 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A||0|0|B|0|DAC|0|1|0|100|DKK|1985|3593|lyfalmen|V0935|3303|00|28|0|56,0000|D.A.C. ehf|D.A.C. ehf|Sertralín||1985||1985|3593| 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|18342|25298|lyfalmen|||02|4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||18342||18342|25298| 021278|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2009|31.01.2010|R|K|3|0|0|*|0|DAC|0|0|0|100|DKK|2957|4922|lyfalmen|||0|2|0|25,0000|D.A.C. ehf|D.A.C. ehf|Latanóprost||2957||2957|4922| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|18871|25962|lyfalmen|||63|98|0|98,0000|Icepharma hf|M.S.D.|Montelúkast||18871||18871|25962| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.12.2009||R|A||0|0|E|0|DAC|0|0|1|100|SEK|1749|3270|lyfalmen|V0108|3270|24|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníð||1749||1749|3270| 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|24742|33330|lyfalmen|||63|98|0|49,0000|Icepharma hf|M.S.D.|Montelúkast||24742||24742|33330| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3000|4330|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||3000||3000|4330| 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|5093|7844|lyfalmen|||00|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5093||5093|7844| 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|16095|22478|lyfalmen|||00|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16095||16095|22478| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14393|20342|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14393||14393|20342| 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|9119|13352|lyfalmen|||00|30|0|9,0000|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||9119||9119|13352| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|29591|39019|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||29591||29591|39019| 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|25170|33867|lyfalmen|||00|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||25170||25170|33867| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|33511|43939|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||33511||33511|43939| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26663|35741|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||26663||26663|35741| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4524|7066|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4524||4524|7066| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|18806|25484|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||18806||18806|25484| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5027|7255|lyfsjukr|||02|50|0|2,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tranexamsýra||5027||5027|7255| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21346|29068|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||21346||21346|29068| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|4195|6616|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4195||4195|6616| 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.01.2010||R|A||0|0|0|0|DAC|0|0|0|100|SEK|5924|8772|lyfalmen|V0085|8772|00|28|0|37,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5771||5771|8772| 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|28018|37045|lyfsjukr|||00|2500|0|2,5000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||28018||28018|37045| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|5798|8809|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5798||5798|8809| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|19981|27355|lyfalmen|||00|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||19981||19981|27355| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21346|29068|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||21346||21346|29068| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|99485|126736|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||99485||99485|126736| 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|779|1550|vetalmen|||16|20|0|0,0000|Vistor hf|LEO Animal Health A/S|||779||779|1550| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríð|||||| 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005|28.02.2010|R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|27300|36541|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||27300||27300|36541| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|7872|11646|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||7872||7872|11646| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|9226|13498|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||9226||9226|13498| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|30625|40713|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||30625||30625|40713| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|9839|14337|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||9839||9839|14337| 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|31562|41889|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||31562||31562|41889| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|344103|433732|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||344103||344103|433732| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|354999|447406|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||354999||354999|447406| 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1301|lyfalmen|V0917|1082|00|20|0|20,0000|Actavis Group hf|Actavis hf|Paroxetín||310||310|1301| 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11248|19622|vetorma|||00|24|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||11248||11248|19622| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|28631|38211|lyfalmen|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||28631||28631|38211| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2487|4338|vetorma|||00|2|0|0,0000|Vistor hf|Bayer HealthCare AG|||2487||2487|4338| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3195|5248|lyfalmen|||00|30|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||3195||3195|5248| 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0,0000|Vistor hf|Bayer Animal Health GmbH||||||2090| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4274|2776|lyfalmen|V0308|2683|00|100|0|100,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||1388||1388|2776| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|7386|3892|lyfalmen|V0310|3798|00|100|0|200,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||2204||2204|3892| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2356|4110|vetorma|||00|1|0|0,0000|Vistor hf|Bayer HealthCare AG|||2356||2356|4110| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|814|1991|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||814||814|1991| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2366|4114|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2366||2366|4114| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1525|2660|vetorma|||00|1|0|0,0000|Vistor hf|Bayer HealthCare AG|||1525||1525|2660| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|5132|7898|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5132||5132|7898| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A||0|0|B|0|ACA|0|1|0|100|IKR|2400|2619|lyfalmen|V0919|2619|00|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1273||1273|2619| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|1998|lyfalmen|V0918|1717|00|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||819||819|1998| 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|1352|2590|lyfalmen|||00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Metótrexat||1252||1252|2590| 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|14884|20959|lyfalmen|V0192|5084|00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||14884||14884|20959| 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|270985|341969|lyfsjukr|||00|3|0|0,0000|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||270985||270985|341969| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||2955| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2725|lyfalmen|||67|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2725|31.03.2010 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4095|lyfalmen|V0410|4095|67|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4095| 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26663|35741|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||26663||26663|35741| 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21346|29068|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||21346||21346|29068| 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992|28.02.2010|R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4490|7019|lyfalmen|||19|100|0|33,3333|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4490||4490|7019| 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6205|9365|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||6205||6205|9365| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|131891|167406|lyfsjukr|||00|30|0|0,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||131891||131891|167406| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|28218|37693|lyfalmen|||00|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||28218||28218|37693| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|44056|57569|lyfalmen|||00|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||44056||44056|57569| 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|22310|30278|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||22310||22310|30278| 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6268|9452|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||6268||6268|9452| 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|22537|30563|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||22537||22537|30563| 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|22876|30592|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Roche|Flúmazeníl||22876||22876|30592| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|4903|7584|lyfalmen|V0714|7584|00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||4903||4903|7584| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|5712|8691|lyfalmen|||00|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||5712||5712|8691|31.03.2010 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|18090|24982|lyfalmen|||00|34|0|0,0000|Vistor hf|Dentsply DeTrey GmbH|Blöndur||18090||18090|24982| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9429|13608|lyfsjukr|||00|0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||9429||9429|13608| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|37115|48462|lyfsjukr|||00|0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||37115||37115|48462| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|28091|37137|lyfsjukr|||00|0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||28091||28091|37137| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|66871|85806|lyfsjukr|||00|0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||66871||66871|85806| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|44646|57913|lyfsjukr|||00|0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||44646||44646|57913| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|9892|14277|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||9892||9892|14277| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|133657|169622|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||133657||133657|169622| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|24730|32919|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||24730||24730|32919| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|18360|24924|lyfsjukr|||00|0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||18360||18360|24924| 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|13179|18819|lyfalmen|||00|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13179||13179|18819| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|49461|63956|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||49461||49461|63956| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|98920|126027|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||98920||98920|126027| 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|9226|13498|lyfalmen|||00|3|0|14,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||9226||9226|13498| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|213767|270160|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||213767||213767|270160| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|197842|250174|lyfsjukr|||00|200|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||197842||197842|250174| 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|18450|25434|lyfalmen|||00|6|0|28,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||18450||18450|25434| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13838|19646|lyfalmen|||00|4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13838||13838|19646| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|152950|193835|lyfsjukr|||00|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||152950||152950|193835| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|28415|37940|lyfalmen|V0090|32043|00|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||28415||28415|37940| 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4491|7021|lyfalmen|||00|4|0|7,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4491||4491|7021| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3953|6285|lyfalmen|||00|12|0|60,0000|Icepharma hf|Santen Oy|Tímólól||3953||3953|6285| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|67751|86910|lyfsjukr|||00|120|0|100,0000|Icepharma hf|Roche|Saquínavír||67751||67751|86910| 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|11389|16457|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11389||11389|16457| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|103472|131740|lyfsjukr|||00|90|0|36,0000|Vistor hf|Pfizer Limited|Síldenafíl||103472||103472|131740| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3323|5423|lyfalmen|||00|100|0|16,6667|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3323||3323|5423| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|DKK|84990|108545|lyfsjukr|||00|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||84990||84990|108545| 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|6419|9264|lyfsjukr|||03|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||6419||6419|9264| 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3515|5686|lyfalmen|V0102|5591|00|5|0|9,9900|Vistor hf|Janssen-Cilag AB|Fentanýl||3515||3515|5686| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|21679|29486|lyfalmen|||00|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||21679||21679|29486| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2469|3563|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2469||2469|3563| 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|9239|13516|lyfalmen|||00|112|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||9239||9239|13516| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|34673|45397|lyfsjukr|||00|3944|0|3,9400|Icepharma hf|Fresenius Kabi|Blöndur||34673||34673|45397| 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15842|22161|lyfalmen|||00|112|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||15842||15842|22161| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|70128|90290|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||70128||70128|90290| 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26663|35741|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||26663||26663|35741| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8394|12360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8394||8394|12360| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|441|1481|lyfalmen|||00|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||441||441|1481| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8394|12360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8394||8394|12360| 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14143|20029|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14143||14143|20029| 024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14143|20029|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14143||14143|20029| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14167|20059|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14167||14167|20059| 024532|V04CL0007|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14143|20029|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14143||14143|20029| 024559|V04CL0008|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14143|20029|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14143||14143|20029| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14312|20241|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14312||14312|20241| 024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14143|20029|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14143||14143|20029| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8394|12360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8394||8394|12360| 024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14143|20029|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14143||14143|20029| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|79895|102547|lyfalmen|||00|100|0|360,0000|Vistor hf|Novartis Europharm Ltd|||79895||79895|102547| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14312|20241|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14312||14312|20241| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1723|3234|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1723||1723|3234| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8394|12360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8394||8394|12360| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8394|12360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8394||8394|12360| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8394|12360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8394||8394|12360| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1723|3234|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1723||1723|3234| 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|6310|9509|lyfalmen|||00|4|0|28,0000|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||6310||6310|9509| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1006|2253|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1006||1006|2253| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21346|29068|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||21346||21346|29068| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2878|4814|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2878||2878|4814| 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2164|3837|lyfalmen|||0|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2164||2164|3837| 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4118|6510|lyfalmen|||0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4118||4118|6510| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21346|29068|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||21346||21346|29068| 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|DKK|1048|2311|lyfalmen|||08|100|0|2,5000|Icepharma hf|NordMedica A/S|Cefalexín||1048||1048|2311| 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|15126|21262|lyfalmen|||00|12|0|84,0000|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||15126||15126|21262| 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1963|lyfalmen|||00|14|0|3,5000|Icepharma hf|NordMedica A/S|Cefalexín||794||794|1963| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|109801|139683|lyfsjukr|||00|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||109801||109801|139683| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|108551|138114|lyfsjukr|||00|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||108551||108551|138114| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|10578|20484|vetalmen|||00|20|0|0,0000|Vistor hf|Boehringer Ingelheim|||10578||10578|20484| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|19595|26871|lyfalmen|||00|30|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||19595||19595|26871| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|23832|32188|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||23832||23832|32188| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6952|10387|lyfalmen|||00|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6952||6952|10387| 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|34728|45863|lyfalmen|V0798|45863|00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||34728||34728|45863| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|A||0|0|*|0|DAC|0|0|0|100|XEU|2105|3757|lyfalmen|V1090|3757|06|5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||||2105|3757| 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|5792|8800|lyfalmen|||00|1|0|30,0000|Icepharma hf|Roche Registration Limited|||5792||5792|8800| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|15107|21238|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|||15107||15107|21238| 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|45091|lyfsjukr|||00|50|1|0,0000|Distica|Distica - óskráð lyf|||34429||34429|45091| 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|18540|25547|lyfalmen|V0796|25547|00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||18540||18540|25547| 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|26816|35933|lyfalmen|V0797|35933|00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||26816||26816|35933| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|61175|79054|lyfalmen|||00|100|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||61175||61175|79054| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|7381|10653|lyfsjukr|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7381||7381|10653| 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26663|35741|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||26663||26663|35741| 025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|1005|2252|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1005||1005|2252| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3851|6718|vetorma|||16|1|0|0,0000|Vistor hf|Merial (MSD)|||3851||3851|6718| 025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|A||0|0|E|0|MYL|0|0|1|100|SEK|549|1628|lyfalmen|||00|25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||549||549|1628| 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991|28.02.2010|R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1023|2277|lyfalmen|||00|50|0|50,0000|Actavis Group PTC ehf|Merck NM AB|Naproxen||1023||1023|2277| 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1848|3405|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Merck NM AB|Naproxen||1848||1848|3405| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|8716|15205|vetorma|||16|2|0|0,0000|Vistor hf|Merial (MSD)|||8716||8716|15205| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21346|29068|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||21346||21346|29068| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|2006|3621|lyfalmen|||00|14|0|2,3300|Vistor hf|U.C.B|||||2006|3621| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|7601|11275|lyfalmen|||00|56|0|9,3300|Vistor hf|U.C.B|||||7601|11275| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|3963|6298|lyfalmen|||00|14|0|4,6700|Vistor hf|U.C.B|||||3963|6298| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|15696|21978|lyfalmen|||00|56|0|18,6700|Vistor hf|U.C.B|||||15696|21978| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|23520|31797|lyfalmen|||00|56|0|28,0000|Vistor hf|U.C.B|||||23520|31797| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|31345|41617|lyfalmen|||00|56|0|37,3300|Vistor hf|U.C.B|||||31345|41617| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|2075|3716|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||2075||2075|3716| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|431|1467|lyfalmen|||00|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||431||431|1467| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2981|4955|lyfalmen|||10|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2981||2981|4955| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|A||0|0|*|0|ALA|0|0|0|100|USD|2578|4404|lyfalmen|||00|5|0|0,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2578||2578|4404| 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|8300|12231|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Merck NM AB|Cýpróterón||8300||8300|12231| 027281|N06DA0204 |Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|32594|43185|lyfalmen|V0375|43185|00|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||||32594|43185| 027294|M03AC0902|Esmeron (Lyfjaver)|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.10.2009||R|K||0|0|0|1|LVR|0|0|0|100|NOK|11824|16722|lyfsjukr|||00|50|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Rókúrón, brómíð||11824||11824|16722| 027305|N06DA0204 |Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|36579|48186|lyfalmen|V0376|48186|00|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||||36579|48186| 027306|N03AX1205|Neurontin (Lyfjaver)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|5120|7881|lyfalmen|V0714|7584|00|100|0|16,6667|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||5120||5120|7881| 027317|N03AX1205|Neurontin (Lyfjaver)|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|7004|10458|lyfalmen|V0715|10458|00|100|0|22,2222|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||7004||7004|10458| 027328|N03AX1205|Neurontin (Lyfjaver)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|18866|25956|lyfalmen|V2160|25956|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||18866||18866|25956| 027339|L01XE0502|Nexavar (Lyfjaver)|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.10.2009||R|A||0|1|0|1|LVR|0|0|0|100|SEK|663132|809451|lyfsjukr|||00|112|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Sorafeníb||643481||643481|809451| 027362|L01AX0302 |Temodal (Lyfjaver)|hylki|20|mg|20|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|80606|103043|lyfsjukr|||00|20|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||80606|103043| 027373|L01AX0302 |Temodal (Lyfjaver)|hylki|100|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|98546|125558|lyfsjukr|||00|5|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||98546|125558| 027385|L01AX0302 |Temodal (Lyfjaver)|hylki|250|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|212700|268821|lyfsjukr|||00|5|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||212700|268821| 027397|G02CX0102 |Tractocile (Lyfjaver)|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|6450|9309|lyfsjukr|||00|1|0|0,0400|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||6450|9309| 027408|G02CX0102 |Tractocile (Lyfjaver)|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|19213|25995|lyfsjukr|||00|5|0|0,2300|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||19213|25995| 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|2109|3762|lyfalmen|||00|14|0|1,7500|Vistor hf|Eisai Ltd|||2109||2109|3762| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|8438|12420|lyfalmen|||00|56|0|7,0000|Vistor hf|Eisai Ltd|||8438||8438|12420| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|11140|16116|lyfalmen|||00|56|0|14,0000|Vistor hf|Eisai Ltd|||11140||11140|16116| 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|14918|21001|lyfalmen|||00|56|0|28,0000|Vistor hf|Eisai Ltd|||14918||14918|21001| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|927|2145|lyfalmen|V0431|2004|00|100|0|33,3300|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||927||927|2145| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|927|2145|lyfalmen|V0430|1857|00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||927||927|2145| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPE|0|0|0|100|DKK|135933|172478|lyfsjukr|||00|105|0|0,7500|Vistor hf|SP Europe|Posacónazól||135933||135933|172478| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|26163|35114|lyfalmen|||00|28|0|18,6700|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26163||26163|35114| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|35228|46490|lyfalmen|||00|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||35228|46490| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|26163|35114|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26163||26163|35114| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|50619|65806|lyfalmen|||00|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||50619|65806| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|65390|84344|lyfalmen|||00|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||65390|84344| 028045|G03AB0001|Qlaira|töflur|0||84|stk|1|þpakki|3x28 stk|G03AB|01.11.2009||R|A||0|0|0|0|BAP|0|0|0|100|SEK|5190|7977|lyfalmen|||00|84|0||Icepharma hf|Bayer Schering Pharma AG|||||5190|7977| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1200|2404|lyfalmen|V1910|2404|00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1116||1116|2404| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|XEU|26739|35837|lyfalmen|||00|196|0||Icepharma hf|M.S.D.|||26739||26739|35837| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3617|5342|lyfalmen|V1911|5342|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3264||3264|5342| 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4340|6814|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4340|6814| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|20689|28244|lyfalmen|||00|196|0||Icepharma hf|M.S.D.|||||20689|28244| 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15088|21215|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||15088|21215| 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4340|6814|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4340|6814| 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15088|21215|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||15088|21215| 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|5002|7720|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||5002|7720| 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|17402|24119|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||17402|24119| 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|5002|7720|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||5002|7720| 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|17402|24119|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||17402|24119| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2789|4692|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2789||2789|4692| 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|23414|31664|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||23414||23414|31664| 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8960|13134|lyfalmen|||02|1|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||8960||8960|13134| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|1489|2914|lyfalmen|V0712|2914|00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1489||1489|2914| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2122|3780|lyfalmen|||10|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2122||2122|3780| 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3626|5837|lyfalmen|||10|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||3626||3626|5837| 028575|N03AX0901 |Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2625|lyfalmen|||00|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2625| 028586|N03AX0901 |Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8828|lyfalmen|||00|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||5812|8828| 028598|N03AX0901 |Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|15046|lyfalmen|||00|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|15046| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|DKK|1550|2442|lyfalmen|V2010|2442|00|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||1144||1144|2442| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|8779|17030|vetalmen|||27|10|0|0,0000|Icepharma hf|Orion Corporation (I)|||8779||8779|17030| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|DKK|8758|9862|lyfalmen|V2020|9862|00|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||6568||6568|9862| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|DKK|32665|34973|lyfalmen|V2030|34973|00|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||26051||26051|34973| 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1079|2353|lyfalmen|||02|24|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||1079||1079|2353| 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13108|18730|lyfalmen|||00|10|0|5,0000|Icepharma hf|Roche A.S.|Granisetrón||13108||13108|18730| 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2474|4262|lyfalmen|||20|50|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2474||2474|4262| 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1115|2403|lyfalmen|||24|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1115|2403| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|8024|11854|lyfalmen|||00|28|0||Icepharma hf|Servier|||8024||8024|11854| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|24073|32491|lyfalmen|||00|84|0||Icepharma hf|Servier|||24073||24073|32491| 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|640|1753|lyfalmen|||00|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||640||640|1753| 029287|C03DB0105 |Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|261|1234|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|||||261|1234| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8349|10001|lyfalmen|V0362|2314|00|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6670||6670|10001| 029517|L01BB0503 |Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|34604|45311|lyfsjukr|||00|50|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||||34604|45311| 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|22270|29831|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||||22270|29831| 029574|L01XX1904 |Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|22307|29878|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group hf|Írinótekan||||22307|29878| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5140|7909|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||5140|7909| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16142|22537|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||16142|22537| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5140|7909|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||5140|7909| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16142|22537|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||16142|22537| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|117040|148768|lyfsjukr|||00|1|0|8,3300|Vistor hf|Amgen Europe B.V.|||||117040|148768| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|234079|295652|lyfsjukr|||00|1|0|16,6600|Vistor hf|Amgen Europe B.V.|||||234079|295652| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|20725|27892|lyfsjukr|||00|84|0|7,0000|D.A.C. ehf|D.A.C. ehf|Ritonavír||20725||20725|27892| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|26094|35027|lyfalmen|||00|98|0|49,0000|Vistor hf|Eisai Ltd|||26094||26094|35027| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyflausa|||00|60|0|25,0000|Icepharma hf|Navamedic ASA|Glúkósamín|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|10203|14834|lyfalmen|V1400|14833|00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||10203||10203|14834| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3254|5329|lyfalmen|V1401|5327|00|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||3254||3254|5329| 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|994|2237|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||994||994|2237| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1450|2861|lyfalmen|||00|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||1450||1450|2861| 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|921|2137|lyfalmen|||23|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||921||921|2137| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3483|5642|lyfalmen|||17|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3483||3483|5642| 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5496|8395|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5496||5496|8395| 031314|L01AX0301|Temodal|hylki|20|mg|20|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|66339|85138|lyfsjukr|||00|20|0||Vistor hf|Schering-Plough|Temozolomid||66339||66339|85138| 031325|L01AX0301|Temodal|hylki|100|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|80498|102907|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||80498||80498|102907| 031348|L01AX0301|Temodal|hylki|140|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|112712|143336|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||112712||112712|143336| 031371|L01AX0301|Temodal|hylki|180|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|144137|182774|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||144137||144137|182774| 031394|L01AX0301|Temodal|hylki|250|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|199823|252660|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||199823||199823|252660| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2326|4059|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||2326||2326|4059| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6937|10367|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||6937||6937|10367| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|40846|53144|lyfsjukr|||00|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||40846||40846|53144| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|2030|3654|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Merck NM AB|Sótalól||2030||2030|3654| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|10650|15248|lyfsjukr|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||10650|15248| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|15567|21419|lyfsjukr|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||15567|21419| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|53863|69481|lyfsjukr|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||53863|69481| 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0,0000|Strandmøllen A/S|Strandmøllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0,0000|Strandmøllen A/S|Strandmøllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0,0000|Strandmøllen A/S|Strandmøllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0,0000|Strandmøllen A/S|Strandmøllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0,0000|Strandmøllen A/S|Strandmøllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0,0000|Strandmøllen A/S|Strandmøllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0,0000|Strandmøllen A/S|Strandmøllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|27168|36375|lyfalmen|||00|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||27168||27168|36375| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4200|7327|vetorma|||27|50|0|0,0000|Vistor hf|Merial (MSD)|||4200||4200|7327| 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|154937|196328|lyfsjukr|||0|6|0|0,0000|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||||154937|196328| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|14935|26053|vetorma|||27|200|0|0,0000|Vistor hf|Merial (MSD)|||14935||14935|26053| 032723|N06AX1609|Venlafaxin Ranbaxy|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2009||R|A||0|0|B|0|RAN|0|1|0|100|XEU|10131|9896|lyfalmen|V0955|9896|00|100|0|75,0000|Gróco ehf|Ranbaxy (UK) Ltd|Venlafaxín||6593||6593|9896| 032756|N06AX1609|Venlafaxin Ranbaxy|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.01.2010||R|A||0|0|B|0|RAN|0|1|0|100|XEU|18547|15579|lyfalmen|V0956|15579|00|100|0|150,0000|Gróco ehf|Ranbaxy (UK) Ltd|Venlafaxín||10747||10747|15579| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|A||0|0|0|0|LHS|0|0|0|100|XEU|10135|19633|vetalmen|||27|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||10135|19633| 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1326|2691|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||1326||1326|2691| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|95668|121946|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|||95668||95668|121946| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|141267|179173|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|||141267||141267|179173| 033918|L04AC0501|Stelara|stl|45|mg/hgl|0,5|ml|1|hgl||L04AC05|01.06.2009||R|K|1|0|1|0|1|JCI|0|0|0|100|SEK|618073|777564|lyfsjukr|||AC|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|||||618073|777564| 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2745|5443|vetalmen|||0|10|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||||2745|5443| 034105|A07AA0905|Vancomycin Axellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A||0|0|E|0|MYL|0|0|1|100|DKK|13293|18962|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Mylan AB|Vankómýcín||||13293|18962| 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|826|2007|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||826||826|2007| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|24596|32750|lyfsjukr|||00|25|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||24596||24596|32750| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8995|13182|lyfalmen|||0|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|||||8995|13182| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8995|13182|lyfalmen|||0|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|||||8995|13182| 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2374|4125|lyfalmen|||00|300|0|10,0000|Vistor hf|Astra|Clómetíazól||2374||2374|4125| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|2028|3651|lyfalmen|||00|6|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2028||2028|3651| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3478|5635|lyfalmen|||00|12|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3478||3478|5635| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|205285|259515|lyfsjukr|||00|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||||205285|259515| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9808|14155|lyfsjukr|||02|25|0|0,0000|Vistor hf|LEO Pharma A/S|Prótamín||9808||9808|14155| 035099|C02CA0404 |Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|3675|5422|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Doxazósín||3322||3322|5422|31.03.2010 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|2522|3640|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||2522||2522|3640| 035177|N03AX1203 |Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6625|7929|lyfalmen|V0714|7584|10|100|0|16,6800|D.A.C. ehf|D.A.C. ehf|Gabapentín||5155||5155|7929| 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|17712|24508|lyfalmen|||10|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||17712||17712|24508| 035222|N06DA0403 |Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|13098|18717|lyfalmen|V1370|18717|00|28|0|14,0000|D.A.C. ehf|D.A.C. ehf|Galantamín||13098||13098|18717| 035234|M01AB5502 |Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|5354|8201|lyfalmen|V2130|8201|0|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Díklófenaknatríum í blöndum||5354||5354|8201| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3611|5817|lyfalmen|V2215|5817|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3611|5817| 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2840|lyfalmen|||00|56|0|4,6700|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2840| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3400|lyfalmen|V0703|3400|00|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1844||1844|3400| 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5420|lyfalmen|||00|56|0|18,6700|Actavis Group hf|Actavis hf|Lamótrigín||||3321|5420| 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8974|lyfalmen|||00|56|0|37,3400|Actavis Group hf|Actavis hf|Lamótrigín||||5919|8974| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|133281|169150|lyfsjukr|||00|1|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegaptaníb||133281||133281|169150| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11490|16595|lyfalmen|V2216|16595|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||11490|16595| 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|PCO|0|0|0|100|IKR|926|1336|lyfsjukr|||00|10|1|0,0000|Distica|Distica - óskráð lyf|Digoxín||926||926|1336| 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|49924|64537|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Fitusambönd||49924||49924|64537| 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|981|2219|lyfalmen|||00|60|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||981||981|2219| 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|523|1593|lyfalmen|||00|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||523||523|1593| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|A||0|0|0|0|GZE|0|0|0|100|XEU|33830|44736|lyfalmen|V1200|40648|00|180|0||Vistor hf|Genzyme Europe B.V.|Sevelamer||||33830|44736| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|157790|199909|lyfsjukr|||00|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||||157790|199909| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|6401|9633|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6401||6401|9633| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2955|4920|lyfalmen|V2213|4920|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||2955|4920| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|9403|13740|lyfalmen|V2214|13740|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||9403|13740| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|242193|305835|lyfsjukr|||00|30|0|0,0000|Vistor hf|Pfizer Limited|Sunitíníb||242193||242193|305835| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|432571|544759|lyfsjukr|||00|30|0|0,0000|Vistor hf|Pfizer Limited|Sunitíníb||432571||432571|544759| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|864723|1087110|lyfsjukr|||00|30|0|0,0000|Vistor hf|Pfizer Limited|Sunitíníb||864723||864723|1087110| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|857|2050|lyfalmen|||00|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||857||857|2050| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1448|2858|lyfalmen|||08|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1448||1448|2858| 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|GCO|0|0|0|100|IKR|||lyflausa|||00|30|0|6,0000|Vistor hf|GlaxoSmithKline CH AB|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2858|4787|lyfalmen|||08|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2858||2858|4787| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|866|2062|lyfalmen|||00|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||866||866|2062| 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7001|10454|lyfalmen|||00|42|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7001||7001|10454| 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|13730|19510|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||13730||13730|19510| 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|26264|35240|lyfalmen|||00|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||26264||26264|35240| 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|50330|65443|lyfalmen|||00|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||50330||50330|65443| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2785|4687|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2785||2785|4687| 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1238|2571|lyfalmen|||0|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1238||1238|2571| 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980|31.01.2010|R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|778|1942|lyfalmen|||00|30|0|7,5000|Vistor hf|Hexal A/S|Trímetóprím||778||778|1942| 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2288| 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3835| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8479|12476|lyfalmen|V2212|12476|00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8479|12476| 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980|31.01.2010|R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|2093|3740|lyfalmen|||00|100|0|25,0000|Vistor hf|Hexal A/S|Trímetóprím||2093||2093|3740| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1397|lyfalmen|V0917|1082|00|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1397| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2273|lyfalmen|V0918|1717|00|60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2273| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3054|lyfalmen|V0919|2619|00|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3054| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1153|2454|lyfalmen|||00|50|0|50,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1153||1153|2454| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2751|4640|lyfalmen|V2211|4640|00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||2751|4640| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|236046|298120|lyfsjukr|||00|1|0|0,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||236046||236046|298120| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|K||0|1|0|1|WTE|0|0|0|100|DKK|95350|121547|lyfsjukr|||00|100|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||||95350|121547| 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|6885|10296|lyfalmen|||00|90|0|90,0000|Icepharma hf|Servier|Perindópríl||6885||6885|10296| 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4856|7520|lyfalmen|||00|100|0|33,3333|Medico ehf|Solvay Duphar |Betahistín||4856||4856|7520| 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3283|5368|lyfalmen|||00|2|0|6,6700|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||3283||3283|5368| 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|45354|58802|lyfsjukr|||00|10|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||45354||45354|58802| 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|78918|100925|lyfsjukr|||00|20|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||78918||78918|100925| 039575|D01AE1503 |Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|658|1777|lyfalmen|V0290|1631|00|98|0|32,6667|Actavis Group PTC ehf|Merck NM AB|Atenólól||658||658|1777| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|650|1766|lyfalmen|||00|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||650||650|1766| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1546|2992|lyfalmen|||00|15|0|2,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1546||1546|2992| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2496|4292|lyfalmen|||00|22|0|3,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2496||2496|4292| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|425|613|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||425||425|613| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1630|3080|lyfalmen|V0367|3080|00|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1610||1610|3080| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|8683|12755|lyfalmen|V0508|12755|00|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||8683||8683|12755| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|975|1407|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||975||975|1407| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|1881|3448|lyfalmen|V0507|3448|00|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1879||1879|3448| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1729|2495|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1729||1729|2495| 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3345|5453|lyfalmen|||00|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3345||3345|5453| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0,0000|K.Pétursson hf|Alcon|Gervitár og aðrar óvirkar sam­setningar|||||1621| 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|9073|13289|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Rota-veira, veikluð veira||9073||9073|13289| 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|3343|5450|lyfalmen|||00|63|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3343||3343|5450| 041488|N06AB1002 |Cipralex (D.A.C.)|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|22180|29562|lyfalmen|V2172|27001|00|98|0|196,0000|D.A.C. ehf|D.A.C. ehf|Escítalópram||21739||21739|29562| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4849|8459|vetorma|||AA|100|0|0,0000|Icepharma hf|Intervet International B.V.|||4849||4849|8459| 041795|M02AA1503 |Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|TMC|0|0|0|100|SEK|205302|259933|lyfalmen|||02|100|0|0,0000|TMC Pharma Services Ltd|TMC Pharma Services Ltd|Gadófosveset||205302||205302|259933| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MYL|0|1|0|100|SEK|1196|2513|lyfalmen|||00|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1196|2513| 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1538|2981|lyfalmen|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1538||1538|2981| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|12941|18123|lyfsjukr|||00|500|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||12941||12941|18123| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4020|5802|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4020||4020|5802| 042309|N01BB0902|Naropin|stl/irl|2|mg/ml|200|ml|5|plpok||N01BB09|01.07.2009||R|A||0|0|0|1|AZD|0|0|0|100|SEK|23146|30931|lyfsjukr|||00|1000|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||||23146|30931| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5070|7317|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||5070||5070|7317| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4791|6915|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4791||4791|6915| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7264|10484|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||7264||7264|10484| 042346|N07BA0137 |Nicorette (D.A.C.)|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042357|N07BA0141 |Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|8339|12035|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||8339||8339|12035| 042368|A06AB0602 |Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2326|4059|lyfalmen|||00|500|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2326|4059| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9121|13164|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Kolvetni||9121||9121|13164| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúðir|B05BA03|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4630|6682|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4630||4630|6682| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4843|6990|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4843||4843|6990| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3554|5129|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3554||3554|5129| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3063|4421|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3063||3063|4421| 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|10705|15317|lyfsjukr|||00|2000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||10705||10705|15317| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúðir|B05BB01|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4286|6186|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||4286||4286|6186| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|3264|4711|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3264||3264|4711| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2416|3487|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2416||2416|3487| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7685|11091|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||7685||7685|11091| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2479|3578|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2479||2479|3578| 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|852|2043|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||852||852|2043| 042551|B05BB0209 |Glucos 100 mg/ml med Na40 + K20 Fres|irl|0||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3471|5010|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||||3471|5010| 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|16288|22721|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||16288||16288|22721| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3765|5434|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3765||3765|5434| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|380|1397|lyfalmen|||00|30|0|30,0000|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||380||380|1397| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3600|5196|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3600||3600|5196| 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3891|5967|lyfalmen|||24|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3721||3721|5967| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6617|9550|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||6617||6617|9550| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|622|1728|lyfalmen|||00|30|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||622||622|1728| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1330|2697|lyfalmen|||10|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1330||1330|2697| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis UK Ltd.||||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|15166|20837|lyfalmen|V0011|20710|00|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||14787||14787|20837| 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|28219|37694|lyfalmen|||00|100|0|100,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||28219|37694| 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|105697|134929|lyfalmen|||00|100|0|100,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||105697|134929| 044763|N04BC0502|Sifrol|forðatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|3602|5805|lyfalmen|||00|10|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||3602|5805| 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|41776|54311|lyfsjukr|||00|5|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Írinótekan||41776||41776|54311| 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1376|2760|lyfalmen|||10|50|0|8,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||1376||1376|2760| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|8143|12016|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||8143||8143|12016| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2314|lyfalmen|V0362|2314|00|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1050|2314| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2065|lyfalmen|V0361|2065|00|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||868|2065| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|4481|6467|lyfsjukr|||00|750|0|0,2500|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||4481|6467| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|8573|12373|lyfsjukr|||00|1500|0|0,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||8573|12373| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|23324|44958|vetalmen|||27|10|0|0,0000|Icepharma hf|Pfizer vet.|||23324||23324|44958| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3535|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1943||1943|3535| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|5761|8758|lyfalmen|V1088|8758|02|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||5761||5761|8758| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1929|lyfalmen|V0001|1929|00|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||769||769|1929| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2539|lyfalmen|V0002|2539|00|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||1215||1215|2539| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3096|lyfalmen|V0003|3096|00|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||1622||1622|3096| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|9240|13517|lyfalmen|V1089|13517|02|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||9240||9240|13517| 047042|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|81067|103622|lyfsjukr|||00|100|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||81067||81067|103622| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1025|2279|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1025||1025|2279| 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1050|2314|lyfalmen|||23|14|0|7,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||1050||1050|2314| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||00|50|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|206157|260610|lyfsjukr|||00|200|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||206157||206157|260610| 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|AZA|0|0|0|100|SEK|10440|15159|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca AB|Zafírlúkast||10440||10440|15159| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5327|7688|lyfsjukr|||02|250|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||5327||5327|7688| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8408|12135|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||8408||8408|12135| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|6344|9556|lyfalmen|V0940|9556|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||||6344|9556| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|2765|4660|lyfalmen|V0939|4660|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||||2765|4660| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|9904|14425|lyfalmen|V0938|14425|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||||9904|14425| 048133|N06AB1004|Esopram|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|4932|7624|lyfalmen|V0941|7624|00|28|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||||4932|7624| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|18814|25891|lyfalmen|V0942|24657|00|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||||18814|25891| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|5909|8960|lyfalmen|V0943|8960|00|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||||5909|8960| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|20138|27552|lyfalmen|V2172|27552|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||||20138|27552| 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1291|2643|lyfalmen|||00|100|0|0,0000|Vistor hf|Meda AB|Klídín og geðlyf||1291||1291|2643| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|15311|21494|lyfalmen|||00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||15311||15311|21494| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4735|7354|lyfalmen|||00|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíð dínítrat||4735||4735|7354| 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1980|3586|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1980||1980|3586| 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006|28.02.2010|R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1766|lyfalmen|||00|30|0|5,0100|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||650||650|1766| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|71614|92155|lyfalmen|||00|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||71614||71614|92155| 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|9882|14395|lyfalmen|||00|100|0|200,0000|Actavis Group PTC ehf|Merck NM AB|Selegilín||9882||9882|14395| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|532|1605|lyfalmen|V0772|1396|00|100|0|16,6667|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||532||532|1605| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5349|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||3269||3269|5349| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|18686|25730|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|||18686||18686|25730| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2873|4807|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2873||2873|4807| 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól|||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3735|5987|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3735||3735|5987| 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|10994|15916|lyfalmen|||00|8|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||10994||10994|15916| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|9004|13194|lyfalmen|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB|Amorolfín||9004||9004|13194| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2065|lyfalmen|V0361|2065|00|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||868||868|2065| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2314|lyfalmen|V0362|2314|00|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||1050||1050|2314| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1827|3152|lyfalmen|V0367|3143|00|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1663||1663|3152| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4898|lyfalmen|V0343|4501|00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4898| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1681|3177|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1681||1681|3177| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2230|3928|lyfalmen|||00|30|0|30,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||2230||2230|3928| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|3951|lyfalmen|||00|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||2247||2247|3951| 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5536|8021|lyfalmen|||10|30|0|3,0000|D.A.C. ehf|D.A.C. ehf|Ciklospórín||5222||5222|8021| 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|20314|26622|lyfalmen|||10|30|0|12,0000|D.A.C. ehf|D.A.C. ehf|Ciklospórín||19397||19397|26622| 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A||0|0|E|0|DAC|0|0|0|100|XEU|14336|7204|lyfalmen|V0718|6054|00|12|0|84,0000|D.A.C. ehf|D.A.C. ehf|Alendrónsýra||4625||4625|7204| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|82356|105636|lyfalmen|||00|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||82356||82356|105636| 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8799|12699|lyfsjukr|||02|12|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Tíópentalnatríum||8799||8799|12699| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BAV|0|0|0|100|SEK|663133|809452|lyfsjukr|||00|112|0|0,0000|Vistor hf|Bayer Schering Pharma AG (V)|Sorafeníb||643482||643482|809452| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4140|6541|lyfalmen|||00|14|0|10,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4140||4140|6541| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|14765|20809|lyfalmen|||00|56|0|42,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14765||14765|20809| 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6075|5490|lyfalmen|V2120|5335|00|100|0|100,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||3372||3372|5490| 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|527|1598|lyfalmen|||04|10|0|3,3333|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||527||527|1598| 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1878|3446|lyfalmen|||10|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1878||1878|3446| 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|D.A.C. ehf|D.A.C. ehf|Ketóprófen|||||| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2259|3967|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2259||2259|3967| 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.12.2009||R|A||0|0|E|0|PCO|0|0|1|100|SEK|691|1822|lyfalmen|||72|25|1|10,0000|Distica|Distica - óskráð lyf|Acetýlcýstein||691||691|1822| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1848|3305|lyfalmen|V1912|3305|00|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1775||1775|3305| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|5344|7631|lyfalmen|V1913|7631|00|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4937||4937|7631| 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.12.2009||R|A||0|0|E|0|PCO|0|0|1|100|SEK|2524|4330|lyfalmen|||72|100|1|40,0000|Distica|Distica - óskráð lyf|Acetýlcýstein||2524||2524|4330| 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|38642|50378|lyfsjukr|||00|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||38642||38642|50378| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1909|2683|lyfalmen|V0308|2683|00|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||1320||1320|2683| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|3111|3798|lyfalmen|V0310|3798|00|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||2135||2135|3798| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|215|1171|lyfalmen|V0858|1171|00|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||215||215|1171| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|576|1665|lyfalmen|V0859|1665|00|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||576||576|1665| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|425533|535926|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||425533||425533|535926| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|359|1368|lyfalmen|V0856|1368|00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||359|1368| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|1153|2454|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1153||1153|2454| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|891|2096|lyfalmen|V0855|2096|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||891|2096| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|857380|1077894|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||857380||857380|1077894| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|867186|1090201|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||867186||867186|1090201| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|4286|6740|lyfalmen|||00|3|0||Vistor hf|Allergan|Tímólól í blöndum||4286||4286|6740| 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|12389|17827|lyfalmen|||00|9|0||Vistor hf|Allergan|Tímólól í blöndum||12389||12389|17827| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|36550|47753|lyfsjukr|||63|25|0|6,2500|Actavis Group hf|Pharmachemie|Kalsíumfólínat||36550||36550|47753| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|45102|58486|lyfsjukr|||00|8212|0|8,2000|Icepharma hf|Fresenius Kabi|Blöndur||45102||45102|58486| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36236|47359|lyfsjukr|||00|7698|0|7,7100|Icepharma hf|Fresenius Kabi|Blöndur||36236||36236|47359| 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|48798|63124|lyfsjukr|||63|10|0|8,3333|Actavis Group hf|Pharmachemie|Kalsíumfólínat||48798||48798|63124| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|41929|54503|lyfsjukr|||00|7680|0|7,6800|Icepharma hf|Fresenius Kabi|Blöndur||41929||41929|54503| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|29425|38811|lyfsjukr|||00|7200|0|7,2000|Icepharma hf|Fresenius Kabi|Blöndur||29425||29425|38811| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|47226|61151|lyfsjukr|||00|7880|0|7,9000|Icepharma hf|Fresenius Kabi|Blöndur||47226||47226|61151| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|43938|57025|lyfsjukr|||00|7616|0|7,6000|Icepharma hf|Fresenius Kabi|Blöndur||43938||43938|57025| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2997|4977|lyfalmen|V0903|4977|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2997||2997|4977| 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2471|4257|lyfalmen|||23|63|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2471||2471|4257| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|84426|107837|lyfsjukr|||00|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||84426||84426|107837| 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5818|8836|lyfalmen|||10|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||5818||5818|8836| 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6269|9453|lyfalmen|||02|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6269||6269|9453| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|41055|53803|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||41055||41055|53803| 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000|28.02.2010|R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|12896|18464|lyfalmen|||00|30|0|30,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||12896||12896|18464| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|39276|51570|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||39276||39276|51570| 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000|28.02.2010|R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|6187|9341|lyfalmen|||00|3|0|20,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||6187||6187|9341| 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|122952|156187|lyfsjukr|||43|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|||122952||122952|156187| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|639|1751|lyfalmen|V0902|1751|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||639||639|1751| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|16018|22382|lyfalmen|||00|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16018||16018|22382| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|A||0|0|0|0|OTS|0|1|0|100|DKK|1714|3222|lyfalmen|||00|1|0|0,6600|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1714||1714|3222| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1278|2625|lyfalmen|||20|30|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1278||1278|2625| 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979|31.01.2010|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|932|2152|lyfalmen|||28|20|0|2,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||932||932|2152| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2887|4827|lyfalmen|||02|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2887||2887|4827| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|1,2500|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|72686|93103|lyfsjukr|||00|56|0|22,4000|Icepharma hf|Roche Registration Limited|Ribavirin||72686||72686|93103| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|2,5000|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1487|2911|lyfalmen|||00|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1487||1487|2911| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|100|XEU|1939|3530|lyfalmen|V0914|3530|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1939||1939|3530| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8607|15014|vetorma|||16|20|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||8607||8607|15014| 054936|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.10.2009||R|A||0|0|B|0|LVR|0|1|0|100|DKK|11286|16316|lyfalmen|V0938|14137|00|98|0|98,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||11286||11286|16316| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|836|2021|lyfalmen|||10|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||836||836|2021| 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|10311|14982|lyfalmen|||10|100|0|60,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||10311||10311|14982| 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5310|8141|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||5310||5310|8141| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4359|2426|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2426| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6185|3144|lyfalmen|V2207|3144|00|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3144| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|5945|lyfalmen|V0339|5945|00|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|5945| 056514|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.11.2009||R|K||0|1|0|1|SOI|0|0|0|100|SEK|98697|125747|lyfsjukr|||00|3|0||Swedish Orphan International AB|Swedish Orphan International AB|||||98697|125747| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1349|2723|lyfalmen|||10|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1349||1349|2723| 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|29211|38542|lyfsjukr|||00|81|0|0,0000|xxxxx|Paranova A/S|||29211||29211|38542| 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|269651|340295|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||269651||269651|340295| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|74325|95160|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||74325||74325|95160| 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3611|5817|lyfalmen|V2222|5817|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||3611|5817| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11488|16592|lyfalmen|V2223|16592|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11488|16592| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|20803|27990|lyfsjukr|||02|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||20803||20803|27990| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|11054|15755|lyfsjukr|||02|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||11054||11054|15755| 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7197|10387|lyfsjukr|||00|200|0|0,2000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||7197||7197|10387| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|5951|8589|lyfsjukr|||02|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||5951||5951|8589| 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|27709|36657|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||27709||27709|36657| 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007|31.01.2010|R|A|2|0|0|0|0|SBM|0|0|0|100|NOK|5988|9069|lyfalmen|||00|28|0|56,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5988||5988|9069| 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007|31.01.2010|R|A|2|0|0|0|0|SBM|0|0|0|100|NOK|21306|29018|lyfalmen|||00|98|0|196,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||21306||21306|29018| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|22556|30587|lyfalmen|||0|112|0|56,0000|Vistor hf|Pfizer Limited|||||22556|30587| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|477|1530|lyfalmen|||02|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||477||477|1530| 058283|QI01AD040|Avipro Thymovac|frþlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|181149|316005|vetorma|||00|5000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||181149|316005| 058294|QI01AD040|Avipro Thymovac|frþlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|275184|480045|vetorma|||00|10000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||275184|480045| 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22476|30486|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||22476||22476|30486| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1035|2293|lyfalmen|||00|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1035||1035|2293| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|126642|160818|lyfsjukr|||00|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||126642||126642|160818| 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1732|3247|lyfalmen|||43|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1732||1732|3247| 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2730|4612|lyfalmen|||43|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2730||2730|4612| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4435|6944|lyfalmen|||51|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4435||4435|6944| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1728|3241|lyfalmen|||00|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíð dínítrat||1728||1728|3241| 059295|S01AA0104|Kloramfenikol|augnsm|1|%|5|g|1|túpa||S01AA01|01.10.2009||R|A||0|0|E|0|LVE|0|0|1|100|IKR|1980|3586|lyfalmen|||07|5|1|0,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Klóramfeníkól||1980||1980|3586| 059353|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.02.2010||R|K||0|1|0|1|CEO|0|0|0|100|DKK|259925|328088|lyfsjukr|||00|1|0||Vistor hf|Centocor B.V.|Golimumab||||259925|328088| 059364|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.02.2010||R|K||0|1|0|1|CEO|0|0|0|100|DKK|259925|328088|lyfsjukr|||00|1|0||Vistor hf|Centocor B.V.|Golimumab||||259925|328088| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|115854|147676|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||115854||115854|147676| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|33859|44772|lyfalmen|||51|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||33859||33859|44772| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|127934|162440|lyfsjukr|||00|30|0|0,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||127934||127934|162440| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|A||0|0|E|0|BPC|0|0|0|100|SEK|34599|45701|lyfalmen|||00|30|0||Vistor hf|Bial-Portela & C.S.A.|||34599||34599|45701| 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|8086|11670|lyfsjukr|||00|28|0|7,0000|Vistor hf|Schering-Plough|Búprenorfín í blöndum||8086||8086|11670| 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|18333|24890|lyfsjukr|||00|28|0|28,0000|Vistor hf|Schering-Plough|Búprenorfín í blöndum||18333||18333|24890| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|437291|551079|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||437291||437291|551079| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|221457|280208|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||221457||221457|280208| 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|110729|141244|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||110729||110729|141244| 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|8512|12521|lyfalmen|||10|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||8512||8512|12521| 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2039| 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2039| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|3072|6071|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||3072|6071| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1610|3203|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||1610|3203| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|9508|18429|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Animal Health|||||9508|18429| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|7877|11653|lyfalmen|V1030|11653|00|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||||7877|11653| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|50|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7878|11654|lyfalmen|V1030|11653|00|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7878||7878|11654| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||2064| 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|DKK|174428|220790|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Temsirolímus||174428||174428|220790| 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|50|0|8,3333|Actavis Group hf|Actavis hf|Acetýlsalicýlsýra|||||| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7369|10635|lyfsjukr|||00|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7369||7369|10635| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|19361|26181|lyfsjukr|||00|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||19361||19361|26181| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|27404|36275|lyfsjukr|||00|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||27404||27404|36275| 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|566|1652|lyfalmen|||10|30|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||566||566|1652| 062343|A10BD0401|Avaglim|filmhtfl|8|mg|28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|5147|7918|lyfalmen|||00|28|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||5147||5147|7918| 062376|C05AA0103|Proctosedyl (D.A.C.)|eþ-smyr|0||30|g|1|túpa||C05AA01|01.10.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|D.A.C. ehf|D.A.C. ehf|Hýdrókortisón|||||| 062379|A10BD0401|Avaglim|filmhtfl|12|mg|28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7701|11412|lyfalmen|||00|28|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||7701||7701|11412| 062387|N04BC0502|Sifrol|forðatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|1864|3427|lyfalmen|||00|10|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||1864|3427| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|7438|10735|lyfsjukr|||02|20|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||7438||7438|10735| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|523|755|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||523||523|755| 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1035|2293|lyfalmen|||10|60|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1035||1035|2293| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2282|3999|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2282||2282|3999| 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|20123|35104|vetorma|||16|1000|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||20123||20123|35104| 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|DKK|1935|3524|lyfalmen|||23|63|0|63,0000|Icepharma hf|Wyeth Medica|Gestóden og östrógen||1935||1935|3524| 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|17038|23662|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||17038||17038|23662| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|5739|8728|lyfalmen|||00|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||5739||5739|8728| 063340|D05AX0202|Daivonex (D.A.C.)|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.12.2009||R|A||0|0|B|0|DAC|0|0|0|100|DKK|7513|11155|lyfalmen|V0092|11155|00|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Kalcípótríól||7513||7513|11155| 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2313|4041|lyfalmen|||23|14|0|10,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||2313||2313|4041| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||3077| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4501|lyfalmen|V0343|4501|00|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2649||2649|4501| 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1804|3345|lyfalmen|V1901|3345|00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1804||1804|3345| 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|11456|16260|lyfsjukr|||17|2|0|0,0000|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||11456||11456|16260| 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2830|4937|vetorma|||16|12|0|0,0000|Vistor hf|Fort Dodge Veterinär GmbH|||2830||2830|4937| 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1190|2505|lyfalmen|||10|30|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1190||1190|2505| 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2278|3993|lyfalmen|||10|60|0|60,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2278||2278|3993| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1211340|1522114|lyfsjukr|||00|1|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1211340|1522114| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|484536|609975|lyfsjukr|||00|1|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||484536|609975| 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2619|4460|lyfalmen|||10|30|0|60,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2619||2619|4460| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|4845362|6082812|lyfsjukr|||00|1|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4845362|6082812| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2422682|3042348|lyfsjukr|||00|1|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2422682|3042348| 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|975|2211|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||975||975|2211| 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2182|3862|lyfalmen|||38|25|0|0,0000|Vistor hf|Stiefel Laboratories (UK) Ltd.|Klindamýcín í blöndum||2182||2182|3862| 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|14591|20591|lyfalmen|||51|5|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||14591||14591|20591| 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|6|0|6,0000|Vistor hf|Bayer A/S|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|Vistor hf|Bayer A/S|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|21090|28350|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||||21090|28350| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2797|4703|lyfalmen|V1989|3941|06|2|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||2797||2797|4703| 065722|S01EE0101 |Xalatan|augndr|50|mcg/ml|7,5|ml|1|glas|3 glös í pakka|S01EE01|01.05.2009||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|8385|12348|lyfalmen|V1989|11823|06|8|0|75,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||||8385|12348| 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|101|IKR|||lyflausa|||23|14|0|17,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065778|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.12.2009||R|K||0|1|0|1|WTE|0|0|0|100|DKK|177702|224899|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||||177702|224899| 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|6882|9932|lyfsjukr|||02|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||||6882|9932| 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|2381|4134|lyfalmen|V0195|2234|00|28|0|7,0000|Icepharma hf|M.S.D.|Lósartan||2381||2381|4134| 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984|28.02.2010|R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1203|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||238||238|1203| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|8050|11889|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||8050||8050|11889| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|32628|42831|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||32628||32628|42831| 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|23361|45029|vetalmen|||16|10|0|0,0000|Icepharma hf|Ceva Sante Animale|||23361||23361|45029| 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1034|2292|lyfalmen|||00|100|0|10,0000|Actavis Group PTC ehf|Merck NM AB|Klómípramín||1034||1034|2292| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||02|120|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1989|3598|lyfalmen|V0144|3598|70|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1989||1989|3598| 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|718|1859|lyfalmen|||23|20|0|2,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||718||718|1859| 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7941|11740|lyfalmen|||00|84|0|56,0000|Medico ehf|Solvay Duphar |Betahistín||7941||7941|11740| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1487|2911|lyfalmen|||00|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1487||1487|2911| 067632|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|7599|14764|vetalmen|||0|10|0|0,0000|Dýraheilsa ehf|Laboratorios SYVA S.A.|||||7599|14764| 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A||0|0|0|0|DAC|0|0|1|100|DKK|845|2033|lyfalmen|V0901|2033|00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Nítrazepam||845||845|2033| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3257|lyfalmen|V0551|3257|10|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1740||1740|3257| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|5834|8858|lyfalmen|V0552|8858|10|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||5834||5834|8858| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1909|lyfalmen|V0554|1909|10|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||754||754|1909| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2848|lyfalmen|V0555|2848|10|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||1441||1441|2848| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4297|lyfalmen|V0556|4297|10|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2500||2500|4297| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|22063|29968|lyfalmen|V0557|29968|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||22063||22063|29968| 068043|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|2|glas|sk-úðari|R01AA07|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6812|13253|vetalmen|||27|50|0|0,0000|Icepharma hf|Vétoquinol AG|||6812||6812|13253| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|2499|4296|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||2499||2499|4296| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|7056|10530|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||7056||7056|10530| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3267|lyfalmen|||00|14|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3267| 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|17160|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|17160| 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|DKK|3488|5649|lyfalmen|||00|40|0|10,0000|Icepharma hf|NordMedica A/S|Cefalexín||3488||3488|5649| 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|DKK|1756|3279|lyfalmen|||00|20|0|5,0000|Icepharma hf|NordMedica A/S|Cefalexín||1756||1756|3279| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|18540|25547|lyfalmen|V0796|25547|00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18540|25547| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|26816|35933|lyfalmen|V0797|35933|00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||26816|35933| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|34728|45863|lyfalmen|V0798|45863|00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||34728|45863| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|76176|97483|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||76176||76176|97483| 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|33763|44255|lyfsjukr|||00|10|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||33763||33763|44255| 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|6029|8701|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||6029||6029|8701| 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5625|8118|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5625||5625|8118| 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9879|14258|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||9879||9879|14258| 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6287|9074|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||6287||6287|9074| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|5980|11655|vetalmen|||27|100|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||5980||5980|11655| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|18849|25935|lyfalmen|||00|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||18849||18849|25935| 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|6332|12331|vetalmen|||16|1250|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||6332||6332|12331| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1873|lyfalmen|||00|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||728||728|1873| 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984|28.02.2010|R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1093|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||158||158|1093| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|66863|85796|lyfsjukr|||00|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||66863||66863|85796| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|334315|421448|lyfsjukr|||00|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||334315||334315|421448| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|þpakki||B01AC04|01.01.2010||R|A||0|0|E|0|PSA|0|0|0|100|NOK|7529|11177|lyfalmen|V1091|11177|00|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||7529||7529|11177| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|8697|16872|vetalmen|||27|5|0|0,0000|Vistor hf|Orion-Farmos|||8697||8697|16872| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|15220|21380|lyfalmen|||00|15|0|5,0000|Icepharma hf|Roche A.S.|Granisetrón||15220||15220|21380| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|A||0|0|E|0|PSA|0|0|0|100|NOK|24965|32043|lyfalmen|V0090|32043|00|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||23716||23716|32043| 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21346|29068|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||21346||21346|29068| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|672|970|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Súfentaníl||672||672|970| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|185375|234528|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||185375||185375|234528| 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|2058|2970|lyfsjukr|||02|5|0|0,0000|Vistor hf|Janssen-Cilag AB|Súfentaníl||2058||2058|2970| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|16614|23130|lyfalmen|||00|1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíð||16614||16614|23130| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|16614|23130|lyfalmen|||00|2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíð||16614||16614|23130| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1458|2872|lyfalmen|||00|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1458||1458|2872| 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|4296|5800|lyfalmen|||10|100|0|100,0000|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3599||3599|5800| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1827|3376|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1827||1827|3376| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|341|1344|lyfalmen|V0858|1171|00|20|0|5,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||341||341|1344| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|918|2133|lyfalmen|V0859|1665|00|50|0|12,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||918||918|2133| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1330|2697|lyfalmen|V0855|2096|00|100|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1330||1330|2697| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|576|1665|lyfalmen|V0856|1368|00|20|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||576||576|1665| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1984|3591|lyfalmen|||00|100|0|50,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1984||1984|3591| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|5183|7967|lyfalmen|V0096|7967|00|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||5183||5183|7967| 074027|G04BE0303|Viagra (D.A.C.)|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|5853|8884|lyfalmen|V0097|8884|00|4|0|4,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||5853||5853|8884| 074038|N02AB0304|Durogesic (D.A.C.)|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2009||R|A||1|0|E|0|DAC|0|0|0|100|SEK|3446|5591|lyfalmen|V0102|5591|00|5|0|9,9900|D.A.C. ehf|D.A.C. ehf|Fentanýl||3446||3446|5591| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4008|6360|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4008||4008|6360| 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|11672|16844|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||11672||11672|16844| 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|5114|7873|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5114||5114|7873| 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|15052|21169|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15052||15052|21169| 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|5114|7873|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5114||5114|7873| 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|16896|23484|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||16896||16896|23484| 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6126|9257|lyfalmen|||00|28|0|28,0000|Vistor hf|Abbott Laboratories A/S|Sibutramin||6126||6126|9257| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|41193|53580|lyfsjukr|||00|50|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||41193||41193|53580| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|256|1227|lyfalmen|||00|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||256||256|1227| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|520|1589|lyfalmen|||00|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||520||520|1589| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|23113|40319|vetorma|||58|25|0|0,0000|Vistor hf|Scan Vet Animal Health AS|||23113||23113|40319| 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2429|4200|lyfalmen|||23|4|0|3,5000|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2429||2429|4200| 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6126|9257|lyfalmen|||00|28|0|42,0000|Vistor hf|Abbott Laboratories A/S|Sibutramin||6126||6126|9257| 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1645|2452|lyfalmen|V1910|2404|00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1151||1151|2452| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5458|8344|lyfalmen|||00|30|0||Vistor hf|Novartis Europharm Ltd|||5458||5458|8344| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|16372|22826|lyfalmen|||00|90|0||Vistor hf|Novartis Europharm Ltd|||16372||16372|22826| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|MCN|0|0|1|100|SEK|1827|3376|lyfalmen|||69|10|0|10,0000|Vistor hf|McNeil Sweden AB|Ketókónazól||1827||1827|3376| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5458|8344|lyfalmen|||00|30|0||Vistor hf|Novartis Europharm Ltd|||5458||5458|8344| 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2326|3390|lyfalmen|V1912|3305|00|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1837||1837|3390| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|16372|22826|lyfalmen|||00|90|0||Vistor hf|Novartis Europharm Ltd|||16372||16372|22826| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2929|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1500||1500|2929| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2934|4891|lyfalmen|||00|300|0|300,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2934||2934|4891| 075288|N05AX1203|Abilify (Lyfjaver)|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|DKK|37582|49444|lyfalmen|V0106|49444|00|56|0|12,4000|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||||37582|49444| 075299|M01AH0103|Celebra (Lyfjaver)|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2009||R|A||0|0|E|0|LVR|0|0|1|100|DKK|7841|11603|lyfalmen|||00|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||||7841|11603|31.03.2010 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2978|lyfalmen|||10|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|2978| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2009||R|A||0|0|E|0|LVR|0|0|1|100|DKK|14824|20883|lyfalmen|V2140|20883|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||||14824|20883| 075321|G04BE0803|Cialis (Lyfjaver)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2009||R|A||0|0|0|0|LVR|0|0|0|100|XEU|12969|18555|lyfalmen|V1351|18555|00|8|0|16,0000|Lyfjaver ehf|Lyfjaver ehf|Tadalafíl||||12969|18555| 075334|G04BE0803|Cialis (Lyfjaver)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2009||R|A||0|0|0|0|LVR|0|0|0|100|XEU|6583|9882|lyfalmen|V1350|9882|00|4|0|8,0000|Lyfjaver ehf|Lyfjaver ehf|Tadalafíl||||6583|9882| 075367|L02BG0403|Femar (Lyfjaver)|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.12.2009||R|A||0|0|*|0|LVR|0|0|0|100|DKK|60813|78599|lyfalmen|V0563|78599|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Letrózól||||60813|78599| 075379|G03GA0602|Puregon (Lyfjaver)|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.12.2009||R|K||0|1|E|0|LVR|0|0|0|100|DKK|62241|80392|lyfalmen|||00|1|0|12,0000|Lyfjaver ehf|Lyfjaver ehf|Follitrópín beta||||62241|80392|31.03.2010 075382|V04CL0030|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||8287||8287|12213| 075391|N05AL0502|Solian (Lyfjaver)|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|21782|29615|lyfalmen|V0105|29615|00|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríð||||21782|29615| 075402|N05AL0502|Solian (Lyfjaver)|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|7853|11620|lyfalmen|V0104|11620|00|90|0|11,2500|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríð||||7853|11620| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||8287||8287|12213| 075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.12.2009||R|A||0|0|E|0|LVR|0|0|0|100|XEU|23134|31312|lyfalmen|||00|90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||||23134|31312|28.02.2010 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||8287||8287|12213| 075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.12.2009||R|A||0|0|E|0|LVR|0|0|0|100|XEU|18835|25917|lyfalmen|||00|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||||18835|25917|28.02.2010 075436|G04BE0304|Viagra (Lyfjaver)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|LVR|0|0|0|100|DKK|6405|9639|lyfalmen|V0098|9639|00|4|0|8,0000|Lyfjaver ehf|Lyfjaver ehf|Síldenafíl||||6405|9639| 075440|V04CL0026|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||8287||8287|12213| 075447|G04BE0304|Viagra (Lyfjaver)|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|LVR|0|0|0|100|DKK|17724|24523|lyfalmen|V0099|24523|00|12|0|24,0000|Lyfjaver ehf|Lyfjaver ehf|Síldenafíl||||17724|24523| 075458|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|16125|22516|lyfalmen|V0103|22516|00|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalinum||||16125|22516| 075465|V04CL0024|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8287||8287|12213| 075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8287||8287|12213| 075507|V04CL0018|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8287||8287|12213| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8287||8287|12213| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8287||8287|12213| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8287||8287|12213| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8287||8287|12213| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8287||8287|12213| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||8287||8287|12213| 075689|V04CL0027|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||8287||8287|12213| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||8287||8287|12213| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||8287||8287|12213| 075724|B02BD0901|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|129253|164095|lyfsjukr|||00|1000|0|2,8600|Icepharma hf|Wyeth Europe|Storkuþáttur IX||129253||129253|164095| 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2322|4619|vetalmen|||13|25|0|0,0000|Vistor hf|VetXX A/S|||2322||2322|4619| 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6654|9603|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6654||6654|9603| 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6654|9603|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6654||6654|9603| 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6534|9430|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6534||6534|9430| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|A||0|0|0|0|AEA|0|0|1|100|XEU|502|1564|lyfalmen|||00|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||502||502|1564| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|XEU|7299|10862|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Sítagliptín||7299||7299|10862| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|25250|33968|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Sítagliptín||25250||25250|33968| 076181|L04AA0603|Cellcept (D.A.C.)|töflur|500|mg|50|stk|1|þpakki||L04AA06|01.12.2009||R|A||0|1|*|0|DAC|0|0|0|100|DKK|23394|31639|lyfalmen|||00|50|0|12,5000|D.A.C. ehf|D.A.C. ehf|Mýcófenólsýra||23394||23394|31639| 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000|28.02.2010|R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2976|4948|lyfalmen|||24|30|0|33,2500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||2976||2976|4948| 076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.12.2009||L|A||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1887|lyfalmen|V1070|1887|00|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||738||738|1887| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3241|lyfalmen|V1075|3241|00|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1728||1728|3241| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4103|lyfalmen|V0791|4103|00|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||2358||2358|4103| 076533|N05AB0301 |Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|992|2234|lyfalmen|||00|100|0|6,6667|Vistor hf|Schering-Plough|Perfenazín||||992|2234| 076542|N05AB0301 |Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1376|2760|lyfalmen|||00|100|0|13,3333|Vistor hf|Schering-Plough|Perfenazín||||1376|2760| 076551|N05AB0301 |Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1961|3560|lyfalmen|||00|100|0|26,6667|Vistor hf|Schering-Plough|Perfenazín||||1961|3560| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7951|13870|vetorma|||27|100|0|0,0000|Vistor hf|Merial (MSD)|||7951||7951|13870| 076814|J07AL5201|Synflorix|stl|0||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|K||0|0|0|0|GLB|0|0|0|100|GBP|7951|11754|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||7951||7951|11754| 076859|M01AH0104|Celebrex (D.A.C.)|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.04.2010||R|A||0|0|E|0|DAC|0|0|1|100|DKK|3037|5032|lyfalmen|V0101|5032|00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Celekoxíb||||3037|5032| 076871|D01AC0102|Canesten (D.A.C.)|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077215|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|DKK|6262|9443|lyfalmen|||0|12|0|2,0000|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||6262||6262|9443| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1151|lyfalmen|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||200||200|1151| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1568|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||505||505|1568| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|729|1874|lyfalmen|||02|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||729||729|1874| 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|881|1465|lyfalmen|V0609|1465|10|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak||430||430|1465| 078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Ekónazól|||||| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||29|4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||| 078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||| 078318|L03AB0504|IntronA (D.A.C.)|stl|18|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009||R|K||0|1|0|1|DAC|0|0|0|100|DKK|29008|38288|lyfsjukr|||00|1|0|9,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||29008||29008|38288| 078330|L03AB0504|IntronA (D.A.C.)|stl|30|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009||R|K||0|1|0|1|DAC|0|0|0|100|DKK|47250|61181|lyfsjukr|||00|1|0|15,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||47250||47250|61181| 078341|L03AB0504|IntronA (D.A.C.)|stl|60|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009||R|K||0|1|0|1|DAC|0|0|0|100|DKK|96723|123270|lyfsjukr|||00|1|0|30,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||96723||96723|123270| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|534|1608|lyfalmen|||00|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||534||534|1608| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|813|1989|lyfalmen|||00|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||813||813|1989| 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|998|2242|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Flúoxetín||998||998|2242| 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|4110|6500|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Flúoxetín||4110||4110|6500| 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|3344|5452|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Merck NM AB|Míanserín||3344||3344|5452| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|160186|202916|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||160186||160186|202916| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|9898|6553|lyfalmen|V0197|3872|00|98|0|98,0000|Icepharma hf|M.S.D.|Lósartan||4149||4149|6553| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2657|3835|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||2657||2657|3835| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4721|6814|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||4721||4721|6814| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|7944|11465|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||7944||7944|11465| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3730|5980|lyfalmen|||00|10|0|4,6700|Icepharma hf|Roche Registration Limited|Oseltamivír||3730||3730|5980| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|20532|28047|lyfalmen|||02|10|0|154,5714|Vistor hf|Schering-Plough|Perfenazín||20532||20532|28047| 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2305|3327|lyfsjukr|||03|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2305||2305|3327| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1415|lyfalmen|V0514|1415|00|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1415| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1750|lyfalmen|V0518|1750|00|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1750| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1762|lyfalmen|V0522|1762|00|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1762| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2475|lyfalmen|V0526|2475|00|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2475| 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||05|1|0|1,5000|Vistor hf|Janssen-Cilag AB|Ekónazól|||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2501|4298|lyfalmen|||00|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2501||2501|4298| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|6360|9577|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||6360||6360|9577| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|3160|5200|lyfalmen|||00|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3160||3160|5200| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|33844|59039|vetorma|||27|500|0|0,0000|Vistor hf|Merial (MSD)|||33844||33844|59039| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|26744|35446|lyfsjukr|||00|1|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||26744||26744|35446| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|44435|57648|lyfsjukr|||00|1|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||44435||44435|57648| 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|43114|56387|lyfalmen|||02|12|0|34,7222|Vistor hf|AstraZeneca A/S DK|Natríumhýalúrónat||43114||43114|56387| 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2299|3318|lyfsjukr|||02|10|0|3,3333|Icepharma hf|Roche|Mídazólam||2299||2299|3318| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.04.2010||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|21751|29577|lyfalmen|V0813|29577|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||||21751|29577| 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|6148|9287|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6148||6148|9287| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10404|15109|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10404||10404|15109| 082040|D07XC0101|Diprosalic|áburður|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3696|5933|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||||3696|5933| 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3261|4844|lyfalmen|||23|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2900||2900|4844| 082701|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|705|1842|lyfalmen|||00|60|0|3,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||705||705|1842| 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5327|8164|lyfalmen|||23|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5327||5327|8164| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|1102|2385|lyfalmen|||00|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1102||1102|2385| 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1761|3286|lyfalmen|||00|200|0|10,0000|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1761||1761|3286| 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|5536|8450|lyfalmen|||00|100|0|6,2500|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5536||5536|8450| 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|6083|9198|lyfalmen|||00|40|0|12,5000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6083||6083|9198| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14576|20572|lyfalmen|||00|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14576||14576|20572| 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|19281|26477|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19281||19281|26477| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|15223|21384|lyfalmen|V1372|21383|00|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||15223||15223|21384| 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|7735|11458|lyfalmen|||00|40|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7735||7735|11458| 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|MSE|0|0|0|100|SEK|53018|68817|lyfalmen|||03|10|0|10,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||53018||53018|68817| 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|MSE|0|0|0|100|SEK|107718|137465|lyfalmen|||03|10|0|20,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||107718||107718|137465| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|85073|108649|lyfsjukr|||00|450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||85073||85073|108649| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|33034|43737|lyfalmen|||00|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||33034||33034|43737| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|9423|13600|lyfsjukr|||02|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||9423||9423|13600| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|298|1285|lyfalmen|||02|10|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||298||298|1285| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|574|1662|lyfalmen|||02|20|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||574||574|1662| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|70348|90169|lyfsjukr|||00|0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||70348||70348|90169| 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2465|lyfalmen|||00|100|0|6,6667|Actavis Group hf|Actavis hf|Kínín||1161||1161|2465| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|91733|117007|lyfsjukr|||00|0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||91733||91733|117007| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|109370|139142|lyfsjukr|||00|0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||109370||109370|139142| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|23594|31493|lyfsjukr|||00|0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||23594||23594|31493| 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4240|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Kínín||2458||2458|4240| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|35306|46192|lyfsjukr|||00|0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||35306||35306|46192| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|46964|60822|lyfsjukr|||00|0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||46964||46964|60822| 084751|B03XA0301 |Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|14001|19454|lyfsjukr|||00|0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||14001|19454| 084778|B03XA0301 |Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|53371|68863|lyfsjukr|||00|0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||53371|68863| 084787|B03XA0301 |Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|164379|208178|lyfsjukr|||00|0|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||164379|208178| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|1133|2427|lyfalmen|||00|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||1133||1133|2427| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|13103|18723|lyfalmen|||00|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||13103||13103|18723| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|43682|57100|lyfalmen|||00|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||43682||43682|57100| 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|17138|23787|lyfalmen|||10|100|0|100,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||17138||17138|23787| 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|6411|7497|lyfalmen|V2206|7497|0|98|0|49,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4839||4839|7497| 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4352|lyfalmen|V2170|4323|0|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4352| 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4530|7074|lyfalmen|V2171|7074|0|98|0|98,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||4530|7074| 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5379|lyfalmen|||0|28|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||3291|5379| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3362|5476|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||3362||3362|5476| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|33034|43737|lyfalmen|||00|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||33034||33034|43737| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|802|1974|lyfalmen|||00|50|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||802||802|1974| 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|14500|20080|lyfsjukr|||00|4|0|40,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||14500||14500|20080| 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|22480|30491|lyfalmen|||00|375|0|12,5000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||22480||22480|30491| 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|39995|52473|lyfalmen|||00|750|0|25,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||39995||39995|52473| 085829|S01EB0104|Pilokarpin|augndr|2|%|0,5|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2270|3982|lyfalmen|||00|10|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||2270||2270|3982| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5712|5800|lyfalmen|V1911|5342|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3599||3599|5800| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6868|8112|lyfalmen|V1913|7631|00|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5289||5289|8112| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8885|12823|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8885||8885|12823| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|14672|20296|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14672||14672|20296| 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|70305|90115|lyfsjukr|||00|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |||70305||70305|90115| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|A||0|0|0|1|ROA|0|0|0|100|DKK|53203|68652|lyfsjukr|||00|100|0|5,5000|Icepharma hf|Roche A.S.|||||53203|68652| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3580|5775|lyfalmen|||00|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3580||3580|5775| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14,4000|Vistor hf|Janssen-Cilag AB|Silíkonsambönd|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|177987|225256|lyfsjukr|||00|60|0|15,0000|Vistor hf|Pfizer Limited|Maravíroc||177987||177987|225256| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|307|1297|lyfalmen|||00|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||307||307|1297| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|270|1247|lyfalmen|V0886|1234|00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||270||270|1247| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|3194|5246|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||3194||3194|5246| 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||01|500|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||3485| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|EMA|0|0|0|100|SEK|881|2082|lyfalmen|||00|5|0|27,7778|Icepharma hf|E. Merck AB|Klómífen||881||881|2082| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|16357|17640|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||12240||12240|17640| 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Lyfjaver ehf|Lyfjaver ehf|Nikótín|||||| 088033|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|29803|39285|lyfsjukr|||00|1|0|9,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||29803||29803|39285| 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|48544|62805|lyfsjukr|||00|1|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||48544||48544|62805| 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|99364|126584|lyfsjukr|||00|1|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||99364||99364|126584| 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1397|2788|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1397||1397|2788| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1852|3411|lyfalmen|||14|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1852||1852|3411| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|9183|13439|lyfalmen|||14|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||9183||9183|13439| 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|561|1645|lyfalmen|||04|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||561||561|1645| 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|172523|218399|lyfsjukr|||00|70|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|||||172523|218399| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|46475|45258|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||34246||34246|45258| 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|120|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||5572| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|177987|225256|lyfsjukr|||00|60|0|30,0000|Vistor hf|Pfizer Limited|Maravíroc||177987||177987|225256| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2298|4021|lyfalmen|||00|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2298||2298|4021| 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|XEU|44967|58316|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||44967||44967|58316| 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|XEU|224834|284049|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||224834||224834|284049| 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1870|3435|lyfalmen|||24|16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1870||1870|3435| 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|893|2099|lyfalmen|||00|60|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||893||893|2099| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2079|2563|lyfalmen|V0001|1929|00|90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríð||1232||1232|2563| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3742|3549|lyfalmen|V0002|2539|00|90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríð||1953||1953|3549| 092005|N06AB1001 |Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|B|0|LBK|0|0|0|100|DKK|4263|6709|lyfalmen|||00|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4263|6709| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|8052|15634|vetalmen|||16|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||8052||8052|15634| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|8327|12268|lyfalmen|V1091|10432|00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||8327||8327|12268| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|10400|15104|lyfalmen|||00|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||10400||10400|15104|31.03.2010 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|29164|38880|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||29164|38880| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|29164|38880|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||29164|38880| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|442|1482|lyfalmen|||10|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||442||442|1482| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|575|1664|lyfalmen|||10|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||575||575|1664| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5534|8447|lyfalmen|||00|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5534||5534|8447| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|29121|50800|vetorma|||00|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||29121||29121|50800| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|17024|23248|lyfsjukr|||00|5|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||17024||17024|23248| 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|19506|26759|lyfalmen|||10|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||19506||19506|26759| 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|50118|65177|lyfalmen|||10|98|0|261,3300|Icepharma hf|Norpharma |Oxýcódon||50118||50118|65177| 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2220|3914|lyfalmen|||10|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2220||2220|3914| 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4439|6950|lyfalmen|||10|100|0|66,6667|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||4439||4439|6950| 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2886|4825|lyfalmen|V0385|4825|23|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2886||2886|4825| 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1962|3903|vetalmen|||00|8|0|0,0000|Vistor hf|Boehringer Ingelheim|||1962||1962|3903| 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|14307|20234|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14307||14307|20234| 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|20494|27999|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||20494||20494|27999| 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|92215|118009|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||92215||92215|118009| 094933|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|DKK|43792|57238|lyfalmen|||0|84|0|14,0000|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||43792||43792|57238| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3035|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráð lyf|||1577||1577|3035| 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3641|5858|lyfalmen|||00|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||3641||3641|5858| 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17914|24761|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17914||17914|24761| 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|43141|56421|lyfalmen|||00|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||43141||43141|56421| 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17914|24761|lyfalmen|||00|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17914||17914|24761| 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|39093|51341|lyfalmen|||00|56|0|56,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||39093||39093|51341| 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17914|24761|lyfalmen|||00|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17914||17914|24761| 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|68830|88661|lyfalmen|||00|56|0|84,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||68830||68830|88661| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4003|7859|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4003||4003|7859| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5283|10317|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5283||5283|10317| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9620|18644|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9620||9620|18644| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2882|4159|lyfsjukr|||02|60|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||2882||2882|4159| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|15048|20768|lyfsjukr|||17|10|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||15048||15048|20768| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|120389|152971|lyfsjukr|||17|100|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||120389||120389|152971| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1482|2905|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1482||1482|2905| 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17697|24489|lyfalmen|||00|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17697||17697|24489| 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|786|1935|lyfalmen|V1500|1935|07|5|0|0,0000|D.A.C. ehf|D.A.C. ehf|Fúsidínsýra||773||773|1935| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1066179|1339937|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||1066179|1339937| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|978924|1230432|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||978924|1230432| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1030127|1294692|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||1030127|1294692| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1131163|1421492|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||1131163|1421492| 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17697|24489|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17697||17697|24489| 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1692|3192|lyfalmen|||00|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1692||1692|3192| 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|35395|46700|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||35395||35395|46700| 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|97596|124365|lyfsjukr|||00|1|0|1,0000|Vistor hf|Pfizer Limited|Anidulafungin||97596||97596|124365| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.04.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|37607|49079|lyfsjukr|||00|10000|0|10,0000|Actavis Group hf|Braun|Hýdróxyetýl sterkja||||37607|49079| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2400|4093|lyfalmen|V0426|4093|00|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2351||2351|4093| 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1222|2549|lyfalmen|||00|120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1222||1222|2549| 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|23026|30780|lyfsjukr|||00|20|1|0,0000|Distica|Distica - óskráð lyf|||23026||23026|30780| 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998|28.02.2010|R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1928|3515|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1928||1928|3515| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4858|4409|lyfalmen|V0003|3096|00|90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríð||2582||2582|4409| 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4623|lyfalmen|V0831|4623|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4623| 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3500|lyfalmen|V0832|3500|00|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3500| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1206|2527|lyfalmen|V1151|2527|00|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1206||1206|2527| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|7494|3872|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||2189||2189|3872|28.02.2010 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|11051|3915|lyfalmen|||00|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||2221||2221|3915|31.03.2010 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998|28.02.2010|R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|18756|25818|lyfalmen|||02|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||18756||18756|25818| 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|3485|5576|lyfalmen|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||3435||3435|5576| 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|11597|16310|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||11282||11282|16310| 098486|G03GA3001|Pergoveris|sts|225|ae|1|hgl|1|pakki|+ leysir|G03GA30|01.03.2009||R|A|3|0|1|E|0|SEU|0|0|0|100|SEK|13917|19745|lyfalmen|||0|1|0|0,0000|Icepharma hf|Serono Europe Ltd|||||13917|19745| 098504|G03GA3001|Pergoveris|sts|225|ae|10|hgl|1|pakki|+ leysir|G03GA30|01.03.2009||R|A|3|0|1|E|0|SEU|0|0|0|100|SEK|129094|164292|lyfalmen|||0|1|0|0,0000|Icepharma hf|Serono Europe Ltd|||||129094|164292| 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2500|lyfalmen|||06|5|1|25,0000|Distica|Distica - óskráð lyf|||1186||1186|2500| 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22241|30192|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||22241||22241|30192| 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|787|1954|lyfalmen|V1500|1935|07|5|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||787||787|1954| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|6191|9346|lyfalmen|V0725|9346|00|100|0|6,2500|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||6191||6191|9346| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|14137|20021|lyfalmen|V0726|20021|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||14137||14137|20021| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|22877|30990|lyfalmen|V0727|30990|00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||22877||22877|30990| 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|628|1665|lyfalmen|V0730|1278|10|20|0|3,3333|D.A.C. ehf|D.A.C. ehf|Tramadól||576||576|1665| 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Mundipharma|Joð/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Mundipharma|Joð/pólývídón|||||| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|51855|66961|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||51855||51855|66961| 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|76760|98216|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||76760||76760|98216| 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|56148|72348|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||56148||56148|72348| 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|||lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð|||||| 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14424|20381|lyfalmen|||00|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14424|20381| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14424|20381|lyfalmen|||00|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14424|20381| 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|SEU|0|0|0|100|SEK|14993|21095|lyfalmen|||00|1|0|1,0000|Icepharma hf|Serono Europe Ltd|Lutropin alfa||14993||14993|21095| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18866|25956|lyfalmen|V2160|25956|0|100|0|33,3300|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||18866||18866|25956| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|31803|42192|lyfalmen|||0|100|0|44,4400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||31803||31803|42192| 101386|R06AX1301|Clarityn|saft|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|100|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|SEU|0|0|0|100|SEK|44979|58728|lyfalmen|||00|3|0|3,0000|Icepharma hf|Serono Europe Ltd|Lutropin alfa||44979||44979|58728| 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|SEU|0|0|0|100|SEK|149932|190444|lyfalmen|||00|10|0|10,0000|Icepharma hf|Serono Europe Ltd|Lutropin alfa||149932||149932|190444| 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|2238|3939|lyfalmen|||00|28|0|18,6667|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||2238||2238|3939| 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|7023|10484|lyfalmen|||00|98|0|65,3333|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||7023||7023|10484| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2648|4500|lyfalmen|V1152|4500|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2648||2648|4500| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|4641|7226|lyfalmen|V1153|7226|00|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||4641||4641|7226| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9679|13553|lyfalmen|V0736|9302|00|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||9266||9266|13553| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|12104|23414|vetalmen|||0|250|0|0,0000|Vistor hf|Boehringer Ingelheim|||||12104|23414| 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989|31.03.2010|R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1607|3076|lyfalmen|||43|28|0|42,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1607||1607|3076| 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3733|5984|lyfalmen|V0139|2798|43|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3733||3733|5984| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|2604|3758|lyfsjukr|||02|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||2604||2604|3758| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|5404|7799|lyfsjukr|||00|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||5404||5404|7799| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|IKR|8135|5241|lyfalmen|V2219|5241|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||3190||3190|5241| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|IKR|13469|5241|lyfalmen|V2220|5241|00|98|0|196,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||3190||3190|5241| 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|4295|3873|lyfalmen|V0197|3872|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||2190||2190|3873| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2587|3448|lyfalmen|V0507|3448|00|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||1879||1879|3448| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|10755|12186|lyfalmen|V0508|12148|00|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||8267||8267|12186| 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|14889|9896|lyfalmen|V0955|9896|00|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||6593||6593|9896| 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|28338|15579|lyfalmen|V0956|15579|00|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||10747||10747|15579| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1899| 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|21702|29119|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||||21702|29119| 104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.05.2009||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|8463|10127|lyfalmen|V0933|5003|00|98|0|98,0000|D.A.C. ehf|D.A.C. ehf|Sertralín||6762||6762|10127| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|4082|6461|lyfalmen|||23|2|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4082||4082|6461| 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2374|4125|lyfalmen|||00|21|0|21,0000|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2374||2374|4125| 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|9101|13327|lyfalmen|||04|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9101||9101|13327| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5977|9053|lyfalmen|||56|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5977||5977|9053| 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5784|8789|lyfalmen|||10|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5784||5784|8789| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4399|6895|lyfalmen|V0084|6895|00|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4399||4399|6895| 105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2009||R|A||0|0|0|0|DAC|0|0|0|100|SEK|8490|12067|lyfalmen|||00|56|0|37,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||8180||8180|12067|28.02.2010 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|15137|21276|lyfalmen|V0087|21276|00|100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||15137||15137|21276| 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A||0|0|0|0|DAC|0|0|0|100|SEK|21117|28781|lyfalmen|V0089|28781|00|100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||21117||21117|28781| 105315|G03AA0705 |Microgynon (D.A.C.)|töflur|0||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1202|2522|lyfalmen|V2200|2522|23|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1202||1202|2522| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4340|6814|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4340||4340|6814| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15088|21215|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15088||15088|21215| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|5002|7720|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||5002||5002|7720| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|17402|24119|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||17402||17402|24119| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2634|4480|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2634||2634|4480| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2869|4802|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2869||2869|4802| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3666|5892|lyfalmen|||63|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3666||3666|5892| 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1598|lyfalmen|V0167|1598|0|100|0|50,0000|Portfarma ehf|Portfarma|Enalapríl||527||527|1598| 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2078|lyfalmen|V0168|2078|0|100|0|100,0000|Portfarma ehf|Portfarma|Enalapríl||878||878|2078| 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|2374|lyfalmen|V0169|2374|0|100|0|200,0000|Portfarma ehf|Portfarma|Enalapríl||1094||1094|2374| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|19015|25746|lyfsjukr|||00|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19015||19015|25746| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10516|15080|lyfsjukr|||00|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10516||10516|15080| 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|0|0|LEI|0|0|0|100|SEK|19778|27100|lyfalmen|||10|30|0|15,0000|Icepharma hf|Leiras Oy|Klódrónsýra||19778||19778|27100|28.02.2010 107050|A10BD0401|Avaglim|filmhtfl|8|mg|84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15249|21417|lyfalmen|||00|84|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||15249||15249|21417| 107061|A10BD0401|Avaglim|filmhtfl|12|mg|84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|22958|31091|lyfalmen|||00|84|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||22958||22958|31091| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1966|3567|lyfalmen|||10|100|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||1966||1966|3567| 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|0|0|LEI|0|0|0|100|SEK|19778|27100|lyfalmen|||10|30|0|15,0000|Icepharma hf|Leiras Oy|Klódrónsýra||19778||19778|27100|28.02.2010 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0,2000|Actavis Group hf|Actavis hf|Paracetamól|||||| 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0,0000|Icepharma hf|Icevet ehf||||||2953| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|982|2221|lyfalmen|||00|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||982||982|2221| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|3437|5579|lyfalmen|||63|100|0|33,3333|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||3437||3437|5579| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|3624|5835|lyfalmen|||00|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3624||3624|5835| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|10756|15591|lyfalmen|||00|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||10756||10756|15591| 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1173|2482|lyfalmen|||24|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1173||1173|2482| 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1784|3318|lyfalmen|V0108|3270|24|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1784||1784|3318| 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1278|lyfalmen|V0730|1278|00|20|0|3,3333|Actavis Group hf|Actavis hf|Tramadól||293||293|1278| 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1567|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Tramadól||504||504|1567|31.03.2010 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|258|1230|lyfalmen|V0775|1219|00|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||258||258|1230| 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|988|2229|lyfalmen|V0780|2206|00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||988||988|2229| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26663|35741|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||26663||26663|35741| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21346|29068|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||21346||21346|29068| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8287|12213|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||8287||8287|12213| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1396|lyfalmen|V0772|1396|00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||379||379|1396| 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|702|1838|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||702||702|1838| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|783|1948|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||783||783|1948| 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1691|3190|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1691||1691|3190| 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4954|7654|lyfalmen|||10|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4954||4954|7654| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|823|2003|lyfalmen|||00|100|0|33,3300|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||823||823|2003| 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|885|2088|lyfalmen|||06|5|0|0,0000|Vistor hf|Schering-Plough|Gentamícín||885||885|2088| 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990|31.01.2010|R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1487|2911|lyfalmen|||68|100|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||1487||1487|2911| 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|4281|6733|lyfalmen|||23|30|0|90,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||4281||4281|6733| 112641|M05BA0407 |Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|9018|6058|lyfalmen|V0718|6054|00|12|0|84,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||3787||3787|6058| 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10595|15371|lyfalmen|||00|60|0|0,0000|Vistor hf|Novartis Europharm Ltd|||||10595|15371| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|29164|38880|lyfalmen|||00|180|0|0,0000|Vistor hf|Novartis Europharm Ltd|||||29164|38880| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10595|15371|lyfalmen|||00|60|0|0,0000|Vistor hf|Novartis Europharm Ltd|||||10595|15371| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4087|6468|lyfalmen|||00|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4087||4087|6468| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|29164|38880|lyfalmen|||00|180|0|0,0000|Vistor hf|Novartis Europharm Ltd|||||29164|38880| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7071|10550|lyfalmen|||00|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7071||7071|10550| 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|42423|55123|lyfsjukr|||00|20|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Cetúxímab||42423||42423|55123| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|808744|1016856|lyfsjukr|||00|112|0|0,0000|Vistor hf|Novartis Europharm Ltd|Nilotiníb||808744||808744|1016856| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|717|1858|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||717||717|1858| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|911|2123|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||911||911|2123| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1391|2780|lyfalmen|||00|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1391||1391|2780| 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|806|1980|lyfalmen|||23|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||806||806|1980| 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|2160|2619|lyfalmen|||00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1591||1273|2619|31.03.2010 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|1390|1717|lyfalmen|V0918|1717|00|60|0|60,0000|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||614||614|1717| 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|526|1082|lyfalmen|V0917|1082|00|20|0|20,0000|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||150||150|1082| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|XEU|4529|7073|lyfalmen|||00|28|0|14,0000|Icepharma hf|M.S.D.|Etoríkoxíb||4529||4529|7073| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2584|4412|lyfalmen|||06|5|0|0,0000|Icepharma hf|M.S.D.|Tímólól í blöndum||2584||2584|4412| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3874|6177|lyfalmen|||0|750|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||3874||3874|6177| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|2024|3646|lyfalmen|||00|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||2024||2024|3646| 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11613|16763|lyfalmen|||0|2250|0|10,2300|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11613||11613|16763| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|23228|31430|lyfalmen|||0|4500|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||23228||23228|31430| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3874|6177|lyfalmen|||0|1100|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||3874||3874|6177| 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11613|16763|lyfalmen|||0|3300|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11613||11613|16763| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|23228|31430|lyfalmen|||0|6600|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||23228||23228|31430| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2107|3760|lyfalmen|V1090|3757|06|5|0|16,6667|Icepharma hf|M.S.D.|Dorzólamíð||2107||2107|3760| 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3721|5967|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3721||3721|5967| 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3993|5763|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3993||3993|5763| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|2087|3012|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2087||2087|3012| 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10,0000|Icepharma hf|Galderma Nordic AB||||||| 116327|D07AC1301 |Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3289|5376|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3289|5376| 116418|D07AC1301 |Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3289|5376|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3289|5376| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|868|2065|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||868||868|2065| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|486|1542|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||486||486|1542| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1125|2416|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||1125||1125|2416| 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|20008|27389|lyfalmen|||00|84|0|84,0000|Vistor hf|Pfizer Limited|||||20008|27389| 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7081|10564|lyfalmen|||00|28|0|28,0000|Vistor hf|Pfizer Limited|||||7081|10564| 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7521|11166|lyfalmen|||00|28|0|56,0000|Vistor hf|Pfizer Limited|||||7521|11166| 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|22663|30721|lyfalmen|||00|84|0|168,0000|Vistor hf|Pfizer Limited|||||22663|30721| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|K||0|0|0|0|WLV|0|0|0|100|DKK|9066|13279|lyfalmen|||00|0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||||9066|13279| 116985|N06AX1607 |Efexor Depot (D.A.C.)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|USD|13192|18835|lyfalmen|V0955|9698|00|98|0|73,5000|D.A.C. ehf|D.A.C. ehf|Venlafaxín||13192||13192|18835| 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|37582|49444|lyfalmen|V1702|49444|00|56|0|37,3300|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||37582||37582|49444| 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|37327|49124|lyfalmen|V1703|49124|00|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||37327||37327|49124| 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|11033|21358|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||11033||11033|21358| 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|9422|13766|lyfalmen|||10|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||9422||9422|13766| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|6410|9646|lyfalmen|||00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||6410||6410|9646| 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|14788|20838|lyfalmen|||00|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||14788|20838| 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26137|35081|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26137|35081| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2643|4493|lyfalmen|||10|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2643||2643|4493| 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4519|7059|lyfalmen|||00|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4519|7059| 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|45194|58998|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||45194|58998| 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|52274|67883|lyfalmen|||00|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||52274|67883| 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB||||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10677|18625|vetorma|||00|250|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||10677||10677|18625| 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|3150|5186|lyfalmen|||61|28|0|28,0000|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||3150||3150|5186| 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|5541|8457|lyfalmen|||61|98|0|98,0000|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||5541||5541|8457| 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|9008|13200|lyfalmen|||61|98|0|196,0000|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||9008||9008|13200| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7707|14971|vetalmen|||00|1200|0|0,0000|Icepharma hf|Kela Laboratoria NV|||7707||7707|14971| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|13517|26127|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||13517||13517|26127| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4386|4523|lyfalmen|V0809|4523|00|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2665||2665|4523| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|6234|5655|lyfalmen|V0810|5655|00|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3493||3493|5655| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|24175|21153|lyfalmen|V0812|21153|00|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||15039||15039|21153| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18833|16901|lyfalmen|||00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||11714||11714|16901|31.03.2010 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1797|3335|lyfalmen|||65|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1797||1797|3335| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||00|4|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|782|1947|lyfalmen|||04|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||782||782|1947| 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|7833|11592|lyfalmen|||04|50|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||7833||7833|11592| 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2330|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||1062||1062|2330| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|19381|17406|lyfalmen|||00|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||12053||12053|17406|31.03.2010 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|10096|14688|lyfalmen|||00|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||10096||10096|14688| 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|29699|39551|lyfalmen|||00|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||29699||29699|39551| 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3253|5327|lyfalmen|V1401|5327|00|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||3253||3253|5327| 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|10202|14833|lyfalmen|V1400|14833|00|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||10202||10202|14833| 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|92309|117730|lyfsjukr|||00|5|0|0,0000|Vistor hf|Amgen Europe B.V.|Panitúmúmab||92309||92309|117730| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|494600|623002|lyfalmen|||00|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|||||494600|623002| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|494600|623002|lyfalmen|||00|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|||||494600|623002| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1025|2279|lyfalmen|||06|10|0|0,0000|K.Pétursson hf|Alcon|Cýklópentólat||1025||1025|2279| 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|51631|66679|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Lilly ICOS Limited|Pemetrexed||||51631|66679| 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|13098|18717|lyfalmen|V1370|18717|00|28|0|14,0000|Lyfjaver ehf|Lyfjaver ehf|Galantamín||13098||13098|18717| 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|41859|54812|lyfalmen|V1371|54812|00|84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Galantamín||41859||41859|54812| 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|DKK|3433|5573|lyfalmen|V0939|4660|00|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||3433||3433|5573| 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|24725|33309|lyfalmen|||00|200|0|200,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||24725||24725|33309| 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|19579|26851|lyfalmen|V1710|26851|00|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||||19579|26851| 121164|A02BC0501 |Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6047|9149|lyfalmen|||00|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||||6047|9149| 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991|28.02.2010|R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|850|2040|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Merck NM AB|Tríazólam||850||850|2040| 121286|M03AC0901 |Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10839|15485|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíð||||10839|15485| 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|366|1378|lyfalmen|||24|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||366||366|1378| 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|415|1445|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||415||415|1445| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2201|3888|lyfalmen|||00|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||2201||2201|3888| 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3738|5991|lyfalmen|||98|30|0|10,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3738||3738|5991| 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998|28.02.2010|R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2939|lyfalmen|||00|100|0|16,6700|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||1507||1507|2939| 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|606|1706|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||606||606|1706| 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|945|2170|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||945||945|2170| 123253|L02BB0301|Casodex|töflur|150|mg|28|stk|1|þpakki||L02BB03|01.06.2009|31.01.2010|R|A|4|0|0|*|0|AZA|0|0|0|100|SEK|37139|48889|lyfalmen|||00|28|0|84,0000|Vistor hf|AstraZeneca AB|Bíkalútamíð||37139||37139|48889| 123264|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996|31.01.2010|R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|14054|19917|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Alpharma ApS|Vankómýcín||||14054|19917| 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|DKK|2337|4074|lyfalmen|||00|100|1|40,0000|Parlogis hf|Parlogis - óskráð lyf|||2337||2337|4074| 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|26622|35690|lyfalmen|||00|28|0|3,5000|Actavis Group hf|Alpharma ApS|Vankómýcín||||26622|35690| 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|XEU|437|1475|lyfalmen|||00|100|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||437||437|1475| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|47842|62321|lyfalmen|||00|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||47842||47842|62321| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|2000|3978|vetalmen|||00|42|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals|||||2000|3978| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|A||0|0|0|0|SBM|0|0|0|100|NOK|39932|52394|lyfalmen|||00|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||39932|52394| 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1242|2576|lyfalmen|||00|20|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|||1242||1242|2576| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1099|2381|lyfalmen|||00|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1099||1099|2381| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|612|1714|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||612||612|1714| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|878|2078|lyfalmen|V0168|2078|00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||878||878|2078| 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|1989|3598|lyfalmen|V0144|3598|0|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||1989||1989|3598| 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A||0|0|*|0|DAC|0|1|0|100|DKK|19239|26424|lyfalmen|V1701|26424|00|28|0|6,2000|D.A.C. ehf|D.A.C. ehf|Aripiprazól||19239||19239|26424| 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|14770|20815|lyfalmen|V1732|20815|00|100|0|11,1100|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14770||14770|20815| 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|14615|20621|lyfalmen|V1730|20621|00|100|0|22,2200|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14615||14615|20621| 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|15967|22318|lyfalmen|V1731|22318|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15967||15967|22318| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||10|16|0|3,2000|Vistor hf|Janssen-Cilag AB|Lóperamíð|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|115341|146635|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||115341|146635| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|29601|39032|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||29601|39032| 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|27833|36813|lyfsjukr|||00|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||27833||27833|36813| 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|3045|5043|lyfalmen|||00|56|0|56,0000|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||3045||3045|5043| 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|9277|13389|lyfsjukr|||00|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||9277||9277|13389| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|49191|63617|lyfsjukr|||00|50|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||49191||49191|63617| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|98383|125353|lyfsjukr|||00|100|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||98383||98383|125353| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|196766|248824|lyfsjukr|||00|200|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||196766||196766|248824| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCN|0|0|0|100|SEK|1212|2535|lyfalmen|||10|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||1212||1212|2535| 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9567|6609|lyfalmen|V0810|5655|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4190||4190|6609| 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstil|0||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6661|12963|vetalmen|||0|30|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||||6661|12963| 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|553|1634|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Merck NM AB|Verapamíl||553||553|1634| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1353|2728|lyfalmen|||10|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1353||1353|2728| 128777|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||| 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4789|6912|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||4789||4789|6912| 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|32311|20079|lyfalmen|||00|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||14183||14183|20079| 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|37488|24928|lyfalmen|V0812|21153|00|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||18047||18047|24928| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0,0000|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3106| 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|5127|7891|lyfalmen|||00|120|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||5127||5127|7891| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|18500|22540|lyfalmen|V0726|20021|00|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16144||16144|22540| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|29285|34354|lyfalmen|V0727|30990|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||25558||25558|34354| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2329|4063|lyfalmen|||63|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||||2329|4063| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4390|6883|lyfalmen|||02|125|0|31,2500|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4390||4390|6883| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|2425|4195|lyfalmen|||63|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||||2425|4195| 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|12493|17958|lyfalmen|||0|53|0|20,6700|Vistor hf|Pfizer Limited|||||12493|17958| 130772|QI10A0001 |Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|67545|129869|vetalmen|||0|500|0|0,0000|Vistor hf|PHARMAQ AS|||||67545|129869| 131136|R03CA0202|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||R03CA02|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3333|5437|lyfalmen|||00|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríð||||3333|5437| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|470|1520|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||470||470|1520| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|901|2110|lyfalmen|||00|100|0|15,0000|Vistor hf|Recip AB|||901||901|2110| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|987|2227|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|||987||987|2227| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1092|2371|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|||1092||1092|2371| 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6585|9885|lyfalmen|||23|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||6585||6585|9885| 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|8963|13138|lyfalmen|||0|10|0|10,0000|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||8963|13138| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|26890|36026|lyfalmen|||0|30|0|30,0000|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||26890|36026| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|89633|114768|lyfalmen|||0|100|0|100,0000|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||89633|114768| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|258|1149|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||199||199|1149| 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|270|1247|lyfalmen|||00|28|0|9,3300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||270||270|1247| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|IKR|14144|5166|lyfalmen|V0192|5084|00|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3135||3135|5166| 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|IKR|9789|5052|lyfalmen|V2221|5052|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3052||3052|5052| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1734|3249|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Kódein||1734||1734|3249| 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8895|13045|lyfalmen|||0|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||||8895|13045| 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||23|8|0|8,0000|Icepharma hf|Napp|Joð/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1169|2476|lyfalmen|||06|15|0|0,0000|K.Pétursson hf|Alcon|Proxýmetakaín||1169||1169|2476| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1376|2760|lyfalmen|||23|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1376||1376|2760| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|39371|51293|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||39371|51293| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|43987|57086|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||43987|57086| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|48875|63221|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||48875|63221| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|9849|14350|lyfalmen|||10|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||9849||9849|14350| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|121314|154132|lyfsjukr|||00|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||121314||121314|154132| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2603|4438|lyfalmen|||00|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2603||2603|4438| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|4384|6874|lyfalmen|||00|9|0||Icepharma hf|Santen Oy|Taflúprost||4384||4384|6874| 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|2793|4031|lyfsjukr|||0|5|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||2793|4031| 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4174|6024|lyfsjukr|||0|10|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||4174|6024| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|11682|16543|lyfsjukr|||0|25|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||11682|16543| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|A||0|1|0|1|BRS|0|0|0|100|DKK|96008|122373|lyfsjukr|||43|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||96008||96008|122373| 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|181329|229349|lyfsjukr|||00|30|0|0,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||181248||181248|229349| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|75054|96075|lyfsjukr|||00|12|0|17,9910|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||75054||75054|96075| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|1096|2377|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1096||1096|2377| 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|2283|4000|lyfalmen|||23|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2283||2283|4000| 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1818|3364|lyfalmen|||23|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1818||1818|3364| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|7326|10899|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíð||7326||7326|10899| 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|120315|152878|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||120315||120315|152878| 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|89092|113693|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||89092||89092|113693| 136964|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|19343|26158|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||19343|26158| 136975|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|38961|50779|lyfsjukr|||00|17|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||38961|50779| 136987|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|95648|121921|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||95648|121921| 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|111786|142174|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||111786|142174| 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1641| 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||2056| 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|160613|203452|lyfsjukr|||00|0|0|0,0000|Vistor hf|Novartis Europharm Ltd|Ranibizumab||160613||160613|203452| 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4776|7411|lyfalmen|||10|100|0|100,0000|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4776||4776|7411| 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|33881|44403|lyfsjukr|||00|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||33881||33881|44403| 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|13973|19419|lyfsjukr|||00|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||13973||13973|19419| 137831|M05BA0303|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|18317|24870|lyfsjukr|||00|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||18317||18317|24870| 137842|M05BA0304|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|24067|32087|lyfsjukr|||00|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||24067||24067|32087| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1809|2611|lyfsjukr|||00|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1809||1809|2611| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2935|4236|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||2935||2935|4236| 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2202|3889|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||2202||2202|3889| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2338|4076|lyfalmen|||00|30|0|60,0000|Icepharma hf|Santen Oy|Tímólól||2338||2338|4076| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3274|5356|lyfalmen|||00|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||3274||3274|5356| 140130|V03AB3501 |Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|186789|236303|lyfsjukr|||00|20|0|0,0000|Vistor hf|N.V. Organon|||||186789|236303| 140141|V03AB3501 |Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|466975|587936|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|||||466975|587936| 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988|28.02.2010|R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2865|4796|lyfalmen|||19|100|0|33,3333|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2865||2865|4796| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1863|3426|lyfalmen|V2010|2442|00|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1863||1863|3426| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|15440|21260|lyfsjukr|||02|10|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||15440||15440|21260| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|696|1005|lyfsjukr|||02|5|0|3,3333|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||696||696|1005| 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1473|2892|lyfalmen|||03|2|0|4,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1473||1473|2892| 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa||N01BB20|01.11.2008||R|A||0|0|0|0|DAC|0|0|1|100|SEK|3634|5848|lyfalmen|V2002|5848|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Blöndur||3634||3634|5848| 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1484|2907|lyfalmen|||08|80|0|0,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1484||1484|2907| 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|9717|14024|lyfsjukr|||00|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||9717||9717|14024| 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|14686|20710|lyfalmen|V0011|20710|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||14686||14686|20710| 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|29453|38846|lyfsjukr|||00|1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||29453||29453|38846| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3601|5803|lyfalmen|||00|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||3601||3601|5803| 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4849|6013|lyfalmen|||0|84|0|0,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3754||3754|6013| 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|686|1816|lyfalmen|||00|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||||686|1816| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9406|13744|lyfalmen|V2020|9862|00|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||9406||9406|13744| 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|524|1594|lyfalmen|||00|100|0|6,2500|Actavis Group PTC ehf|Merck NM AB|Própranólól||524||524|1594| 142190|C07AA0511|Propranolol Mylan|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|673|1798|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||673||673|1798| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|9062|13079|lyfsjukr|||02|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||9062||9062|13079| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1170|2478|lyfalmen|||70|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1170||1170|2478| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2865|4796|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2865||2865|4796| 142596|C07AA0511|Propranolol Mylan|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|933|2154|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||933||933|2154| 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2245|3948|lyfalmen|||03|1|0|6,2500|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||2245||2245|3948| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4720|6812|lyfsjukr|||03|1|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||4720||4720|6812| 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|798|1969|lyfalmen|||07|5|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Prednisólón||798||798|1969| 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|DKK|1372|2754|lyfalmen|||00|30|1|0,0000|Distica|Distica - óskráð lyf|||1372||1372|2754| 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3524|5698|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||3524||3524|5698| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|965|2197|lyfalmen|||06|15|0|0,0000|K.Pétursson hf|Alcon|Trópíkamíð||965||965|2197| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1904|3482|lyfalmen|||00|2|0|3,3333|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1904||1904|3482| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2437|4211|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||2437||2437|4211| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|9477|13841|lyfalmen|||0|56|0|0,0000|Icepharma hf|M.S.D.|||||9477|13841| 143642|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010|28.02.2010|R|A||0|0|*|0|MSD|0|0|0|100|XEU|27814|37186|lyfalmen|||00|196|0||Icepharma hf|M.S.D.|||27814||27814|37186| 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|10457|6513|lyfalmen|||00|98|0|98,0000|D.A.C. ehf|D.A.C. ehf|Cítalópram||4120||4120|6513|31.03.2010 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1006|2253|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1006||1006|2253| 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1315|2676|lyfalmen|||10|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1315||1315|2676| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2764|4658|lyfalmen|V0429|4580|00|3|0|5,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2764||2764|4658| 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4614|6659|lyfsjukr|||02|5|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||4614||4614|6659| 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|8868|12799|lyfsjukr|||02|10|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||8868||8868|12799| 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|2810|4721|lyfalmen|||10|100|0|16,6667|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2810||2810|4721| 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5192|7980|lyfalmen|||51|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5192||5192|7980| 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|15599|21459|lyfsjukr|||02|25|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||15599||15599|21459| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|88127|112482|lyfsjukr|||AC|2|0|22,4888|Vistor hf|Novo-Nordisk|Sómatrópín||88127||88127|112482| 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.02.2009||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|65866|84544|lyfsjukr|||AC|2|0|15,0675|Vistor hf|Novo-Nordisk|Sómatrópín||65866||65866|84544| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|42826|55629|lyfsjukr|||AC|2|0|7,4213|Vistor hf|Novo-Nordisk|Sómatrópín||42826||42826|55629| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|982|2221|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||982||982|2221| 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|457|1502|lyfalmen|||00|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||457||457|1502| 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|789|1957|lyfalmen|||00|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||789||789|1957| 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3476|5632|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3476||3476|5632| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5395|8257|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||5395||5395|8257| 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|19524|13220|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||9023||9023|13220| 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|11356|16134|lyfsjukr|||0|2|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||||11356|16134| 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|26901|35643|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||||26901|35643| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|A||0|1|0|0|ELI|0|0|0|100|XEU|19756|27073|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||19756||19756|27073| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|915|2129|lyfalmen|||41|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||915||915|2129| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|5274|7612|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||5274|7612| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4449|6421|lyfsjukr|||0|10|0|0,0000|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||4449|6421| 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|14592|20195|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14592||14592|20195| 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|23326|31157|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||23326||23326|31157| 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|123536|157317|lyfalmen|||00|750|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||123536||123536|157317| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1159|2463|lyfalmen|||00|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1159||1159|2463| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|8428|12164|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||8428||8428|12164| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|13191|18437|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||13191||13191|18437| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HOS|0|0|0|100|SEK|25436|33805|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||25436||25436|33805| 148961|N06DA0203 |Aricept (D.A.C.)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|52699|68416|lyfalmen|V0376|47222|00|98|0|130,6700|D.A.C. ehf|D.A.C. ehf|Dónepezíl||52699||52699|68416| 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|14884|5084|lyfalmen|V0192|5084|00|98|0|196,0000|D.A.C. ehf|D.A.C. ehf|Valsartan og þvagræsilyf||3075||3075|5084| 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3978|7811|vetalmen|||27|25|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||3978||3978|7811| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|SEK|1915|3497|lyfalmen|||00|75|1|18,7500|Distica|Distica - óskráð lyf|||1915||1915|3497| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|2240|3941|lyfalmen|V1989|3941|06|2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||2240||2240|3941| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|17266|23948|lyfalmen|||10|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||17266||17266|23948| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|4140|6541|lyfalmen|||00|28|0||Icepharma hf|M.S.D.|||||4140|6541| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|6867|10271|lyfalmen|||00|56|0||Icepharma hf|M.S.D.|||||6867|10271| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3702|5941|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3702|5941| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|7853|11620|lyfalmen|||02|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||7853||7853|11620| 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1233|2564|lyfalmen|||05|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1233||1233|2564| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|17465|24198|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||17465|24198| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|53927|69957|lyfalmen|||00|28|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||53927|69957| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|7257|5697|lyfalmen|V0437|5363|00|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||3523||3523|5697| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1760|3285|lyfalmen|||10|100|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1760||1760|3285| 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1214|2538|lyfalmen|||10|100|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1214||1214|2538| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|765|1104|lyfsjukr|||02|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||765||765|1104| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|25|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4528|7071|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4528||4528|7071| 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6776|10146|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6776||6776|10146| 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|11733|16927|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||11733||11733|16927| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1905|3483|lyfalmen|||10|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1905||1905|3483| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1784|3318|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||1784||1784|3318| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2308|4034|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2308||2308|4034| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1593|3056|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||1593||1593|3056| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2189|3872|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2189||2189|3872| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|405989|511399|lyfsjukr|||00|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||405989||405989|511399| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|6383|9609|lyfalmen|||10|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6383||6383|9609| 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|9365|13688|lyfalmen|||02|5|0|250,0000|Vistor hf|Hexal A/S|Hýdroxókóbalamín||9365||9365|13688| 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4157|lyfsjukr|||00|1|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4157| 154464|D05AX5203 |Xamiol|hlaup|0||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|5157|7932|lyfalmen|||00|30|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||5157|7932| 154475|D05AX5203 |Xamiol|hlaup|0||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|9876|14387|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||9876|14387| 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6693|10033|lyfalmen|||00|30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||6693||6693|10033| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1478|2899|lyfalmen|||10|20|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||1478||1478|2899| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5355|8203|lyfalmen|V2130|8201|10|100|0|50,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||5355||5355|8203| 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2179|3858|lyfalmen|V0954|3858|00|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||2179|3858| 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7716|11432|lyfalmen|V0438|9319|00|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7716||7716|11432| 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|8838|9716|lyfalmen|V0955|9698|00|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||6461||6461|9716| 154750|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3770|6034|lyfalmen|V0957|6034|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3770|6034| 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|14624|15284|lyfalmen|V0956|15267|00|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||10532||10532|15284| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|XEU|1724|3236|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1724||1724|3236| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|SEK|3241|5311|lyfalmen|V0709|5311|00|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||||3241|5311| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|SEK|5267|8082|lyfalmen|V0710|8082|00|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||||5267|8082| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|SEK|9521|13901|lyfalmen|V0711|13901|00|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||||9521|13901| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1845|3401|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1845||1845|3401| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|572|1660|lyfalmen|||00|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||572||572|1660| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|12077|17436|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||12077||12077|17436| 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6938|10368|lyfalmen|||00|42|0|14,0000|Icepharma hf|Roche|Orlístat||6938||6938|10368| 156563|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|18577|25197|lyfsjukr|||00|15|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||18577||18577|25197| 156574|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|6306|9101|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||6306||6306|9101| 156585|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|20630|27773|lyfsjukr|||00|45|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||20630||20630|27773| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9243|13521|lyfalmen|||00|84|0|28,0000|Icepharma hf|Roche|Orlístat||9243||9243|13521| 156597|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|38351|50013|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||38351||38351|50013| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|946|2171|lyfalmen|||00|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||946||946|2171| 156964|N07BA0137 |Nicorette (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 156986|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 156997|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157020|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157031|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|8000|13956|vetorma|||16|260|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||8000||8000|13956| 157419|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157430|N07BA0140 |Nicorette Peppermynte (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157463|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|DKK|545|1623|lyfalmen|||07|4|1|0,0000|Distica|Distica - óskráð lyf|||545||545|1623| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|A||0|0|E|0|NOH|0|0|0|100|DKK|1673|3166|lyfalmen|||00|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1673||1673|3166| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1105|2389|lyfalmen|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1105||1105|2389| 158431|B02BD0801 |NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|113494|144317|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||113494|144317| 158442|B02BD0801 |NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|226990|286755|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||226990|286755| 158453|B02BD0801 |NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|643624|809631|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||643624|809631| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|57968|74632|lyfsjukr|||0|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|||||57968|74632| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|91299|116463|lyfsjukr|||0|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|||||91299|116463| 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1229|2558|lyfalmen|||23|5|0|13,3333|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||1229||1229|2558| 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|1027|2282|lyfalmen|V0608|2282|10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1027|2282| 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2423|4192|lyfalmen|V2003|3186|00|98|0|31,0300|D.A.C. ehf|D.A.C. ehf|Metóprólól||2423||2423|4192| 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3851|6145|lyfalmen|V1050|6145|00|5|0|20,8333|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||3851|6145| 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7416|11022|lyfalmen|V1051|11022|00|5|0|41,6667|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||7416|11022| 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|10377|15072|lyfalmen|V1052|15072|00|5|0|62,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||10377|15072| 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|12475|17935|lyfalmen|V1053|17935|00|5|0|83,3333|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||12475|17935| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7129|4925|lyfalmen|V0925|3309|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2959||2959|4925| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|28225|37701|lyfalmen|||00|30|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||28225||28225|37701| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|14592|13363|lyfalmen|V0929|7974|00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9127||9127|13363| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2063|2702|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1334||1334|2702| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|3572|3865|lyfalmen|V0923|2144|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2184||2184|3865| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7361|5194|lyfalmen|V0927|3389|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3156||3156|5194| 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|495|1554|lyfalmen|||72|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||495||495|1554| 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1597|3062|lyfalmen|||72|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1597||1597|3062| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|APC|0|0|0|100|DKK|186471|235904|lyfsjukr|||00|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||186471||186471|235904| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2495|3601|lyfsjukr|||02|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2495||2495|3601| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|87173|111285|lyfsjukr|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||87173||87173|111285| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|110152|140123|lyfsjukr|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||110152||110152|140123| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1044|2305|lyfalmen|||00|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1044||1044|2305| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2599|4433|lyfalmen|||42|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2599||2599|4433| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|174344|220684|lyfsjukr|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||174344||174344|220684| 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|388|1408|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||388|1408| 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|A||0|0|E|0|BOI|0|0|1|100|DKK|1551|2999|lyfalmen|||24|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1551||1551|2999| 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|407|1434|lyfalmen|||14|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||407||407|1434| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|90671|115675|lyfsjukr|||0|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|||||90671|115675| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|841|2028|lyfalmen|||03|1|0|2,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||841||841|2028| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1968|2840|lyfsjukr|||03|1|0|8,3333|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||1968||1968|2840| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3024|4364|lyfsjukr|||03|5|0|16,6667|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||3024||3024|4364| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|771|1932|lyfalmen|||03|1|0|3,3333|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||771||771|1932| 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5862|8896|lyfalmen|||23|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5862||5862|8896| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|66253|85427|lyfalmen|||00|100|0|100,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||66253||66253|85427| 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|DKK|3366|4858|lyfsjukr|||00|2|0|0,8333|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||3366||3366|4858| 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120,0000|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd|||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|DKK|6611|9541|lyfsjukr|||00|5|0|1,6667|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||6611||6611|9541| 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|DKK|20879|28086|lyfsjukr|||00|18|0|5,8333|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||20879||20879|28086| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2600|4434|lyfalmen|||00|100|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||2600||2600|4434| 162929|G04CA0205 |Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|5219|5959|lyfalmen|V0437|5959|00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||3715||3715|5959| 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2283|4000|lyfalmen|||24|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2283||2283|4000| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1259|2599|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1259||1259|2599| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|2013|3631|lyfalmen|||41|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||2013||2013|3631| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|223|1182|lyfalmen|||0|20|0|20,0000|Actavis hf|Actavis EAD|||||223|1182| 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3042|4844|lyfalmen|||24|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2900||2900|4844| 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|12012|lyfalmen|||00|454|1|0,0000|Distica|Distica - óskráð lyf|||8140||8140|12012| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|XEU|3799|6074|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||3799||3799|6074| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2997|4977|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Merck NM AB|Selegilín||||2997|4977| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|954|2182|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Merck NM AB|Klómípramín||||954|2182| 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|7322|10893|lyfalmen|V0299|10893|98|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7322||7322|10893| 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5809|8824|lyfalmen|||43|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5809||5809|8824| 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5072|7815|lyfalmen|V0324|3967|43|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5072||5072|7815| 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3274|5356|lyfalmen|V0316|2821|43|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3274||3274|5356| 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|15861|22185|lyfalmen|||23|4|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||15861||15861|22185| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|1032|2289|lyfalmen|||00|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||1032||1032|2289| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|366|1378|lyfalmen|||00|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||366||366|1378| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|377493|475636|lyfsjukr|||00|500|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||377493||377493|475636| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|0||3|g|20|spr||QJ51RC22|01.02.2010||R|A||0|0|0|0|INI|0|0|0|100|DKK|5149|10059|vetalmen|||16|60|0||Icepharma hf|Intervet International B.V.|||||5149|10059| 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2723|4602|lyfalmen|||10|100|0|100,0000|Vistor hf|Schering-Plough|Dexklórfeníramín||2723||2723|4602| 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|1071|2342|lyfalmen|||00|10|0|1,0000|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||1071||1071|2342| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2769|4665|lyfalmen|||00|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2769||2769|4665| 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|16720|23263|lyfalmen|||23|8|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||16720||16720|23263| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2221|3915|lyfalmen|||10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2221||2221|3915| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|4205|6629|lyfalmen|||10|100|0|100,0000|Actavis Group PTC ehf|Merck NM AB|Naproxen||4205||4205|6629| 166709|G04CA0103|Alfuzosin Ranbaxy|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|10862|9319|lyfalmen|V0438|9319|00|90|0|120,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||6171||6171|9319| 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|30248|39844|lyfsjukr|||00|1|0|1,4286|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||30248||30248|39844| 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|60494|77802|lyfsjukr|||00|1|0|2,8571|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||60494||60494|77802| 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|546|1624|lyfalmen|V0953|1624|00|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||546|1624| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|635|1746|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||635|1746| 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|XEU|5436|6889|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||4395||4395|6889| 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1260|2601|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1260||1260|2601| 168739|C07AB0209|Metoprolol Actavis|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.12.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2219|3913|lyfalmen|V0091|3913|00|100|0|15,8300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||||2219|3913| 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3359|5472|lyfalmen|V0789|5469|10|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3359||3359|5472| 168750|C07AB0209|Metoprolol Actavis|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|1875|3186|lyfalmen|V2003|3186|00|98|0|31,0300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||1688||1688|3186| 168761|C07AB0209|Metoprolol Actavis|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2943|4538|lyfalmen|V2004|4538|00|98|0|62,0700|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2676||2676|4538| 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1319|2682|lyfalmen|||10|30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1319||1319|2682| 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6199|9357|lyfalmen|V0713|9354|10|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||6199||6199|9357| 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|54492|70270|lyfsjukr|||00|10|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||54492||54492|70270| 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|247495|312489|lyfsjukr|||00|50|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||247495||247495|312489| 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2929|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráð lyf|||1500||1500|2929| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|26694|35383|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||26694||26694|35383| 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5684|8653|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5684||5684|8653| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|1407|2725|lyfalmen|||67|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2725| 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|2450|4095|lyfalmen|V0410|4095|67|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4095| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2475|lyfalmen|V0526|2475|00|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2475| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1762|lyfalmen|V0522|1762|00|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1762| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1750|lyfalmen|V0518|1750|00|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1750| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1415|lyfalmen|V0514|1415|00|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1415| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3471|5625|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3471||3471|5625| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3730|5980|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3730||3730|5980| 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|26730|35429|lyfsjukr|||00|4|0|0,0000|Icepharma hf|Roche Registration Limited|||||26730|35429| 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|66342|85142|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Roche Registration Limited|||||66342|85142| 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5206|7999|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||5206||5206|7999| 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|132001|167544|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Roche Registration Limited|||||132001|167544| 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5371|8225|lyfalmen|||59|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||5371||5371|8225| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|9865|14372|lyfalmen|||59|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||9865||9865|14372| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2501|4298|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||2501||2501|4298| 170697|M05BA0406 |Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|5208|6054|lyfalmen|V0718|6054|00|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||3784||3784|6054| 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14557|lyfalmen|||10|30|0|1,8750|Icepharma hf|NordMedica A/S|Vankómýcín||10000||10000|14557| 170997|L01BC0701|Vidaza|irþ|25|mg/ml|100|mg|1|hgl||L01BC07|01.09.2009||R|A||0|1|0|1|CEE|0|0|0|100|XEU|72278|92591|lyfsjukr|||00|100|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||72278|92591| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3662|5887|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3662||3662|5887| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3946|6275|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3946||3946|6275| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|NOK|1632|3110|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||1632||1632|3110| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4470|6992|lyfalmen|V0709|5311|00|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4470||4470|6992| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|7359|10944|lyfalmen|V0710|8082|00|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7359||7359|10944| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|54687|70515|lyfsjukr|||02|75|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||54687||54687|70515| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|46978|60840|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||46978||46978|60840| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|13290|18958|lyfalmen|V0711|13901|00|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13290||13290|18958| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|27256|36485|lyfalmen|||00|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||27256||27256|36485| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|81648|104351|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||81648||81648|104351| 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|XEU|3837|6126|lyfalmen|||00|100|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||3837||3837|6126| 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|14882|20956|lyfalmen|||00|98|0|0,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||14882||14882|20956| 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7311|10878|lyfalmen|||10|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||7311||7311|10878| 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13954|19791|lyfalmen|||10|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||13954||13954|19791| 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|23207|31404|lyfalmen|||10|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||23207||23207|31404| 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2523|4329|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2523||2523|4329| 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2523|4329|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2523||2523|4329| 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998|31.01.2010|R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3799|6074|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3799||3799|6074| 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|26643|35716|lyfalmen|||10|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||26643||26643|35716| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|862|2056|lyfalmen|V0901|2033|00|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||862||862|2056| 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2884|4822|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Merck NM AB (A)|||2884||2884|4822| 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3734| 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|6155|9297|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Merck NM AB (A)|||6155||6155|9297| 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1106|2390|lyfalmen|||00|10|0|10,0000|Vistor hf|Meda AS|Tenoxíkam||1106||1106|2390| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|353|1360|lyfalmen|||00|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||353||353|1360| 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|SEK|2940|4899|lyfalmen|||00|250|1|13,8889|Distica|Distica - óskráð lyf|||2940||2940|4899| 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|SEK|12877|18440|lyfalmen|||00|150|1|50,0000|Distica|Distica - óskráð lyf|||12877||12877|18440| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1515|2187|lyfsjukr|||02|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1515||1515|2187| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|675|1801|lyfalmen|||00|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||675||675|1801| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|690|1821|lyfalmen|||00|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||690||690|1821| 174433|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|2063|3699|lyfalmen|||00|5|0|25,0000|Vistor hf|Allergan|||||2063|3699| 174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|261|1234|lyfalmen|V0886|1234|00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||261|1234| 174664|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|6052|9156|lyfalmen|||00|15|0|150,0000|Vistor hf|Allergan|||||6052|9156| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2587|3448|lyfalmen|V0507|3448|00|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||1879||1879|3448| 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7289|5253|lyfalmen|V0809|4523|00|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3199||3199|5253| 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4907|7590|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||4907||4907|7590| 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|857|2050|lyfalmen|||43|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||857||857|2050| 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|696|1384|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||696||696|1384| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|610|1712|lyfalmen|||03|1|1|5,3330|Distica|Distica - óskráð lyf|Tríamcínólón||610||610|1712| 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11103|15817|lyfsjukr|||00|60|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíð||11103||11103|15817| 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|6334|9542|lyfalmen|||10|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||6334||6334|9542| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|16884|23469|lyfalmen|||00|98|0|65,3400|Vistor hf|Bristol-Myers Squibb|Pravastatín||16884||16884|23469| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|878|2078|lyfalmen|||30|5|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón og sýkingalyf||878||878|2078| 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|811|1987|lyfalmen|||01|100|0|2,5000|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||811||811|1987| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||23|50|0|5,0000|Vistor hf|Bayer A/S|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|8201|15920|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer vet.|||8201||8201|15920| 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|10767|15395|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||10767||10767|15395| 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|40643|52889|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||40643||40643|52889| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|DKK|5372|10488|vetalmen|||16|100|0|0,0000|Vistor hf|Intervet International BV|||5372||5372|10488| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5937|11572|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||5937||5937|11572| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1309|2668|lyfalmen|||00|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1309||1309|2668| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1004|2251|lyfalmen|||41|21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1004||1004|2251| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1475|lyfalmen|||08|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||437||437|1475| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1965|lyfalmen|||08|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||795||795|1965| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1636|lyfalmen|||00|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||555||555|1636| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|5079|7825|lyfalmen|||98|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5079||5079|7825| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|25673|34499|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||25673||25673|34499| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|60814|78601|lyfalmen|V0563|78599|00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||60814||60814|78601| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2387|lyfalmen|||00|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1104||1104|2387| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|5570|8497|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5570||5570|8497| 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008|31.01.2010|R|A|3|0|0|B|0|MNA|0|1|0|100|SEK|1184|2497|lyfalmen|||00|90|0|15,0000|Actavis Group PTC ehf|Merck NM AB|Míanserín||1184||1184|2497| 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5818|8836|lyfalmen|||00|100|1|20,0000|Distica|Distica - óskráð lyf|||5818||5818|8836| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3223|5286|lyfalmen|||00|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3223||3223|5286| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2238|3939|lyfalmen|||00|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2238||2238|3939| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|11463|16269|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Novartis Healthcare A/S|Deferoxamín||11463||11463|16269| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3345|5453|lyfalmen|||03|5|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||3345||3345|5453| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1131|2424|lyfalmen|||03|2|0|4,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1131||1131|2424| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|547|1626|lyfalmen|||03|1|0|2,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||547||547|1626| 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|888|2092|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||888||888|2092| 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|481|1535|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||481||481|1535| 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972|28.02.2010|R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2031|3656|lyfalmen|||10|100|0|25,0000|Actavis Group hf|Actavis Group hf|Indómetacín||2031||2031|3656| 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4923|7105|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||4923||4923|7105| 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|5021|7247|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||5021||5021|7247| 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|6483|9357|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||6483||6483|9357| 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|4,6875|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1769|3297|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1769||1769|3297| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|493|1552|lyfalmen|||10|25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||493||493|1552| 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|21,6000|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2132| 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1239|2572|lyfalmen|||02|50|0|2,5091|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||1239||1239|2572| 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4495|lyfalmen|||00|20|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4495| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|1172|1691|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||1172||1172|1691| 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2264|3974|lyfalmen|||00|100|0|16,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2264||2264|3974| 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|545|1623|lyfalmen|||00|20|0|3,3333|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||545||545|1623| 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BAV|0|0|1|100|SEK|2130|3791|lyfalmen|V0514|1415|00|10|0|2,5000|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||2130||2130|3791| 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BAV|0|0|1|100|SEK|4620|7197|lyfalmen|V0518|1750|00|20|0|5,0000|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||4620||4620|7197| 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BAV|0|0|1|100|SEK|4525|7067|lyfalmen|V0522|1762|00|10|0|5,0000|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||4525||4525|7067| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1425|2827|lyfalmen|||00|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||||1425|2827| 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BAV|0|0|1|100|SEK|8777|12884|lyfalmen|V0526|2475|00|20|0|10,0000|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||8777||8777|12884| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2120|3777|lyfalmen|||03|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2120||2120|3777| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|866|2062|lyfalmen|||03|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||866||866|2062| 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCN|0|0|0|100|SEK|1041|2301|lyfalmen|||10|40|0|8,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||1041||1041|2301| 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|23890|32261|lyfalmen|||00|1|0|1014,9254|Vistor hf|N.V. Organon|Etónógestrel||23890||23890|32261| 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|804|1977|lyfalmen|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur||804||804|1977| 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|387|1407|lyfalmen|||10|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||387||387|1407| 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|917|2132|lyfalmen|||10|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||917||917|2132| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1659|3147|lyfalmen|||00|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||||1659|3147| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1461|2876|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1461||1461|2876| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2815|5578|vetalmen|||27|10|0|0,0000|Icepharma hf|Intervet International B.V.|||2815||2815|5578| 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|13403|25908|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||13403||13403|25908| 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60,0000|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6484| 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|838|2024|lyfalmen|||06|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||838||838|2024| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|937|2159|lyfalmen|V0857|1762|00|20|0|20,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||937||937|2159| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4440|6951|lyfalmen|||00|100|0|100,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||4440||4440|6951| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2325|4058|lyfalmen|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2325||2325|4058| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|XEU|2318|4048|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||2318||2318|4048| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|11179|15912|lyfsjukr|||02|200|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúóróúracíl||11179||11179|15912| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|458|661|lyfsjukr|||02|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||458||458|661| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|40803|53487|lyfalmen|||00|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estramústín||40803||40803|53487| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|692|1824|lyfalmen|||00|30|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||692||692|1824| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6890|10302|lyfalmen|||44|8|0|4,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||6890||6890|10302| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|61934|79610|lyfsjukr|||00|5|0|0,4000|Icepharma hf|Centocor -|Abciximab||61934||61934|79610| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5458|8170|lyfalmen|||00|60|1|12,0000|Distica|Distica - óskráð lyf|||5331||5331|8170| 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|5122|7884|lyfalmen|||00|100|1|1,2500|Parlogis hf|Parlogis - óskráð lyf|||5122||5122|7884| 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9131|lyfalmen|||00|10|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Skópólamín||6034||6034|9131| 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3784|lyfalmen|||00|100|1|1,2500|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3784| 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5686|lyfsjukr|||00|20|1|3,3333|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5686| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|628|906|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||628||628|906| 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|21132|28403|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||21132||21132|28403| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|642|927|lyfsjukr|||03|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||642||642|927| 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9839| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|3362|5476|lyfalmen|||00|30|0|3,7500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3362||3362|5476| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|7854|11621|lyfalmen|V0104|11620|00|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||7854||7854|11621| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4528|7071|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4528||4528|7071| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|11237|16249|lyfalmen|||00|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||11237||11237|16249| 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|114621|145732|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||114621||114621|145732| 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|228609|288787|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||228609||228609|288787| 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|604780|760881|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||604780||604780|760881| 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2745|4632|lyfalmen|||23|66|0|88,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2745||2745|4632| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|21783|29617|lyfalmen|V0105|29615|00|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||21783||21783|29617| 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|4440|6951|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4440||4440|6951| 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|7611|11289|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7611||7611|11289| 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|10170|14789|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10170||10170|14789| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3203|5259|lyfalmen|||44|2|0|1,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||3203||3203|5259| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|691|1822|lyfalmen|||00|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||691||691|1822| 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5031|7759|lyfalmen|||00|30|0|30,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||5031||5031|7759| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|11661|16829|lyfalmen|||00|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11661||11661|16829| 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|1,5000|Vistor hf|Janssen-Cilag AB|Ekónazól|||||| 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997|31.01.2010|R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|13557|19293|lyfalmen|||00|30|0|30,0000|Vistor hf|AstraZeneca AB|Bíkalútamíð||13557||13557|19293| 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3033|5026|lyfalmen|||23|15|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||3033||3033|5026| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|9763|14233|lyfalmen|||00|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9763||9763|14233| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|11753|16955|lyfalmen|||00|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11753||11753|16955| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|13594|19340|lyfalmen|||00|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||13594||13594|19340| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4918|7605|lyfalmen|||63|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4918||4918|7605| 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992|28.02.2010|R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|41847|54797|lyfalmen|||63|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||41847||41847|54797| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|11294|12755|lyfalmen|V0508|12755|00|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||8683||8683|12755| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|172660|218571|lyfsjukr|||00|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||172660||172660|218571| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|179840|227582|lyfsjukr|||00|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||179840||179840|227582| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|225487|284869|lyfsjukr|||00|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||225487||225487|284869| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1652|3137|lyfalmen|||00|12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1652||1652|3137| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|2043|3672|lyfalmen|||00|12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2043||2043|3672| 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|31744|41721|lyfsjukr|||00|0|0|0,0000|Vistor hf|Aventis Pharma SA|Docetaxel||31744||31744|41721| 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|127459|161844|lyfsjukr|||00|2|0|0,0000|Vistor hf|Aventis Pharma SA|Docetaxel||127459||127459|161844| 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6565|9858|lyfalmen|||17|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6565||6565|9858| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6124|9255|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6124||6124|9255| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6996|10447|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6996||6996|10447| 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999|28.02.2010|R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1507|lyfalmen|||00|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||460||460|1507| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0,0000|Vistor hf|Bayer Animal Health GmbH||||||1891| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8483|14798|vetorma|||00|20|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||8483||8483|14798| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995|31.01.2010|L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|63043|81398|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||63043||63043|81398| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|801|1593|vetalmen|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||801||801|1593| 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|245812|310377|lyfsjukr|||00|200|0|28,5714|Zeneus Pharma Limited|Zeneus Pharma Limited|Amfóterícín||245812||245812|310377| 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3708|5950|lyfalmen|V2002|5848|00|25|0|5,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||3708||3708|5950| 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|4182|6598|lyfalmen|||00|30|0|30,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||4182||4182|6598| 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|8134|12004|lyfalmen|||23|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||8134||8134|12004| 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4935|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4935| 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2606|4442|lyfalmen|V0388|4442|23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2606||2606|4442| 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2381|4134|lyfalmen|||23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2381||2381|4134| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|755|1910|lyfalmen|V0408|1910|00|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||755||755|1910| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|699|1833|lyfalmen|||00|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||699||699|1833| 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|370196|466478|lyfsjukr|||02|4000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||370196||370196|466478| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1065|2334|lyfalmen|||00|3|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1065||1065|2334| 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13108|18730|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Granisetrón||13108||13108|18730| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3210|5268|lyfalmen|||01|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||3210||3210|5268| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7693|11401|lyfalmen|||00|100|0|50,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||7693||7693|11401| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3038|5033|lyfalmen|V0101|5032|00|20|0|20,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||3038||3038|5033| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|14824|20883|lyfalmen|V2140|20883|00|100|0|100,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||14824||14824|20883| 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3377|5497|lyfalmen|||00|50|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||3377||3377|5497| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|flaska||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17339|lyfalmen|||00|50|1||Distica|Distica - óskráð lyf|Ondansetrón||||12000|17339| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5506|10745|vetalmen|||16|24|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5506||5506|10745| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|214495|271074|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||214495||214495|271074| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|11801|16693|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche|Capecitabín||11801||11801|16693| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|62676|80541|lyfsjukr|||00|120|0|0,0000|Icepharma hf|Roche|Capecitabín||62676||62676|80541| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3400|lyfalmen|V0703|3400|00|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1844||1844|3400| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|9919|14446|lyfalmen|||02|3|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||9919||9919|14446| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1870|3435|lyfalmen|||06|8|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1870||1870|3435| 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6121|9250|lyfalmen|||10|100|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||6121||6121|9250| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|398|1422|lyfalmen|||00|25|0|12,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||398||398|1422| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|474|1526|lyfalmen|||00|100|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||474||474|1526| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|283|1264|lyfalmen|||00|25|0|7,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||283||283|1264| 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|834|2018|lyfalmen|||00|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||834||834|2018| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1334|2702|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1334||1334|2702| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2582|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2582| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3613|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3613| 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|716|1857|lyfalmen|||51|0|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||716||716|1857| 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1749|3479|vetalmen|||58|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1749||1749|3479| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5649|11019|vetalmen|||27|20|0|0,0000|Vistor hf|Intervet International BV|||5649||5649|11019| 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7695|11404|lyfalmen|||10|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||7695||7695|11404| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1494|2921|lyfalmen|||06|14|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1494||1494|2921| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0,0000|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||1842| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|102409|130406|lyfsjukr|||02|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||102409||102409|130406| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|688|993|lyfsjukr|||02|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||688||688|993| 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1816|3361|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1816||1816|3361| 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|22401|30392|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||22401||22401|30392| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22666|30725|lyfalmen|||00|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22666||22666|30725| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22666|30725|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22666||22666|30725| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22666|30725|lyfalmen|||00|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22666||22666|30725| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22892|31009|lyfalmen|||00|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22892||22892|31009| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|69014|88892|lyfalmen|||00|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||69014||69014|88892| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|74854|96221|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||74854||74854|96221| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|80693|103549|lyfalmen|||00|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||80693||80693|103549| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|7649|11341|lyfalmen|||00|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||7649||7649|11341| 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974|28.02.2010|R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|655|1773|lyfalmen|||10|30|0|7,5000|Actavis Group hf|Actavis Group hf|Indómetacín||655||655|1773| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2281|3998|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||2281||2281|3998| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|268|1244|lyfalmen|||00|25|0|5,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||268||268|1244| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|416|1446|lyfalmen|||00|100|0|20,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||416||416|1446| 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1167|2474|lyfalmen|||20|20|0|20,0000|Vistor hf|Schering-Plough|Betametasón||1167||1167|2474| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|5354|8201|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||5354||5354|8201| 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1167|2474|lyfalmen|||20|20|0|20,0000|Vistor hf|Schering-Plough|Betametasón||1167||1167|2474| 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3188|5238|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||3188||3188|5238| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|5732|8718|lyfalmen|||08|35|0|1,7500|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5732||5732|8718| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|4233|6668|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||4233||4233|6668| 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4443|6955|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4443||4443|6955| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|13675|19441|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||13675||13675|19441| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3336|5441|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3336||3336|5441| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|11638|22519|vetalmen|||27|120|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||11638||11638|22519| 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1664|lyfalmen|V0290|1664|00|100|0|33,3333|Actavis Group hf|Actavis hf|Atenólól||||575|1664| 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|11081|16035|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||11081||11081|16035| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1326|2691|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Klórókín||1326||1326|2691| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|776|1939|lyfalmen|||23|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Tretínóín||776||776|1939| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|679|1806|lyfalmen|||00|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||679||679|1806| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|7058|10186|lyfsjukr|||02|50|0|16,6667|Icepharma hf|Roche|Mídazólam||7058||7058|10186| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|25722|34164|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín||25722||25722|34164| 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2045|3675|lyfalmen|||67|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2045||2045|3675| 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7831|11590|lyfalmen|||98|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7831||7831|11590| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|26075|35003|lyfalmen|||00|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||26075||26075|35003| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|4445|6415|lyfsjukr|||00|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4445||4445|6415| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|11003|21300|vetalmen|||02|100|0|0,0000|Vistor hf|Merial|||11003||11003|21300| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|3412|5545|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3412||3412|5545| 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990|28.02.2010|R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1420|2820|lyfalmen|||00|30|0|30,0000|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||1420||1420|2820| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|A||0|0|*|0|MYL|0|0|0|100|SEK|4743|7365|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4743||4743|7365| 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|126458|160587|lyfsjukr|||00|12|0|0,0000|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||126458||126458|160587| 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|DKK|2355|4099|lyfalmen|||00|2|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2355||2355|4099| 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4991|7705|lyfalmen|||00|90|0|54,0000|Icepharma hf|Servier|Indapamíð||4991||4991|7705| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1595|3059|lyfalmen|||00|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1595||1595|3059| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2086|3731|lyfalmen|V0418|3729|05|15|0|15,0000|Vistor hf|Novo-Nordisk|Estradíól||2086||2086|3731| 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|3931|6255|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||3931||3931|6255| 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|10413|10274|lyfalmen|V2219|5241|00|98|0|98,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||6869||6869|10274| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|GBP|5154|7928|lyfalmen|||00|300|1|15,0000|Distica|Distica - óskráð lyf|Ranitidín||5154||5154|7928| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3175|5220|lyfalmen|||23|10|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||3175||3175|5220| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|26695|35781|lyfalmen|||23|150|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||26695||26695|35781| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1230|2560|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1230||1230|2560| 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995|31.01.2010|R|A|3|0|0|0|0|MER|0|0|0|100|XEU|614|1221|vetalmen|||00|10|0|0,0000|Vistor hf|Merial|||614||614|1221| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|42101|54719|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Abacavír||42101||42101|54719| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|5081|7828|lyfalmen|||10|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5081||5081|7828| 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1913|3494|lyfalmen|||20|50|0|50,0000|Vistor hf|Schering-Plough|Betametasón||1913||1913|3494| 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|10333|15012|lyfalmen|V0299|10893|00|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||10333||10333|15012| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2141|4259|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2141||2141|4259| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2779|5509|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2779||2779|5509| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4488|7017|lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||4488||4488|7017| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7818|11572|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7818||7818|11572| 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|69089|88589|lyfsjukr|||00|10|0|0,0000|Vistor hf|Schering-Plough|Doxórúbicín||69089||69089|88589| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|60842|78239|lyfsjukr|||00|180|0|30,0000|Icepharma hf|M.S.D.|Indínavír||60842||60842|78239| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|51465|66471|lyfsjukr|||00|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||51465||51465|66471| 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|851|2041|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||851||851|2041| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|13253|18912|lyfalmen|||02|10|0|40,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13253||13253|18912| 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993|28.02.2010|R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|13812|19217|lyfsjukr|||00|40|0|40,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13812||13812|19217| 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3958|6292|lyfalmen|||02|2|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||3958||3958|6292| 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|6754|10116|lyfalmen|||02|2|0|20,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||6754||6754|10116| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1989|3598|lyfalmen|V0144|3598|70|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1989||1989|3598| 422121|C07AB0205 |Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1697|3199|lyfalmen|||00|28|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||||1697|3199| 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3729|5281|lyfalmen|V2004|4538|43|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3219||3219|5281| 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7344|10923|lyfalmen|||43|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||7344||7344|10923| 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|9544|13933|lyfalmen|||49|100|0|50,0000|Vistor hf|Meda AS|Brómókriptín||9544||9544|13933| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0,0000|Icepharma hf|Intervet International B.V.||||||2245| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|1066|2335|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||1066||1066|2335| 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|33119|43843|lyfalmen|||52|100|0|25,0000|Vistor hf|Meda AS|Brómókriptín||33119||33119|43843| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|0,5000|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3759|6019|lyfalmen|V0555|2848|10|2|0|1,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3759||3759|6019| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|675|1801|lyfalmen|||00|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||675||675|1801| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|881|2082|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||881||881|2082| 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícós|||||2636| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1093|2372|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1093||1093|2372| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1085|2361|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1085||1085|2361| 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BAV|0|0|0|100|SEK|34805|45563|lyfsjukr|||00|1000|0|4,0000|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||34805||34805|45563| 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BAV|0|0|0|100|SEK|54508|70290|lyfsjukr|||00|2000|0|8,0000|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||54508||54508|70290| 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|551|1631|lyfalmen|||23|14|0|1,7500|Vistor hf|Astellas Pharma A/S|Amoxicillín||551||551|1631| 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|909|2121|lyfalmen|||23|14|0|3,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||909||909|2121| 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1123|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Atenólól||180||180|1123| 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|6101|9223|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||6101||6101|9223| 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|45635|59551|lyfalmen|||AC|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||45635||45635|59551| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|6302|9498|lyfalmen|||00|100|0|133,3333|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||6302||6302|9498| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1972|2846|lyfsjukr|||02|50|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||1972||1972|2846| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2144|3094|lyfsjukr|||02|50|0|3,3333|Icepharma hf|Roche|Mídazólam||2144||2144|3094| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|4206|8249|vetalmen|||27|100|0|0,0000|Vistor hf|Intervet International BV|||4206||4206|8249| 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2789|4692|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2789||2789|4692| 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|837|2022|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||837||837|2022| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1365|2744|lyfalmen|||00|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíð dínítrat||1365||1365|2744| 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989|28.02.2010|R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1951|lyfalmen|||00|100|0|12,5000|Actavis Group hf|Actavis hf|Diltíazem||785||785|1951| 431759|M01AB5503|Arthrotec Forte|töflur|75,02|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PFI|0|0|1|100|DKK|1554|3003|lyfalmen|||00|20|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||||1554|3003| 431783|M01AB5503|Arthrotec Forte|töflur|75,02|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PFI|0|0|1|100|DKK|7053|10525|lyfalmen|||00|100|0|75,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||||7053|10525| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2180|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||952||952|2180| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|12154|17532|lyfalmen|||0|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||12154||12154|17532| 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2726|4606|lyfalmen|||00|28|0|8,4000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2726||2726|4606| 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6687|10025|lyfalmen|||00|28|0|25,2000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||6687||6687|10025| 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9645|14071|lyfalmen|||00|28|0|42,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||9645||9645|14071| 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0,0000|Icepharma hf|Intervet International B.V.||||||1429| 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|MCN|0|0|1|100|SEK|1656|3143|lyfalmen|||20|50|0|50,0000|Vistor hf|McNeil Sweden AB|Blöndur||1656||1656|3143| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|6375|9598|lyfalmen|||00|1|0|0,6000|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6375||6375|9598| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|6375|9598|lyfalmen|||00|1|0|0,3000|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6375||6375|9598| 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|11284|16313|lyfalmen|||00|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||11284||11284|16313| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6714|10062|lyfalmen|||00|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6714||6714|10062| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5244|8051|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5244||5244|8051| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|8286|10768|lyfalmen|V0725|9346|00|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7230||7230|10768| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|3176|5222|lyfalmen|||00|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíð dínítrat||3176||3176|5222| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4091|6474|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4091||4091|6474| 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|10787|15633|lyfalmen|V2221|5052|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||10787||10787|15633| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|814|1991|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||814||814|1991| 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|890|2095|lyfalmen|||10|20|0|15,0000|Actavis Group PTC ehf|Merck NM AB|Naproxen||890||890|2095| 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995|28.02.2010|R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3630|5843|lyfalmen|||10|100|0|75,0000|Actavis Group PTC ehf|Merck NM AB|Naproxen||3630||3630|5843| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|1035|2293|lyfalmen|||00|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||1035||1035|2293| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3628|5840|lyfalmen|||00|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3628||3628|5840| 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|DKK|12598|18090|lyfalmen|V0955|9896|00|100|0|75,0000|Icepharma hf|Wyeth AB|Venlafaxín||12598||12598|18090| 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|DKK|6775|10145|lyfalmen|V0957|6034|00|28|0|42,0000|Icepharma hf|Wyeth AB|Venlafaxín||6775||6775|10145| 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|742|1892|lyfalmen|||00|20|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|||742||742|1892| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1292|2645|lyfalmen|||00|10|0|0,0000|K.Pétursson hf|Alcon|Hýdrókortisón og sýkingalyf||1292||1292|2645| 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|DKK|3549|5732|lyfalmen|V0954|3858|00|28|0|21,0000|Icepharma hf|Wyeth AB|Venlafaxín||3549||3549|5732| 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|DKK|12204|17595|lyfalmen|V0955|9698|00|98|0|73,5000|Icepharma hf|Wyeth AB|Venlafaxín||12204||12204|17595| 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|DKK|23170|31357|lyfalmen|V0956|15267|00|98|0|147,0000|Icepharma hf|Wyeth AB|Venlafaxín||23170||23170|31357| 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|DKK|21359|29085|lyfalmen|V0956|15579|00|100|0|150,0000|Icepharma hf|Wyeth AB|Venlafaxín||21359||21359|29085| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2156|3827|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||2156||2156|3827| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6509|9781|lyfalmen|V0984|3174|00|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||6509||6509|9781| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2337|4074|lyfalmen|||66|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2337||2337|4074| 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9685|14126|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||9685||9685|14126| 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2335|lyfalmen|||00|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2335| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1627|2348|lyfsjukr|||00|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1627||1627|2348| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2569|3708|lyfsjukr|||00|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2569||2569|3708| 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1627|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis hf|Díklófenak||548||548|1627| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1590|3052|lyfalmen|V0221|2926|00|100|0|33,3333|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||1590||1590|3052| 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1434|2839|lyfalmen|||20|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Blöndur||1434||1434|2839| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0,0000|Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|998|2242|lyfalmen|||00|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||998||998|2242| 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|30951|40726|lyfsjukr|||61|40|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zídóvúdín||30951||30951|40726| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|4029|6389|lyfalmen|||02|1|0|1,0000|Vistor hf|Novo-Nordisk|Glúkagon||4029||4029|6389| 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|29664|39507|lyfalmen|||10|90|0|180,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||29664||29664|39507| 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|49595|64124|lyfsjukr|||00|56|0|21,0000|Vistor hf|Bristol-Myers Squibb|Stavúdín||49595||49595|64124| 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|50305|65015|lyfsjukr|||00|56|0|28,0000|Vistor hf|Bristol-Myers Squibb|Stavúdín||50305||50305|65015| 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|3434|5575|lyfalmen|V0914|3530|00|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3434||3434|5575| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2399|4159|lyfalmen|||00|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2399||2399|4159| 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|19952|26922|lyfsjukr|||00|2|0|0,3300|Icepharma hf|Roche|||19952||19952|26922| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1851|3409|lyfalmen|||00|30|0|30,0000|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1851||1851|3409| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1589|3161|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||1589||1589|3161| 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4442|6954|lyfalmen|V0551|3257|10|7|0|1,7500|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4442||4442|6954| 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1892|3465|lyfalmen|V0554|1909|10|1|0|0,7500|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||1892||1892|3465| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12381|17817|lyfalmen|||00|4|0|3,6000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||12381||12381|17817| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7063|10539|lyfalmen|||00|2|0|2,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||7063||7063|10539| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8651|12711|lyfalmen|||00|2|0|2,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||8651||8651|12711| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10388|15088|lyfalmen|||00|3|0|3,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||10388||10388|15088| 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|632|1742|lyfalmen|||04|10|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||632||632|1742| 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1235|2567|lyfalmen|||00|30|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1235||1235|2567| 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|8230|12135|lyfalmen|||02|100|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|||8230||8230|12135| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2590|4420|lyfalmen|V0712|2914|00|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2590||2590|4420| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1395|2786|lyfalmen|||00|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1395||1395|2786| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|6093|8794|lyfsjukr|||00|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||6093||6093|8794| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2281|lyfalmen|V0466|2266|00|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2281| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1169|1917|lyfalmen|V0902|1751|00|20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||760||760|1917| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|4115|5672|lyfalmen|V0903|4977|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||3505||3505|5672| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|57608|74577|lyfalmen|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||57608||57608|74577| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|86414|110729|lyfalmen|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||86414||86414|110729| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|115217|146876|lyfalmen|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||115217||115217|146876| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6290|8621|lyfalmen|||00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5661||5661|8621| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|16612|23127|lyfalmen|||00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||16612||16612|23127| 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|18231|25159|lyfalmen|V0552|8858|10|30|0|7,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||18231||18231|25159| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1276|2623|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1276||1276|2623| 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|61057|78906|lyfalmen|||10|100|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||61057||61057|78906| 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|15462|21684|lyfalmen|||00|3000|0|3,0000|Vistor hf|Laboratories 3M Santé|Imikvímóð||15462||15462|21684| 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|3321|5420|lyfalmen|||00|90|0|0,0000|Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||3321||3321|5420| 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2809|4720|lyfalmen|||10|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2809||2809|4720| 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|8171|12055|lyfalmen|||10|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||8171||8171|12055| 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2620|4461|lyfalmen|||10|100|0|33,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||2620||2620|4461| 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5305|8134|lyfalmen|||10|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||5305||5305|8134| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0,0000|Vistor hf|Merial (MSD)||||||2824| 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|15848|22168|lyfalmen|||10|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||15848||15848|22168| 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|10686|15495|lyfalmen|||10|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||10686||10686|15495| 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|27092|36280|lyfalmen|||10|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||27092||27092|36280| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|3968|5727|lyfsjukr|||02|1|0|0,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||3968||3968|5727| 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2525|4331|lyfalmen|||00|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2525||2525|4331| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16894|23481|lyfalmen|||00|28|0|18,6667|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||16894||16894|23481| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|47833|43569|lyfalmen|V0375|42321|00|98|0|65,3333|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||32900||32900|43569| 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|19060|26199|lyfalmen|||00|28|0|37,3333|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||19060||19060|26199| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|52700|48616|lyfalmen|V0376|47222|00|98|0|130,6667|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||36922||36922|48616| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|54248|69964|lyfsjukr|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||54248||54248|69964| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1202|2391|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1202||1202|2391| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAV|0|0|0|100|SEK|1018|2270|lyfalmen|||00|30|0|5,0000|Vistor hf|Bayer Schering Pharma AG (V)|Acarbósa||1018||1018|2270| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAV|0|0|0|100|SEK|3658|5881|lyfalmen|||00|120|0|20,0000|Vistor hf|Bayer Schering Pharma AG (V)|Acarbósa||3658||3658|5881| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|24105|32531|lyfalmen|||00|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||24105||24105|32531| 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|Icepharma hf|Doetsch Grether|Lídókaín|||||| 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|10|0|0,0000|Icepharma hf|Doetsch Grether|Lídókaín|||||| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1096|2377|lyfalmen|||00|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1096||1096|2377| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1195|2512|lyfalmen|||0|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1195||1195|2512| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|2618|4459|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2618||2618|4459| 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4892|7060|lyfsjukr|||00|12000|0|12,0000|Icepharma hf|Baxter|||4892||4892|7060| 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4892|7060|lyfsjukr|||00|12000|0|12,0000|Icepharma hf|Baxter|||4892||4892|7060| 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5341|7708|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Baxter|||5341||5341|7708| 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5341|7708|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Baxter|||5341||5341|7708| 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7997|11542|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7997||7997|11542| 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7997|11542|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7997||7997|11542| 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7997|11542|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7997||7997|11542| 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10010|14445|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||10010||10010|14445| 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9758|14083|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||9758||9758|14083| 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12973|18164|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12973||12973|18164| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1175|2485|lyfalmen|||00|25|0|5,0000|Vistor hf|Astra|Clómetíazól||1175||1175|2485| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1585|3045|lyfalmen|||43|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1585||1585|3045| 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2304|4029|lyfalmen|||43|30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2304||2304|4029| 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9603|14014|lyfalmen|V0456|14014|00|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9603||9603|14014| 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13075|18292|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||13075||13075|18292| 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13075|18292|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||13075||13075|18292| 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13075|18292|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||13075||13075|18292| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1564|2257|lyfsjukr|||02|2|0|0,1667|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1564||1564|2257| 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|93890|119714|lyfsjukr|||00|10|0|1,6700|Icepharma hf|Roche|||93890||93890|119714| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1917|2767|lyfsjukr|||02|4|0|0,3333|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1917||1917|2767| 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2219|3913|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||2219||2219|3913| 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2433|4205|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||2433||2433|4205| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2669|4528|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2669||2669|4528| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4803|7448|lyfalmen|||00|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4803||4803|7448| 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1105|2389|lyfalmen|||23|20|0|5,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||1105||1105|2389| 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4662|7255|lyfalmen|||51|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4662||4662|7255| 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1212|2535|lyfalmen|||23|20|0|10,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||1212||1212|2535| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2535|4345|lyfalmen|||23|20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||2535||2535|4345| 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001|31.03.2010|R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|20292|27349|lyfsjukr|||00|20|0|0,0000|Vistor hf|Schering-Plough|Temozolomid||20292||20292|27349| 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyflausa|||23|120|0|120,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól|||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|6670|10001|lyfalmen|||51|5|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||6670||6670|10001| 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001|31.03.2010|R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|81164|103743|lyfsjukr|||00|20|0|0,0000|Vistor hf|Schering-Plough|Temozolomid||81164||81164|103743| 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001|31.03.2010|R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|80160|102483|lyfsjukr|||00|5|0|0,0000|Vistor hf|Schering-Plough|Temozolomid||80160||80160|102483| 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001|31.03.2010|R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|199038|251675|lyfsjukr|||00|5|0|0,0000|Vistor hf|Schering-Plough|Temozolomid||199038||199038|251675| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1141|lyfalmen|||00|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1141| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|680|1807|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||680||680|1807| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|680|1807|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||680||680|1807| 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8590|12628|lyfalmen|||56|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||8590||8590|12628| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7371|14326|vetalmen|||02|20|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7371||7371|14326| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5880|11463|vetalmen|||00|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5880||5880|11463| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|LPI|0|1|0|100|DKK|1946|3539|lyfalmen|||00|100|0|8,3333|Swedish Orphan International AB|Lundbeck Pharmaceuticals Ireland Ltd.|Melperón||1946||1946|3539| 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1306|2598|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1306||1306|2598| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1233|2453|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1233||1233|2453| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1322|2630|vetalmen|||27|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1322||1322|2630| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|696|1384|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||696||696|1384| 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|825|2006|lyfalmen|||10|25|0|2,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||825||825|2006| 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2270|3982|lyfalmen|||10|100|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2270||2270|3982| 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1755|3278|lyfalmen|||10|25|0|7,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1755||1755|3278| 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6716|10064|lyfalmen|||10|100|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||6716||6716|10064| 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3374|5493|lyfalmen|||10|25|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||3374||3374|5493| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8703|12783|lyfalmen|||10|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8703||8703|12783| 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5401|8266|lyfalmen|||10|25|0|25,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5401||5401|8266| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|5773|8774|lyfalmen|||64|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||5773||5773|8774| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|17443|23773|lyfsjukr|||00|0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||17443||17443|23773| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|27338|36192|lyfsjukr|||00|0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||27338||27338|36192| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|29601|39032|lyfsjukr|||00|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||29601||29601|39032| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|48215|62392|lyfsjukr|||00|1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||48215||48215|62392| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|DKK|37241|49017|lyfalmen|||00|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||37241||37241|49017| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|16978|23586|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||16978||16978|23586| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|98696|125746|lyfsjukr|||00|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||98696||98696|125746| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|32328|42851|lyfalmen|||10|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32328||32328|42851| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|836|1207|lyfsjukr|||00|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||836||836|1207| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7046|7123|lyfalmen|V0922|4575|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4566||4566|7123| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|487|703|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||487||487|703| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|10259|6779|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4314||4314|6779| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|25921|13848|lyfalmen|V0930|8557|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9482||9482|13848| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11174|16163|lyfalmen|||00|98|0|49,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||11174||11174|16163| 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3191|5242|lyfalmen|||00|20|0|13,3333|Icepharma hf|Grunenthal|Tramadól||3191||3191|5242| 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|13006|18602|lyfalmen|V0738|13633|00|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||13006||13006|18602| 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2495|4290|lyfalmen|||00|20|0|10,0000|Icepharma hf|Grunenthal|Tramadól||2495||2495|4290| 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|9876|14387|lyfalmen|V0736|9302|00|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||9876||9876|14387| 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1695|3196|lyfalmen|V0733|2630|00|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||1695||1695|3196| 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6746|10105|lyfalmen|V0734|6367|00|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||6746||6746|10105| 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5487|8383|lyfalmen|||24|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5487||5487|8383| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|12401|17446|lyfsjukr|||02|150|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||12401||12401|17446| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|10021|14459|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||10021||10021|14459| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9231|lyfsjukr|||02|100|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||6396||6396|9231| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|16730|22879|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||16730||16730|22879| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|14378|19927|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||14378||14378|19927| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2188|3870|lyfalmen|||68|100|0|50,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||2188||2188|3870| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0,0000|Icepharma hf|Intervet International B.V.||||||2591| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2569|4392|lyfalmen|||00|100|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2569||2569|4392| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5234|10223|vetalmen|||27|10|0|0,0000|Vistor hf|Orion Corporation|||5234||5234|10223| 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2472|3683|lyfalmen|V2003|3186|43|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2051||2051|3683| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2541|4353|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2541||2541|4353| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|15506|21343|lyfsjukr|||00|400|0|0,4000|Vistor hf|Meda AB|Dextran||15506||15506|21343| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1112|2398|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||1112||1112|2398| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|45806|59369|lyfsjukr|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||45806||45806|59369| 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2035|3661|lyfalmen|||00|140|0|35,0000|Vistor hf|Schering-Plough|Mómetasón||2035||2035|3661| 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1862|lyfalmen|||00|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||720||720|1862| 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4525|7067|lyfalmen|||23|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||4525||4525|7067| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|250|1219|lyfalmen|V0775|1219|00|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||250||250|1219| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|347|1352|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||347||347|1352| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|971|2206|lyfalmen|V0780|2206|00|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||971||971|2206| 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|3699|5937|lyfalmen|||00|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3699||3699|5937| 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|4949|7647|lyfalmen|||00|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4949||4949|7647| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6126|9257|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||6126||6126|9257| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|5202|7993|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5202||5202|7993| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1173|2482|lyfalmen|||00|50|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1173||1173|2482| 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|7547|11201|lyfalmen|||00|30|0|7,5000|Vistor hf|AstraZeneca AB|Quetíapín||7547||7547|11201| 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|11468|16565|lyfalmen|||00|30|0|15,0000|Vistor hf|AstraZeneca AB|Quetíapín||11468||11468|16565| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4603|7174|lyfalmen|||00|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4603||4603|7174| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|11073|16025|lyfalmen|||00|98|0|130,6667|Vistor hf|Meda AS|Benazepríl||11073||11073|16025| 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|23755|32092|lyfalmen|||00|98|0|261,3333|Vistor hf|Meda AS|Benazepríl||23755||23755|32092| 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|5123|7885|lyfalmen|||00|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||5123||5123|7885| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|13264|18925|lyfalmen|||00|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||13264||13264|18925| 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|11897|17152|lyfalmen|||00|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||11897||11897|17152| 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|37564|49025|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Clostridium botulinum toxín-A||37564||37564|49025| 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|68242|87923|lyfalmen|V0557|27970|10|28|0|28,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||68242||68242|87923| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3956|5709|lyfsjukr|||00|50|0|0,5000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3956||3956|5709| 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5477|7905|lyfsjukr|||00|100|0|1,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5477||5477|7905| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|90473|115426|lyfsjukr|||00|3|0|83,9552|Vistor hf|Ferring|Triptórelín||90473||90473|115426| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|6519|9795|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Fínasteríð||6519||6519|9795| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1461|2876|lyfalmen|||00|300|0|0,0000|Vistor hf|Meda AB (V)|Benzýdamín||1461||1461|2876| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|493|1552|lyfalmen|||29|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||493||493|1552| 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|704|1840|lyfalmen|||29|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||704||704|1840| 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|2736|4620|lyfalmen|||00|30|0|15,0000|Icepharma hf|Servier|Perindópríl||2736||2736|4620| 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|3993|6339|lyfalmen|||00|30|0|30,0000|Icepharma hf|Servier|Perindópríl||3993||3993|6339| 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|886|2089|lyfalmen|||00|25|0|6,2500|Vistor hf|Recip AB|Nítrófúrantóín||886||886|2089| 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|953|2181|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||953||953|2181| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2836|4757|lyfalmen|||00|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2836||2836|4757| 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1315| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|6906|10324|lyfalmen|||67|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6906||6906|10324| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|19321|26527|lyfalmen|||67|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||19321||19321|26527| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1140|lyfalmen|||67|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1140| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|882|1516|lyfalmen|V0609|1465|67|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1516| 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2666|4524|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2666||2666|4524| 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2971|4941|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2971||2971|4941| 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|9430|13777|lyfalmen|||00|5|0|1,6667|Icepharma hf|Roche A.S.|Granisetrón||9430||9430|13777| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5188|7974|lyfalmen|||00|30|0|15,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||5188||5188|7974| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11901|11434|lyfalmen|||00|100|0|50,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||7717||7717|11434| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8052|11892|lyfalmen|||00|30|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||8052||8052|11892| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|16890|15570|lyfalmen|V2207|3144|00|100|0|100,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||10741||10741|15570| 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12498|17964|lyfalmen|||00|30|0|60,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||12498||12498|17964| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|21481|19286|lyfalmen|V0339|5945|00|100|0|200,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||13551||13551|19286| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|49858|64454|lyfsjukr|||00|3|0|21,0084|Vistor hf|N.V. Organon|BCG bóluefni||49858||49858|64454| 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3643|5861|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3643||3643|5861| 492512|A02BC0102 |Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12593|18083|lyfalmen|V2206|7650|00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12593||12593|18083| 492546|A02BC0102 |Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994|28.02.2010|R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1548|2995|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Merck NM AB|Míanserín||1548||1548|2995| 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4708|7318|lyfalmen|||00|28|0|18,6667|Vistor hf|Bristol-Myers Squibb|Pravastatín||4708||4708|7318| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1778|3309|lyfalmen|||00|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1778||1778|3309| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4318|6784|lyfalmen|||00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||4318||4318|6784| 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|93336|119019|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||93336||93336|119019| 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|233339|294723|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||233339||233339|294723| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2493|4288|lyfalmen|||00|60|0|60,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2493||2493|4288| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2844|4768|lyfalmen|V0408|1910|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Estradíól||2844||2844|4768| 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3608|5813|lyfalmen|V0388|4442|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3608||3608|5813| 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|2415|4181|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2415||2415|4181| 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|0|0|GSK|0|0|0|100|IKR|||lyfalmen|||14|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||4160| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|18891|25987|lyfalmen|||00|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||18891||18891|25987| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7348|10929|lyfalmen|V1088|8758|02|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7348||7348|10929| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10498|15238|lyfalmen|V1089|13517|02|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||10498||10498|15238| 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2883|4821|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2883||2883|4821| 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4645|9092|vetalmen|||0|10|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||||4645|9092| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4164|6573|lyfalmen|||02|100|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||4164||4164|6573| 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1051|2315|lyfalmen|||00|50|0|8,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||1051||1051|2315| 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3299|5390|lyfalmen|||00|100|0|33,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3299||3299|5390| 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|613|1716|lyfalmen|||04|10|0|4,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||613||613|1716| 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|931|2151|lyfalmen|||00|20|0|2,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||931||931|2151| 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3548|5731|lyfalmen|||00|100|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3548||3548|5731| 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2294|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2294| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|419|1450|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||419||419|1450| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|527|1598|lyfalmen|V0167|1598|00|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||527||527|1598| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1094|2374|lyfalmen|V0169|2374|00|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1094||1094|2374| 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Icepharma hf|Bioglan AB|Klórhexidín|||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|881|2082|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||881||881|2082| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1495|2922|lyfalmen|||03|2|0|35,0000|Vistor hf|Schering-Plough|Betametasón||1495||1495|2922| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|18636|25667|lyfalmen|||00|56|0|14,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||18636||18636|25667| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|19880|27228|lyfalmen|||00|56|0|28,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||19880||19880|27228| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|29361|39127|lyfalmen|||00|56|0|42,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||29361||29361|39127| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|29917|39825|lyfalmen|||00|56|0|56,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||29917||29917|39825| 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|881|2082|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||881||881|2082| 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5253|lyfalmen|||67|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||3199||3199|5253| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3217|5278|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3217||3217|5278| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3280|5364|lyfalmen|||00|100|0|25,0000|Vistor hf|Amdipharm Ltd|Maprótilín||3280||3280|5364| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|33944|44482|lyfsjukr|||00|1|0|27,9851|Vistor hf|Ferring|Triptórelín||33944||33944|44482| 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2478|4267|lyfalmen|||20|50|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2478||2478|4267| 504191|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2442|4218|lyfalmen|||00|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2442||2442|4218| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1276|2623|lyfalmen|||00|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1276||1276|2623| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|9023|13220|lyfalmen|||00|100|0|75,0000|Vistor hf|Amdipharm Ltd|Maprótilín||9023||9023|13220| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3632|5242|lyfsjukr|||02|5|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||3632||3632|5242| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|7070|10204|lyfsjukr|||02|10|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||7070||7070|10204| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|10902|15565|lyfsjukr|||02|25|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||10902||10902|15565| 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|31835|41835|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Ísóflúran||31835||31835|41835| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2692|4560|lyfalmen|||10|100|0|50,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||2692||2692|4560| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|440|1479|lyfalmen|||10|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||440||440|1479| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1263| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5369| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|9990|17427|vetorma|||13|1000|0|0,0000|Icepharma hf|Intervet International B.V.|||9990||9990|17427| 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2763|5478|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||2763||2763|5478| 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2810|4721|lyfalmen|||10|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2810||2810|4721| 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5616|10956|vetalmen|||0|100|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||||5616|10956| 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4504|8821|vetalmen|||0|50|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||4504||4504|8821| 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|13934|26928|vetalmen|||0|100|0|0,0000|Vistor hf|Bayer Animal Health GmbH|||13934||13934|26928| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|10969|15882|lyfalmen|||02|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||10969||10969|15882| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2900| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|48860|63202|lyfsjukr|||00|60|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín og lamívúdín||48860||48860|63202| 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|14442|20007|lyfsjukr|||00|2|0|6,0000|Icepharma hf|Roche|Epóetín||14442||14442|20007| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|26274|34856|lyfsjukr|||00|2|0|12,0000|Icepharma hf|Roche|Epóetín||26274||26274|34856| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|33719|44200|lyfsjukr|||00|2|0|18,0000|Icepharma hf|Roche|Epóetín||33719||33719|44200| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|55319|71308|lyfsjukr|||00|2|0|30,0000|Icepharma hf|Roche|Epóetín||55319||55319|71308| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|107189|136405|lyfsjukr|||00|4|0|60,0000|Icepharma hf|Roche|Epóetín||107189||107189|136405| 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|270112|340873|lyfsjukr|||00|4|0|120,0000|Icepharma hf|Roche|Epóetín||270112||270112|340873| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4576|5869|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||3649||3649|5869| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3133|5163|lyfalmen|||00|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3133||3133|5163| 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2958|4924|lyfalmen|V0385|4825|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2958||2958|4924| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|23326|31157|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||23326||23326|31157| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14592|20195|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14592||14592|20195| 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|10450|14997|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||10450||10450|14997| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2190|3873|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2190||2190|3873| 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2307|4033|lyfalmen|||00|20|0|10,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2307||2307|4033| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|4855|7519|lyfalmen|||00|60|0|30,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4855||4855|7519| 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2015|3634|lyfalmen|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||2015||2015|3634| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4332|6803|lyfalmen|||00|90|0|11,2500|Vistor hf|Novo-Nordisk|Repaglíníð||4332||4332|6803| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|5084|7832|lyfalmen|||00|90|0|22,5000|Vistor hf|Novo-Nordisk|Repaglíníð||5084||5084|7832| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|6254|9432|lyfalmen|||00|90|0|45,0000|Vistor hf|Novo-Nordisk|Repaglíníð||6254||6254|9432| 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1008|2256|lyfalmen|||00|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||1008||1008|2256| 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3716|5961|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3716||3716|5961| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2291|4011|lyfalmen|||23|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2291||2291|4011| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1105|2389|lyfalmen|||08|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1105||1105|2389| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|9093|13316|lyfalmen|||02|2|0|5,7222|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||9093||9093|13316| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5289|8112|lyfalmen|V0096|7967|00|4|0|2,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5289||5289|8112| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5973|9048|lyfalmen|V0097|8884|00|4|0|4,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5973||5973|9048| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|16831|23402|lyfalmen|||00|12|0|12,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||16831||16831|23402| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6406|9640|lyfalmen|V0098|9639|00|4|0|8,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||6406||6406|9640| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17725|24524|lyfalmen|V0099|24523|00|12|0|24,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||17725||17725|24524| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1355|2731|lyfalmen|V0308|2683|00|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||1355||1355|2731| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2163|3836|lyfalmen|V0310|3798|00|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||2163||2163|3836| 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|446|1487|lyfalmen|||00|30|0|8,7500|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||446||446|1487| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|35232|46495|lyfalmen|V2030|34973|00|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||35232||35232|46495| 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12522|lyfsjukr|||00|100|1|0,0000|Distica|Distica - óskráð lyf|||8676||8676|12522| 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8779|17030|vetalmen|||16|320|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||8779||8779|17030| 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3649|5869|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||3649||3649|5869| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|291912|368232|lyfsjukr|||00|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||291912||291912|368232| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|487|1543|lyfalmen|||00|20|0|3,3300|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||487||487|1543| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|847|2036|lyfalmen|||00|100|0|16,6700|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||847||847|2036| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|10699|15513|lyfalmen|||00|250|0|208,3333|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||10699||10699|15513| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|946|2171|lyfalmen|V0732|2171|02|10|0|1,6667|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||946||946|2171| 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9766|14237|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||9766||9766|14237| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|444|1485|lyfalmen|||00|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||444||444|1485| 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1293| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1323|2687|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1323||1323|2687| 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|26222|35188|lyfalmen|||00|84|0|28,0000|Vistor hf|Schering-Plough|Flútamíð||26222||26222|35188| 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1121|2411|lyfalmen|||43|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1121||1121|2411| 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2848|4773|lyfalmen|||43|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2848||2848|4773| 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1193| 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1171| 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|1223|2550|lyfalmen|||00|100|0|29,2000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||1223||1223|2550| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1110|2396|lyfalmen|||00|15|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1110||1110|2396| 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2973|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|2973| 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7861|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7861| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|11116|16083|lyfalmen|||00|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||11116||11116|16083| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|8013|11839|lyfalmen|||00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||8013||8013|11839| 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4557|7111|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4557||4557|7111| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|7322|14232|vetalmen|||16|188|0|0,0000|Vistor hf|Intervet International BV|||7322||7322|14232| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3898|6210|lyfalmen|||10|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3898||3898|6210| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|16254|22281|lyfsjukr|||00|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||16254||16254|22281| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1304|2661|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Emedastín||1304||1304|2661| 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2107|3041|lyfsjukr|||00|7|0|1,7500|Vistor hf|Schering-Plough|Búprenorfín||2107||2107|3041| 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4698|9193|vetalmen|||16|72|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||4698||4698|9193| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4047|7943|vetalmen|||16|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||4047||4047|7943| 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5388|7776|lyfsjukr|||00|7|0|7,0000|Vistor hf|Schering-Plough|Búprenorfín||5388||5388|7776| 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|79259|101353|lyfsjukr|||00|100|0|11,1000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Fosfenýtóín||79259||79259|101353| 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|11659|16515|lyfsjukr|||00|1|0|0,0000|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||11659||11659|16515| 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|63229|81235|lyfsjukr|||00|6|0|0,0000|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||63229||63229|81235| 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3406|5536|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3406||3406|5536| 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2982|4956|lyfalmen|||43|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2982||2982|4956| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|9953|14365|lyfsjukr|||00|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||9953||9953|14365| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|891|2096|lyfalmen|||01|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||891||891|2096| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|348|1353|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||348||348|1353| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1008|2256|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1008||1008|2256| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|279|1259|lyfalmen|||00|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||279||279|1259| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1776|3307|lyfalmen|||00|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1776||1776|3307| 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2013|3631|lyfalmen|||43|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2013||2013|3631| 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|Bioglan Pharma AB|Dísúlfíram í blöndum|||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6845|10241|lyfalmen|||00|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6845||6845|10241| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|460|1507|lyfalmen|||06|10|0|25,0000|K.Pétursson hf|Alcon|Pílókarpín||460||460|1507| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|586|1679|lyfalmen|||06|10|0|25,0000|K.Pétursson hf|Alcon|Pílókarpín||586||586|1679| 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|17175|23834|lyfalmen|||52|100|0|12,5000|Vistor hf|Meda AS|Brómókriptín||17175||17175|23834| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||694| 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2449| 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|150276|190479|lyfsjukr|||00|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||150276||150276|190479| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|11338|16387|lyfalmen|||00|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||11338||11338|16387| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|192|1140|lyfalmen|||00|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||192||192|1140| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|419|1450|lyfalmen|||00|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||419||419|1450| 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2794|4699|lyfalmen|||23|40|0|8,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2794||2794|4699| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|3062|5066|lyfalmen|||00|250|0|250,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||3062||3062|5066| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|6446|9695|lyfalmen|||06|15|0|0,0000|Icepharma hf|M.S.D.|Tímólól í blöndum||6446||6446|9695| 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2132|3794|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2132||2132|3794| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|10444|15164|lyfalmen|||10|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||10444||10444|15164| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|16918|23511|lyfalmen|||10|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||16918||16918|23511| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1644|3126|lyfalmen|||10|28|0|28,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1644||1644|3126| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1817|3363|lyfalmen|||00|100|1|100,0000|Parlogis hf|Parlogis - óskráð lyf|||1817||1817|3363| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4834|7490|lyfalmen|||00|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||4834||4834|7490| 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|2,5000|Actavis Group hf|Actavis hf|Dífenhýdramín í blöndum|||||| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|9,3750|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|MSE|0|0|0|100|SEK|27808|37178|lyfalmen|||00|10|0|5,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||27808||27808|37178| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|747|1899|lyfalmen|||00|15|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||747||747|1899| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1307|2665|lyfalmen|||00|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1307||1307|2665| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3475|5631|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||3475||3475|5631| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|33197|43941|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||33197||33197|43941| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|26765|35869|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||26765||26765|35869| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|33393|44187|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||33393||33393|44187| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|28369|37882|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||28369||28369|37882| 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1590|lyfalmen|||10|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||521||521|1590| 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|9072|13287|lyfalmen|||00|56|1|37,3333|Parlogis hf|Parlogis - óskráð lyf|||9072||9072|13287| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4690| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10434|14977|lyfsjukr|||00|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||10434||10434|14977| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3438|4962|lyfsjukr|||00|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3438||3438|4962| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|9415|13756|lyfalmen|||63|0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||9415||9415|13756| 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4836|7493|lyfalmen|||63|0|0|0,6667|Vistor hf|N.V. Organon|Follitrópín beta||4836||4836|7493| 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|17946|24801|lyfalmen|||00|98|0|98,0000|Vistor hf|Abbott Laboratories A/S|Sibutramin||17946||17946|24801| 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|17946|24801|lyfalmen|||00|98|0|147,0000|Vistor hf|Abbott Laboratories A/S|Sibutramin||17946||17946|24801| 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2305|3327|lyfsjukr|||03|10|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2305||2305|3327| 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|6406|9640|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|||6406||6406|9640| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|17485|24223|lyfalmen|||00|84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|||17485||17485|24223| 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001|31.01.2010|R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|45066|58837|lyfalmen|||00|28|0|168,0000|Vistor hf|Sanofi-aventis Norge AS|||45066||45066|58837| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|113942|144880|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||113942||113942|144880| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9487|13855|lyfalmen|||02|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9487||9487|13855| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|162521|205846|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||162521||162521|205846| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2178|3857|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefna­vakar||2178||2178|3857| 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4,0000|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||1490| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0,4800|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0,4167|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|10972|15886|lyfalmen|||00|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10972||10972|15886| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1828|3378|lyfalmen|||03|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1828||1828|3378| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|4169|6580|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4169||4169|6580| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2115|lyfalmen|||00|20|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||905||905|2115| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2157|2411|lyfalmen|||00|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1121||1121|2411| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|4398|lyfalmen|||00|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||2574||2574|4398| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2720|4598|lyfalmen|||00|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||2720||2720|4598| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|4233|2214|lyfalmen|||00|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||977||977|2214| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7916|4790|lyfalmen|||00|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||2860||2860|4790| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BAV|0|0|0|100|SEK|4299|6758|lyfalmen|||63|100|0|66,6667|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||4299||4299|6758| 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|659|1779|lyfalmen|||00|10|0|7,5000|Actavis Group hf|Actavis Group hf|Díklófenak||659||659|1779| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|5031|7759|lyfalmen|||00|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5031||5031|7759| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3838|6127|lyfalmen|||00|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3838||3838|6127| 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3810|6089|lyfalmen|||00|50|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3810||3810|6089| 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PFI|0|0|0|100|DKK|13183|18824|lyfalmen|||00|18|0|18,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||||13183|18824| 553313|N02CC0601|Relpax|filmhtfl|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2616|4456|lyfalmen|||00|3|0|3,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||2616||2616|4456| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4508|7044|lyfalmen|||00|6|0|6,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||4508||4508|7044| 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7958|15453|vetalmen|||27|500|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||7958||7958|15453| 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3468|5005|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3468||3468|5005| 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|6672|9629|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Kolvetni||6672||6672|9629| 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5658|8166|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||5658||5658|8166| 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4168|6015|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4168||4168|6015| 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3875|5593|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3875||3875|5593| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5355|8203|lyfalmen|||00|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5355||5355|8203| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7388|10984|lyfalmen|||00|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7388||7388|10984| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|10440|15159|lyfalmen|||00|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||10440||10440|15159| 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1752|3274|lyfalmen|||38|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1752||1752|3274| 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|182359|230743|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Schering AG|Gadópentetat||182359||182359|230743| 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1075|2348|lyfalmen|||10|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1075||1075|2348| 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2134|3796|lyfalmen|||10|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2134||2134|3796| 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1077|2351|lyfalmen|||10|100|0|16,6667|Icepharma hf|Grunenthal|Tramadól||1077||1077|2351| 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|644|1758|lyfalmen|V0730|1278|10|20|0|3,3333|Icepharma hf|Grunenthal|Tramadól||644||644|1758| 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1797|3335|lyfalmen|||04|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||1797||1797|3335| 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1033|2290|lyfalmen|V0732|2171|02|10|0|1,6667|Icepharma hf|Grunenthal|Tramadól||1033||1033|2290| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2661|4517|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2661||2661|4517| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6287|9478|lyfalmen|||23|1|0|90,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estradíól||6287||6287|9478| 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3163|5204|lyfalmen|||23|30|0|30,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3163||3163|5204| 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3493|5655|lyfalmen|||23|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3493||3493|5655| 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|SEK|16472|22555|lyfsjukr|||00|240|0|0,0000|Icepharma hf|Baxter|Desflúran||16472||16472|22555| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1363| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3108|5129|lyfalmen|||00|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3108||3108|5129| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2,0000|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1773|3303|lyfalmen|||07|4|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1773||1773|3303| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5924|8981|lyfalmen|||00|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5924||5924|8981| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6424|9665|lyfalmen|||00|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6424||6424|9665| 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|110081|140034|lyfsjukr|||00|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||110081||110081|140034| 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|626676|593202|lyfsjukr|||00|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||471171||471171|593202| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2666|4524|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2666||2666|4524| 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|36581|48188|lyfalmen|||00|250|0|250,0000|Vistor hf|N.V. Organon|Mirtazapín||36581||36581|48188| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|27337|36587|lyfalmen|||02|6|0|17,1667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||27337||27337|36587| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|42083|55093|lyfalmen|||02|10|0|28,6111|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||42083||42083|55093| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|691|1822|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||691||691|1822| 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995|28.02.2010|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2247|3951|lyfalmen|||20|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2247||2247|3951| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A||0|0|B|0|GSK|0|0|1|100|GBP|691|1822|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||691||691|1822| 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995|28.02.2010|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2247|3951|lyfalmen|||20|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2247||2247|3951| 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1780|3312|lyfalmen|||10|100|0|5,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1780||1780|3312| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|226068|285994|lyfalmen|||02|60|0|171,6667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||226068||226068|285994| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5207|8000|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5207||5207|8000| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5485|8380|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5485||5485|8380| 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9698|14144|lyfalmen|||00|98|0|32,6667|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||9698||9698|14144| 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|12279|17689|lyfalmen|||00|98|0|65,3400|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||12279||12279|17689| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|166714|211109|lyfsjukr|||00|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||166714||166714|211109| 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|5678|8644|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||5678||5678|8644| 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|8521|12534|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|||8521||8521|12534| 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|1507|2939|lyfalmen|||00|28|1|4,6667|Parlogis hf|Parlogis - óskráð lyf|||1507||1507|2939| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|12685|18199|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||12685||12685|18199| 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995|28.02.2010|R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2888|lyfalmen|||00|14|0|7,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1470||1470|2888| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1456|2869|lyfalmen|||06|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíð||1456||1456|2869| 566661|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|81067|103622|lyfsjukr|||00|100|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||81067||81067|103622| 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|6349|9562|lyfalmen|V0556|4297|10|4|0|3,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||6349||6349|9562| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|2354|4097|lyfalmen|||00|100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2354||2354|4097| 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8118|11982|lyfalmen|||00|56|0|37,3333|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||||8118|11982| 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6428|9670|lyfalmen|||00|28|0|37,3333|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||6428||6428|9670| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6497|9765|lyfalmen|V0791|4103|00|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6497||6497|9765| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|14988|21089|lyfalmen|V0793|7294|00|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||14988||14988|21089| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|24911|33542|lyfalmen|V0794|11833|00|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||24911||24911|33542| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|33007|43703|lyfalmen|V0795|18555|00|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||33007||33007|43703| 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||24|15|0|12,5000|Vistor hf|Janssen-Cilag AB|Levókabastín|||||| 567636|N05BA1205|Alprazolam Mylan|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|647|1762|lyfalmen|V0857|1762|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||647|1762| 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|16169|10230|lyfalmen|||00|120|0|120,0000|Vistor hf|Eisai Ltd|Rabeprazól||6837||6837|10230| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1111|2397|lyfalmen|||00|3|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1111||1111|2397| 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1546|lyfalmen|||04|10|0|3,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1546| 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2879|lyfalmen|V0316|2879|10|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2879| 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|4048|lyfalmen|V0324|4048|10|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2318||2318|4048| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|19531|26394|lyfsjukr|||02|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||19531||19531|26394| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|19531|26394|lyfsjukr|||02|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||19531||19531|26394| 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2523|4329|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2523||2523|4329| 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998|31.01.2010|R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3799|6074|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3799||3799|6074| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|148905|188758|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||148905||148905|188758| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|194908|246492|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||194908||194908|246492| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|366671|462055|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||366671||366671|462055| 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4050|6417|lyfalmen|||23|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||4050||4050|6417| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|106876|136012|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Roche|Trastuzumab||106876||106876|136012| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|31562|41493|lyfsjukr|||00|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||31562||31562|41493| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|61772|79406|lyfsjukr|||00|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||61772||61772|79406| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2557|lyfalmen|V0610|2501|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2557| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|3258|3713|lyfalmen|V0931|2268|00|28|0|28,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||2073||2073|3713| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|8464|10129|lyfalmen|V0933|5003|00|98|0|98,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||6763||6763|10129| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|6774|5628|lyfalmen|V0935|3303|00|28|0|56,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||3473||3473|5628| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|15079|16514|lyfalmen|V0937|7851|00|98|0|196,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||11431||11431|16514| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|16720|22866|lyfsjukr|||00|12|0|0,0000|Vistor hf|Sanofi - Aventis|Adenósín||16720||16720|22866| 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|98449|125436|lyfsjukr|||00|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||98449||98449|125436| 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3365|5480|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||3365||3365|5480| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1310|2669|lyfalmen|||02|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1310||1310|2669| 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|DKK|775|1937|lyfalmen|||00|30|0|30,0000|Icepharma hf|Wyeth AB|Metótrexat||775||775|1937| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|33680|44151|lyfsjukr|||02|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||33680||33680|44151| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|67057|86039|lyfsjukr|||02|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||67057||67057|86039| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|128512|163165|lyfsjukr|||02|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||128512||128512|163165| 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|1,8750|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5455|9516|vetorma|||16|50|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5455||5455|9516| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|20554|35855|vetorma|||16|200|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||20554||20554|35855| 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|61248|78749|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||61248||61248|78749| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|156007|197671|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||156007||156007|197671| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|816|1993|lyfalmen|||00|28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||816||816|1993| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|66423|85243|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||66423||66423|85243| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|123152|156438|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||123152||123152|156438| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1188|2502|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Merck NM AB|Sótalól||1188||1188|2502| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|183846|232609|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||183846||183846|232609| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|75184|96238|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||75184||75184|96238| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|147639|187169|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||147639||147639|187169| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|199495|252249|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||199495||199495|252249| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4176|6027|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||4176||4176|6027| 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2174|3138|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2174||2174|3138| 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|8029|11588|lyfsjukr|||00|1500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||8029||8029|11588| 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6587|9507|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Kolvetni||6587||6587|9507| 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3200|4618|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3200||3200|4618| 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9146|13200|lyfsjukr|||00|3000|0|3,0000|Icepharma hf|Fresenius Kabi|Kolvetni||9146||9146|13200| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3619|5223|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3619||3619|5223| 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4313|6225|lyfsjukr|||00|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4313||4313|6225| 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2439|3520|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2439||2439|3520| 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|3000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4088|6469|lyfalmen|||64|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíð||4088||4088|6469| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10918|15585|lyfsjukr|||02|20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10918||10918|15585| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3977|5740|lyfsjukr|||02|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3977||3977|5740| 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|39045|50884|lyfsjukr|||00|12|0|3,0000|Icepharma hf|M.S.D.|Imipenem og ensímhemill||39045||39045|50884| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3689|5924|lyfalmen|||02|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3689||3689|5924| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|37867|49802|lyfalmen|||00|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||37867||37867|49802| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2878|4814|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2878||2878|4814| 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3389|4891|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3389||3389|4891| 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1643|3125|lyfalmen|||06|5|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1643||1643|3125| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2401|4162|lyfalmen|V0426|4093|43|20|0|5,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2401||2401|4162| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|14496|20472|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||14496||14496|20472| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9611|14025|lyfalmen|||23|2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9611||9611|14025| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6659|11616|vetorma|||16|3|0|0,0000|Icepharma hf|Pfizer Animal Health|||6659||6659|11616| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2581|4502|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||2581||2581|4502| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6425|11208|vetorma|||16|6|0|0,0000|Icepharma hf|Pfizer Animal Health|||6425||6425|11208| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3470|6053|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||3470||3470|6053| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3604|6287|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||3604||3604|6287| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2792|4871|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||2792||2792|4871| 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4387|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4387| 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8374|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8374| 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|164436|208250|lyfsjukr|||00|250|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||164436||164436|208250| 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|93970|119815|lyfsjukr|||00|336|0|28,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||93970||93970|119815| 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|Vistor hf|Bayer A/S|Klótrímazól|||||| 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyflausa|||00|15|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Ýmis lyf|||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2798|lyfalmen|V0139|2798|10|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1404||1404|2798| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|29020|38699|lyfalmen|||02|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||29020||29020|38699| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|214011|270466|lyfsjukr|||00|1|0|1,2500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||214011||214011|270466| 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3561|5139|lyfsjukr|||02|12|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Tíópentalnatríum||3561||3561|5139| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|1,6000|Actavis Group hf|Actavis hf|Paracetamól|||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|566|1652|lyfalmen|||00|50|0|3,1250|Icepharma hf|Roche|Klónazepam||566||566|1652| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|982|2221|lyfalmen|||00|150|0|9,3750|Icepharma hf|Roche|Klónazepam||982||982|2221| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1463|2879|lyfalmen|||00|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1463||1463|2879| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|21432|29176|lyfalmen|||03|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||21432||21432|29176| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||645| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5369| 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3124|4509|lyfsjukr|||02|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3124||3124|4509| 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1121|2230|vetalmen|||27|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1121||1121|2230| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|9535|13761|lyfsjukr|||02|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9535||9535|13761| 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|629|1738|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||629||629|1738| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4254|6697|lyfalmen|||43|24|0|3,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||4254||4254|6697| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1094|2374|lyfalmen|||00|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||1094||1094|2374| 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|LDR|0|0|0|100|DKK|1458|2872|lyfalmen|||00|20|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||1458||1458|2872| 908048|J07AM5201|Tetagam P/Tetanogamma P|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|19419|26650|lyfalmen|||00|1|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||19419||19419|26650| 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|SEK|4871|7541|lyfalmen|||00|50|1|25,0000|Distica|Distica - óskráð lyf|||4871||4871|7541| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|SEK|2696|4565|lyfalmen|||00|100|1|33,3333|Distica|Distica - óskráð lyf|||2696||2696|4565| 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|DKK|3053|4406|lyfsjukr|||00|4|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||3053||3053|4406| 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1534|lyfalmen|||00|4|1|0,0000|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||480||480|1534| 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6978|lyfalmen|||00|100|1|100,0000|Distica|Distica - óskráð lyf|||4460||4460|6978| 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|12095|17458|lyfalmen|||00|20|1|200,0000|Distica|Distica - óskráð lyf|||12095||12095|17458| 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3296|lyfalmen|||00|180|1|15,0300|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3296| 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2064|2979|lyfsjukr|||02|10|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Epínefrín (adrenalín)||2064||2064|2979| 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|11317|16358|lyfalmen|||00|100|1|160,0000|Parlogis hf|Parlogis - óskráð lyf|||11317||11317|16358| 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|2403|4164|lyfalmen|||00|11|1|4,4000|Parlogis hf|Parlogis - óskráð lyf|||2403||2403|4164| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|4731|7349|lyfalmen|||00|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|||4731||4731|7349| 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4984|lyfalmen|||00|10|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4984| 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|44432|58041|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||44432||44432|58041| 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6446|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||4071||4071|6446| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|GBP|9990|14543|lyfalmen|||00|100|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||9990||9990|14543| 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|GBP|10832|15695|lyfalmen|||00|10|1|100,0000|Distica|Distica - óskráð lyf|||10832||10832|15695| 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2245|3948|lyfalmen|||00|1|1|83,3300|Distica|Distica - óskráð lyf|Estradíól||2245||2245|3948| 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4490|7019|lyfalmen|||00|1|1|166,6700|Distica|Distica - óskráð lyf|Estradíól||4490||4490|7019| 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|8395|12361|lyfalmen|||00|1|1|333,3300|Distica|Distica - óskráð lyf|Estradíól||8395||8395|12361| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|2938|4896|lyfalmen|||00|1|1|1,3900|Distica|Distica - óskráð lyf|Testósterón||2938||2938|4896| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5186|7971|lyfalmen|||00|100|1|13,3300|Distica|Distica - óskráð lyf|||5186||5186|7971| 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002|31.03.2010|R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2329|lyfalmen|||00|1|1|8,3330|Distica|Distica - óskráð lyf|Testósterón||1061||1061|2329| 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1345|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||342||342|1345| 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1044|lyfalmen|||00|28|1|2,8000|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1044| 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1345|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||342||342|1345| 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|GBP|18364|24929|lyfsjukr|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||18364||18364|24929| 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1533|2974|lyfalmen|||00|20|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||1533||1533|2974| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|4014|lyfalmen|||00|10|1|10,0000|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|4014| 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|3009|lyfalmen|||00|50|1|25,0000|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|3009| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5033|7762|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|||5033||5033|7762| 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12855|lyfalmen|||00|50|1|133,3300|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12855| 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1673|lyfalmen|||00|20|1|1,5625|Parlogis hf|Parlogis - óskráð lyf|||582||582|1673| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3710|lyfalmen|||00|100|1|33,3300|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3710| 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2363|4110|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|||2363||2363|4110| 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1436|2073|lyfsjukr|||55|10|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||1436||1436|2073| 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|838|2024|lyfalmen|||00|21|1|21,0000|Parlogis hf|Parlogis - óskráð lyf|||838||838|2024| 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|5818|8397|lyfsjukr|||00|10|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|||5818||5818|8397| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4851|7513|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Hýdrókortisón||||4851|7513| 952251|J01CA0101|Ampicillin|sts|500|mg|10|hgl|1|pakki||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6355|lyfsjukr|||00|5000|1|2,5000|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6355| 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|8143|12016|lyfalmen|||00|12|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||8143||8143|12016| 952929|A03AA0403|Duspatalin|töflur|135|mg|100|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5186|7971|lyfalmen|||00|100|1|45,0000|Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||5186|7971| 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1273|lyfalmen|||00|5|1|1,0000|Parlogis hf|Parlogis - óskráð lyf|||289||289|1273| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3435|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráð lyf|Fúrósemíð||||1870|3435| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8661|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráð lyf|Própranólól||||5690|8661| 954645|N03AB0207|Phenytoin|mixtúra|25|mg/ml|237|ml|1|glas||N03AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2953|4917|lyfalmen|||00|237|1||Parlogis hf|Parlogis - óskráð lyf|Fenýtóín||||2953|4917| 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1631|lyfalmen|||00|25|1|12,5000|Parlogis hf|Parlogis - óskráð lyf|||551||551|1631| 955578|A03AA0403|Duspatalin|töflur|135|mg|50|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2593|4424|lyfalmen|||00|50|1|22,5000|Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||2593|4424| 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|848|2037|lyfalmen|||00|10|1|2,5000|Parlogis hf|Parlogis - óskráð lyf|||848||848|2037| 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|17077|lyfsjukr|||00|10|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|17077| 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3740|lyfalmen|||00|238|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3740| 959132|J01XE0103|Nitrofurantoin|mixtúra|5|mg/ml|300|ml|1|glas||J01XE01|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|23718|32045|lyfalmen|||00|300|1||Parlogis hf|Parlogis - óskráð lyf|Nítrófúrantóín||||23718|32045| 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|DKK|18814|25494|lyfsjukr|||00|30|1|112,0000|Distica|Distica - óskráð lyf|||18814||18814|25494| 961202|A03AA0405|Mebeverine|töflur|135|mg|100|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|GBP|1591|3054|lyfalmen|||00||1||Distica|Distica - óskráð lyf|Mebeverín||||1591|3054| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2471|4257|lyfalmen|||00|20|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|||2471||2471|4257| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2150|3818|lyfalmen|||00|20|1||Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||||2150|3818| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5051|7787|lyfalmen|||00|25|1|16,7000|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||5051||5051|7787| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5598|lyfalmen|||00|100|1|266,6600|Parlogis hf|Parlogis - óskráð lyf|||||3451|5598| 962523|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|10|fl||B05BB01|01.05.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|11181|15915|lyfsjukr|||0|1000|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||11181||11181|15915| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|þpakki||R06AB02|01.11.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2936|4894|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|||2936||2936|4894|